S8106171B2	NNP	O
-	:	O
Nel-related	JJ	O
type	NN	O
1	CD	O
polypeptide	NN	O
-	:	O
Google	NN	O
Patents	NNS	O
Info	NNP	O
Links	NNP	O
Images	NNP	O
Classifications	NNP	O
Abstract	NNP	O
Description	NNP	O
CROSS-REFERENCE	NNP	O
TO	NNP	O
RELATED	NNP	O
APPLICATIONS	NNP	O
This	DT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
12/510,074,	,	O
filed	VBN	O
Jul.	.	O
27,	,	O
2009	CD	O
(allowed);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
11/774,330,	,	O
filed	VBN	O
Jul.	.	O
6,	,	O
2007	CD	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
7,592,438);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Continuation	NN	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
10/781,841,	,	O
filed	VBD	O
Feb.	NNP	O
20,	,	O
2004	CD	O
(abandoned);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
10/342,276,	,	O
filed	VBD	O
Jan.	NNP	O
15,	,	O
2003	CD	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
7,420,048);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
09/976,165,	,	O
filed	VBN	O
Oct.	NNP	O
15,	,	O
2001	CD	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
6,562,947);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
09/565,538,	,	O
filed	VBD	O
May	NNP	O
5,	,	O
2000	CD	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
6,333,404);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
09/273,565,	,	O
filed	VBN	O
Mar.	.	O
22,	,	O
1999	CD	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
6,166,190);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
09/055,699,	,	O
filed	VBN	O
Apr.	.	O
7,	,	O
1998	CD	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
6,005,088);	:	O
which	WDT	O
is	VBZ	O
a	DT	O
Divisional	NNP	O
of	IN	O
U.S.	NNP	O
application	NN	O
Ser.	.	O
No.	.	O
08/820,170,	,	O
filed	VBN	O
Mar.	.	O
19,	,	O
1997	CD	O
(U.S.	NNP	O
Pat.	.	O
No.	.	O
5,831,058);	:	O
the	DT	O
disclosure	NN	O
of	IN	O
each	DT	O
of	IN	O
which	WDT	O
is	VBZ	O
incorporated	VBN	O
herein	NN	O
by	IN	O
reference.	.	O
TECHNICAL	NNP	O
FIELD	NNP	O
The	DT	O
present	JJ	O
invention	NN	O
relates	VBZ	O
to	TO	O
a	DT	O
gene	NN	O
useful	JJ	O
as	IN	O
an	DT	O
indicator	NN	O
in	IN	O
the	DT	O
prophylaxis,	,	O
diagnosis	NN	O
and	CC	O
treatment	NN	O
of	IN	O
diseases	NNS	O
in	IN	O
humans.	.	O
More	RBR	O
particularly,	,	O
it	PRP	O
relates	VBZ	O
to	TO	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
analogous	JJ	O
to	TO	O
rat,	,	O
mouse,	,	O
yeast,	,	O
nematode	NN	O
and	CC	O
known	VBN	O
human	JJ	O
genes,	,	O
among	IN	O
others,	,	O
and	CC	O
utilizable,	,	O
after	IN	O
cDNA	NN	O
analysis	NN	O
thereof,	,	O
chromosome	NN	O
mapping	NN	O
of	IN	O
cDNA	NN	O
and	CC	O
function	NN	O
analysis	NN	O
of	IN	O
cDNA,	,	O
in	IN	O
gene	NN	O
diagnosis	NN	O
using	VBG	O
said	VBD	O
gene	NN	O
and	CC	O
in	IN	O
developing	VBG	O
a	DT	O
novel	JJ	O
therapeutic	JJ	O
method.	.	O
BACKGROUND	NNP	O
ART	NNP	O
The	DT	O
genetic	JJ	O
information	NN	O
of	IN	O
a	DT	O
living	JJ	O
thing	NN	O
has	VBZ	O
been	VBN	O
accumulated	VBN	O
as	IN	O
sequences	NNS	O
(DNA)	)	O
of	IN	O
four	CD	O
bases,	,	O
namely	RB	O
A,	,	O
C,	,	O
G	NNP	O
and	CC	O
T,	,	O
which	WDT	O
exist	VBP	O
in	IN	O
cell	NN	O
nuclei.	.	O
Said	NNP	O
genetic	JJ	O
information	NN	O
has	VBZ	O
been	VBN	O
preserved	VBN	O
for	IN	O
line	NN	O
preservation	NN	O
and	CC	O
ontogeny	NN	O
of	IN	O
each	DT	O
individual	JJ	O
living	NN	O
thing.	.	O
In	IN	O
the	DT	O
case	NN	O
of	IN	O
human	JJ	O
being,	,	O
the	DT	O
number	NN	O
of	IN	O
said	VBD	O
bases	NNS	O
is	VBZ	O
said	VBD	O
to	TO	O
be	VB	O
about	RB	O
3	CD	O
billion	CD	O
(3×109)	)	O
and	CC	O
supposedly	RB	O
there	EX	O
are	VBP	O
50	CD	O
to	TO	O
100	CD	O
thousand	NN	O
genes	NNS	O
therein.	.	O
Such	JJ	O
genetic	JJ	O
information	NN	O
serves	NNS	O
to	TO	O
maintain	VB	O
biological	JJ	O
phenomena	NNS	O
in	IN	O
that	DT	O
regulatory	JJ	O
proteins,	,	O
structural	JJ	O
proteins	NNS	O
and	CC	O
enzymes	NNS	O
are	VBP	O
produced	VBN	O
via	IN	O
such	JJ	O
route	NN	O
that	IN	O
mRNA	NN	O
is	VBZ	O
transcribed	VBN	O
from	IN	O
a	DT	O
gene	NN	O
(DNA)	)	O
and	CC	O
then	RB	O
translated	VBD	O
into	IN	O
a	DT	O
protein.	.	O
Abnormalities	NNS	O
in	IN	O
said	VBD	O
route	NN	O
from	IN	O
gene	NN	O
to	TO	O
protein	VB	O
translation	NN	O
are	VBP	O
considered	VBN	O
to	TO	O
be	VB	O
causative	JJ	O
of	IN	O
abnormalities	NNS	O
of	IN	O
life	NN	O
supporting	VBG	O
systems,	,	O
for	IN	O
example	NN	O
in	IN	O
cell	NN	O
proliferation	NN	O
and	CC	O
differentiation,	,	O
hence	RB	O
causative	NN	O
of	IN	O
various	JJ	O
diseases.	.	O
As	IN	O
a	DT	O
result	NN	O
of	IN	O
gene	NN	O
analyses	NNS	O
so	RB	O
far	RB	O
made,	,	O
a	DT	O
number	NN	O
of	IN	O
genes	NNS	O
which	WDT	O
may	MD	O
be	VB	O
expected	VBN	O
to	TO	O
serve	VB	O
as	IN	O
useful	JJ	O
materials	NNS	O
in	IN	O
drug	NN	O
development,	,	O
have	VBP	O
been	VBN	O
found,	,	O
for	IN	O
example	NN	O
genes	NNS	O
for	IN	O
various	JJ	O
receptors	NNS	O
such	JJ	O
as	IN	O
insulin	NN	O
receptor	NN	O
and	CC	O
LDL	NNP	O
receptor,	,	O
genes	NNS	O
involved	VBN	O
in	IN	O
cell	NN	O
proliferation	NN	O
and	CC	O
differentiation	NN	O
and	CC	O
genes	NNS	O
for	IN	O
metabolic	JJ	O
enzymes	NNS	O
such	JJ	O
as	IN	O
proteases,	,	O
ATPase	NNP	O
and	CC	O
superoxide	JJ	O
dismutases.	.	O
However,	,	O
analysis	NN	O
of	IN	O
human	JJ	O
genes	NNS	O
and	CC	O
studies	NNS	O
of	IN	O
the	DT	O
functions	NNS	O
of	IN	O
the	DT	O
genes	NNS	O
analyzed	VBD	O
and	CC	O
of	IN	O
the	DT	O
relations	NNS	O
between	IN	O
the	DT	O
genes	NNS	O
analyzed	VBN	O
and	CC	O
various	JJ	O
diseases	NNS	O
have	VBP	O
been	VBN	O
just	RB	O
begun	VBN	O
and	CC	O
many	JJ	O
points	NNS	O
remain	VBP	O
unknown.	.	O
Further	JJ	O
analysis	NN	O
of	IN	O
novel	JJ	O
genes,	,	O
analysis	NN	O
of	IN	O
the	DT	O
functions	NNS	O
thereof,	,	O
studies	NNS	O
of	IN	O
the	DT	O
relations	NNS	O
between	IN	O
the	DT	O
genes	NNS	O
analyzed	VBN	O
and	CC	O
diseases,	,	O
and	CC	O
studies	NNS	O
for	IN	O
applying	VBG	O
the	DT	O
genes	NNS	O
analyzed	VBN	O
to	TO	O
gene	NN	O
diagnosis	NN	O
or	CC	O
for	IN	O
medicinal	JJ	O
purposes,	,	O
for	IN	O
instance,	,	O
are	VBP	O
therefore	RB	O
desired	VBN	O
in	IN	O
the	DT	O
relevant	JJ	O
art.	.	O
If	IN	O
such	PDT	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
as	IN	O
mentioned	VBN	O
above	IN	O
can	MD	O
be	VB	O
provided,	,	O
it	PRP	O
will	MD	O
be	VB	O
possible	JJ	O
to	TO	O
analyze	VB	O
the	DT	O
level	NN	O
of	IN	O
expression	NN	O
thereof	NN	O
in	IN	O
each	DT	O
cell	NN	O
and	CC	O
the	DT	O
structure	NN	O
and	CC	O
function	NN	O
thereof	NN	O
and,	,	O
through	IN	O
expression	NN	O
product	NN	O
analysis	NN	O
and	CC	O
other	JJ	O
studies,	,	O
it	PRP	O
may	MD	O
become	VB	O
possible	JJ	O
to	TO	O
reveal	VB	O
the	DT	O
pathogenesis	NN	O
of	IN	O
a	DT	O
disease	NN	O
associated	VBN	O
therewith,	,	O
for	IN	O
example	NN	O
a	DT	O
genopathy	NN	O
or	CC	O
cancer,	,	O
or	CC	O
diagnose	VB	O
and	CC	O
treat	VB	O
said	VBD	O
disease,	,	O
for	IN	O
instance.	.	O
It	PRP	O
is	VBZ	O
an	DT	O
object	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
to	TO	O
provide	VB	O
such	PDT	O
a	DT	O
novel	JJ	O
human	JJ	O
gene.	.	O
For	IN	O
attaining	VBG	O
the	DT	O
above	NN	O
object,	,	O
the	DT	O
present	JJ	O
inventors	NNS	O
made	VBD	O
intensive	JJ	O
investigations	NNS	O
and	CC	O
obtained	VBD	O
the	DT	O
findings	NNS	O
mentioned	VBN	O
below.	.	O
Based	VBN	O
thereon,	,	O
the	DT	O
present	JJ	O
invention	NN	O
has	VBZ	O
now	RB	O
been	VBN	O
completed.	.	O
DISCLOSURE	NNP	O
OF	NNP	O
INVENTION	NNP	O
Thus,	,	O
the	DT	O
present	JJ	O
inventors	NNS	O
synthesized	VBD	O
cDNAs	NNS	O
based	VBN	O
on	IN	O
mRNAs	NN	O
extracted	VBN	O
from	IN	O
various	JJ	O
tissues,	,	O
inclusive	NN	O
of	IN	O
human	JJ	O
fetal	JJ	O
brain,	,	O
adult	NN	O
blood	NN	O
vessels	NNS	O
and	CC	O
placenta,	,	O
constructed	VBN	O
libraries	NNS	O
by	IN	O
inserting	VBG	O
them	PRP	O
into	IN	O
vectors,	,	O
allowing	VBG	O
colonies	NNS	O
of	IN	O
Escherichia	NNP	O
coli	NNS	O
transformed	VBD	O
with	IN	O
said	VBD	O
libraries	NNS	O
to	TO	O
form	VB	O
on	IN	O
agar	NN	O
medium,	,	O
picked	VBD	O
up	RP	O
colonies	NNS	O
at	IN	O
random	NN	O
and	CC	O
transferred	VBD	O
to	TO	O
96-well	CD	O
micro	NN	O
plates	NNS	O
and	CC	O
registered	VBD	O
a	DT	O
large	JJ	O
number	NN	O
of	IN	O
human	JJ	O
gene-containing	NN	O
E.	NNP	O
coli	NNS	O
clones.	.	O
Each	DT	O
clone	NN	O
thus	RB	O
registered	VBD	O
was	VBD	O
cultivated	VBN	O
on	IN	O
a	DT	O
small	JJ	O
size,	,	O
DNA	NNP	O
was	VBD	O
extracted	VBN	O
and	CC	O
purified,	,	O
the	DT	O
four	CD	O
base-specifically	RB	O
terminating	VBG	O
extension	NN	O
reactions	NNS	O
were	VBD	O
carried	VBN	O
out	RP	O
by	IN	O
the	DT	O
dideoxy	NN	O
chain	NN	O
terminator	NN	O
method	NN	O
using	VBG	O
the	DT	O
cDNA	NN	O
extracted	VBD	O
as	IN	O
a	DT	O
template,	,	O
and	CC	O
the	DT	O
base	JJ	O
sequence	NN	O
of	IN	O
the	DT	O
gene	NN	O
was	VBD	O
determined	VBN	O
over	IN	O
about	RB	O
400	CD	O
bases	NNS	O
from	IN	O
the	DT	O
5′	CD	O
terminus	NN	O
thereof	NN	O
using	VBG	O
an	DT	O
automatic	JJ	O
DNA	NN	O
sequencer.	.	O
Based	VBN	O
on	IN	O
the	DT	O
thus-obtained	JJ	O
base	NN	O
sequence	NN	O
information,	,	O
a	DT	O
novel	JJ	O
family	NN	O
gene	NN	O
analogous	JJ	O
to	TO	O
known	VB	O
genes	NNS	O
of	IN	O
animal	NN	O
and	CC	O
plant	NN	O
species	NNS	O
such	JJ	O
as	IN	O
bacteria,	,	O
yeasts,	,	O
nematodes,	,	O
mice	NN	O
and	CC	O
humans	NNS	O
was	VBD	O
searched	VBN	O
for.	.	O
The	DT	O
method	NN	O
of	IN	O
the	DT	O
above-mentioned	JJ	O
cDNA	NN	O
analysis	NN	O
is	VBZ	O
detailedly	RB	O
described	VBN	O
in	IN	O
the	DT	O
literature	NN	O
by	IN	O
Fujiwara,	,	O
one	CD	O
of	IN	O
the	DT	O
present	JJ	O
inventors	NNS	O
Fujiwara,	,	B
Tsutomu,	,	I
Saibo	NNP	I
Kogaku	NNP	I
(Cell	NNP	I
Engineering),	,	I
14,	,	I
645-654	CD	I
(1995)].[	.	O
Among	IN	O
this	DT	O
group,	,	O
there	EX	O
are	VBP	O
novel	JJ	O
receptors,	,	O
DNA	NNP	O
binding	VBG	O
domain-containing	JJ	O
transcription	NN	O
regulating	VBG	O
factors,	,	O
signal	JJ	O
transmission	NN	O
system	NN	O
factors,	,	O
metabolic	JJ	O
enzymes	NNS	O
and	CC	O
so	RB	O
forth.	.	O
Based	VBN	O
on	IN	O
the	DT	O
homology	NN	O
of	IN	O
the	DT	O
novel	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
obtained	VBN	O
by	IN	O
gene	NN	O
analysis	NN	O
to	TO	O
the	DT	O
genes	NNS	O
analogous	JJ	O
thereto,	,	O
the	DT	O
product	NN	O
of	IN	O
the	DT	O
gene,	,	O
hence	RB	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
protein,	,	O
can	MD	O
approximately	RB	O
be	VB	O
estimated	VBN	O
by	IN	O
analogy.	.	O
Furthermore,	,	O
such	JJ	O
functions	NNS	O
as	IN	O
enzyme	JJ	O
activity	NN	O
and	CC	O
binding	VBG	O
ability	NN	O
can	MD	O
be	VB	O
investigated	VBN	O
by	IN	O
inserting	VBG	O
the	DT	O
candidate	NN	O
gene	NN	O
into	IN	O
an	DT	O
expression	NN	O
vector	NN	O
to	TO	O
give	VB	O
a	DT	O
recombinant.	.	O
According	VBG	O
to	TO	O
the	DT	O
present	JJ	O
invention,	,	O
there	EX	O
are	VBP	O
provided	VBN	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
characterized	VBN	O
by	IN	O
containing	VBG	O
a	DT	O
nucleotide	JJ	O
sequence	NN	O
coding	VBG	O
for	IN	O
an	DT	O
amino	NN	O
acid	NN	O
sequence	NN	O
defined	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:1,	,	O
:4,	,	O
:7,	,	O
:10,	,	O
:13,	,	O
:16,	,	O
:19,	,	O
:22,	,	O
:25,	,	O
:28,	,	O
:31,	,	O
:34,	,	O
:37	NNP	O
or	CC	O
40,	,	O
a	DT	O
human	JJ	O
gene	NN	O
characterized	VBN	O
by	IN	O
containing	VBG	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
defined	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2,	,	O
:5,	,	O
:8,	,	O
:11,	,	O
:14,	,	O
:17,	,	O
:20,	,	O
:23,	,	O
:26,	,	O
:29,	,	O
:32,	,	O
:35,	,	O
:38	NNP	O
or	CC	O
:41,	,	O
respectively	RB	O
coding	VBG	O
for	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
mentioned	VBN	O
above,	,	O
and	CC	O
a	DT	O
novel	JJ	O
human	JJ	O
gene	NN	O
characterized	VBN	O
by	IN	O
the	DT	O
nucleotide	JJ	O
sequence	NN	O
defined	VBN	O
by	IN	O
SEQ	NNP	O
ID	NNP	O
NO:3,	,	O
:6,	,	O
:9,	,	O
:12,	,	O
:15,	,	O
:18,	,	O
:21,	,	O
:24,	,	O
:27,	,	O
:30,	,	O
:33,	,	O
:36,	,	O
:39	NNP	O
or	CC	O
:42.	.	O
The	DT	O
symbols	NNS	O
used	VBD	O
herein	NN	O
for	IN	O
indicating	VBG	O
amino	JJ	O
acids,	,	O
peptides,	,	O
nucleotides,	,	O
nucleotide	JJ	O
sequences	NNS	O
and	CC	O
so	RB	O
on	IN	O
are	VBP	O
those	DT	O
recommended	VBN	O
by	IN	O
IUPAC	NNP	O
and	CC	O
IUB	NNP	O
or	CC	O
in	IN	O
“Guideline	NN	O
for	IN	O
drafting	VBG	O
specifications	NNS	O
etc.	.	O
including	VBG	O
nucleotide	JJ	O
sequences	NNS	O
or	CC	O
amino	NN	O
acid	JJ	O
sequences”	NN	O
(edited	VBN	O
by	IN	O
the	DT	O
Japanese	JJ	O
Patent	NNP	O
Office),	,	O
or	CC	O
those	DT	O
in	IN	O
conventional	JJ	O
use	NN	O
in	IN	O
the	DT	O
relevant	JJ	O
field	NN	O
of	IN	O
art.	.	O
As	IN	O
specific	JJ	O
examples	NNS	O
of	IN	O
such	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention,	,	O
there	EX	O
may	MD	O
be	VB	O
mentioned	VBN	O
genes	NNS	O
deducible	JJ	O
from	IN	O
the	DT	O
DNA	NNP	O
sequences	NNS	O
of	IN	O
the	DT	O
clones	NNS	O
designated	VBN	O
as	IN	O
“GEN-501D08”,	,	O
“GEN-080G01”,	,	O
“GEN-025F07”,	,	O
“GEN-076C09”,	,	O
“GEN-331G07”,	,	O
“GEN-163D09”,	,	O
“GEN-078D05TA13”,	,	O
“GEN-423A12”,	,	O
“GEN-092E10”,	,	O
“GEN-428B12”,	,	O
“GEN-073E07”,	,	O
“GEN-093E05”	JJ	O
and	CC	O
“GEN-077A09”	JJ	O
shown	VBN	O
later	RB	O
herein	NN	O
in	IN	O
Examples	NNP	O
1	CD	O
to	TO	O
11.	.	O
The	DT	O
respective	JJ	O
nucleotide	JJ	O
sequences	NNS	O
are	VBP	O
as	IN	O
shown	VBN	O
in	IN	O
the	DT	O
sequence	NN	O
listing.	.	O
These	DT	O
clones	NNS	O
have	VBP	O
an	DT	O
open	JJ	O
reading	NN	O
frame	NN	O
comprising	VBG	O
nucleotides	NNS	O
(nucleic	JJ	O
acid)	)	O
respectively	RB	O
coding	VBG	O
for	IN	O
the	DT	O
amino	NN	O
acids	NNS	O
shown	VBN	O
in	IN	O
the	DT	O
sequence	NN	O
listing.	.	O
Their	PRP$	O
molecular	JJ	O
weights	NNS	O
were	VBD	O
calculated	VBN	O
at	IN	O
the	DT	O
values	NNS	O
shown	VBN	O
later	RB	O
herein	NN	O
in	IN	O
the	DT	O
respective	JJ	O
examples.	.	O
Hereinafter,	,	O
these	DT	O
human	JJ	O
genes	NNS	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
are	VBP	O
sometimes	RB	O
referred	VBN	O
to	TO	O
as	IN	O
the	DT	O
designation	NN	O
used	VBN	O
in	IN	O
Examples	NNP	O
1	CD	O
to	TO	O
11.	.	O
In	IN	O
the	DT	O
following,	,	O
the	DT	O
human	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
described	VBN	O
in	IN	O
further	JJ	O
detail.	.	O
As	IN	O
mentioned	VBN	O
above,	,	O
each	DT	O
human	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
analogous	JJ	O
to	TO	O
rat,	,	O
mouse,	,	O
yeast,	,	O
nematode	NN	O
and	CC	O
known	VBN	O
human	JJ	O
genes,	,	O
among	IN	O
others,	,	O
and	CC	O
can	MD	O
be	VB	O
utilized	VBN	O
in	IN	O
human	JJ	O
gene	NN	O
analysis	NN	O
based	VBN	O
on	IN	O
the	DT	O
information	NN	O
about	IN	O
the	DT	O
genes	NNS	O
analogous	JJ	O
thereto	NN	O
and	CC	O
in	IN	O
studying	VBG	O
the	DT	O
function	NN	O
of	IN	O
the	DT	O
gene	NN	O
analyzed	VBD	O
and	CC	O
the	DT	O
relation	NN	O
between	IN	O
the	DT	O
gene	NN	O
analyzed	VBD	O
and	CC	O
a	DT	O
disease.	.	O
It	PRP	O
is	VBZ	O
possible	JJ	O
to	TO	O
use	VB	O
said	VBD	O
gene	NN	O
in	IN	O
gene	NN	O
diagnosis	NN	O
of	IN	O
the	DT	O
disease	NN	O
associated	VBN	O
therewith	NN	O
and	CC	O
in	IN	O
exploitation	NN	O
studies	NNS	O
of	IN	O
said	VBD	O
gene	NN	O
for	IN	O
medicinal	JJ	O
purposes.	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
represented	VBN	O
in	IN	O
terms	NNS	O
of	IN	O
a	DT	O
single-stranded	JJ	O
DNA	NNP	O
sequence,	,	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:2.	.	O
It	PRP	O
is	VBZ	O
to	TO	O
be	VB	O
noted,	,	O
however,	,	O
that	IN	O
the	DT	O
present	JJ	O
invention	NN	O
also	RB	O
includes	VBZ	O
a	DT	O
DNA	NN	O
sequence	NN	O
complementary	JJ	O
to	TO	O
such	VB	O
a	DT	O
single-stranded	JJ	O
DNA	NNP	O
sequence	NN	O
and	CC	O
a	DT	O
component	NN	O
comprising	VBG	O
both.	.	O
The	DT	O
sequence	NN	O
of	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
as	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:3n−1	NNP	O
(where	WRB	O
n	NN	O
is	VBZ	O
an	DT	O
integer	NN	O
of	IN	O
1	CD	O
to	TO	O
14)	)	O
is	VBZ	O
merely	RB	O
an	DT	O
example	NN	O
of	IN	O
the	DT	O
codon	NN	O
combination	NN	O
encoding	VBG	O
the	DT	O
respective	JJ	O
amino	NN	O
acid	NN	O
residues.	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
is	VBZ	O
not	RB	O
limited	JJ	O
thereto	NN	O
but	CC	O
can	MD	O
of	IN	O
course	NN	O
have	VBP	O
a	DT	O
DNA	NN	O
sequence	NN	O
in	IN	O
which	WDT	O
the	DT	O
codons	NNS	O
are	VBP	O
arbitrarily	RB	O
selected	VBN	O
and	CC	O
combined	VBN	O
for	IN	O
the	DT	O
respective	JJ	O
amino	NN	O
acid	NN	O
residues.	.	O
The	DT	O
codon	NN	O
selection	NN	O
can	MD	O
be	VB	O
made	VBN	O
in	IN	O
the	DT	O
conventional	JJ	O
manner,	,	O
for	IN	O
example	NN	O
taking	VBG	O
into	IN	O
consideration	NN	O
the	DT	O
codon	NN	O
utilization	NN	O
frequencies	NNS	O
in	IN	O
the	DT	O
host	NN	O
to	TO	O
be	VB	O
used	VBN	O
Nucl.	.	B
Acids	NNP	I
Res.,	,	I
9,	,	I
43-74	CD	I
(1981)].[	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
further	RBR	O
includes	VBZ	O
DNA	NNP	O
sequences	NNS	O
coding	VBG	O
for	IN	O
functional	JJ	O
equivalents	NNS	O
derived	VBN	O
from	IN	O
the	DT	O
amino	NN	O
acid	JJ	O
sequence	NN	O
mentioned	VBN	O
above	IN	O
by	IN	O
partial	JJ	O
amino	NN	O
acid	NN	O
or	CC	O
amino	NN	O
acid	JJ	O
sequence	NN	O
substitution,	,	O
deletion	NN	O
or	CC	O
addition.	.	O
These	DT	O
polypeptides	NNS	O
may	MD	O
be	VB	O
produced	VBN	O
by	IN	O
spontaneous	JJ	O
modification	NN	O
(mutation)	)	O
or	CC	O
may	MD	O
be	VB	O
obtained	VBN	O
by	IN	O
posttranslational	JJ	O
modification	NN	O
or	CC	O
by	IN	O
modifying	VBG	O
the	DT	O
natural	JJ	O
gene	NN	O
(of	IN	O
the	DT	O
present	JJ	O
invention)	)	O
by	IN	O
a	DT	O
technique	NN	O
of	IN	O
genetic	JJ	O
engineering,	,	O
for	IN	O
example	NN	O
by	IN	O
site-specific	JJ	O
mutagenesis	NN	O
Methods	NNP	B
in	IN	I
Enzymology,	,	I
154,	,	I
p.	NN	I
350,	,	I
367-382	CD	I
(1987);	:	I
ibid.,	,	B
100,	,	I
p.	NN	I
468	CD	I
(1983);	:	I
Nucleic	NNP	B
Acids	NNP	I
Research,	,	I
12,	,	I
p.	NN	I
9441	CD	I
(1984);	:	I
Zoku	NNP	B
Seikagaku	NNP	I
Jikken	NNP	I
Koza	NNP	I
(Sequel	NNP	I
to	TO	I
Experiments	NNS	I
in	IN	I
Biochemistry)	)	I
1,	,	I
“Idensi	JJR	I
Kenkyu-ho	NNP	I
(Methods	NNP	I
in	IN	I
Gene	NNP	I
Research)	)	I
II”,	,	I
edited	VBN	I
by	IN	I
the	DT	I
Japan	NNP	I
Biochemical	NNP	I
Society,	,	I
p.	VBZ	I
105	CD	I
(1986)]	NN	I
[or	CC	O
synthesizing	VBG	O
mutant	JJ	O
DNAs	NNP	O
by	IN	O
a	DT	O
chemical	JJ	O
synthetic	JJ	O
technique	NN	O
such	JJ	O
as	IN	O
the	DT	O
phosphotriester	NN	O
method	NN	O
or	CC	O
phosphoamidite	VB	O
method	JJ	O
J.	.	B
Am.	.	I
Chem.	.	I
Soc.,	,	I
89,	,	I
p.	NN	I
4801	CD	I
(1967);	:	I
ibid.,	,	B
91,	,	I
p.	NN	I
3350	CD	I
(1969);	:	I
Science,	,	B
150,	,	I
p.	NN	I
178	CD	I
(1968);	:	I
Tetrahedron	NNP	B
Lett.,	,	I
22,	,	I
p.	NN	I
1859	CD	I
(1981);	:	I
ibid.,	,	B
24,	,	I
p.	NN	I
245	CD	I
(1983)],[	,	O
or	CC	O
by	IN	O
utilizing	VBG	O
the	DT	O
techniques	NNS	O
mentioned	VBN	O
above	IN	O
in	IN	O
combination.	.	O
The	DT	O
protein	NN	O
encoded	VBN	O
by	IN	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
expressed	VBN	O
readily	RB	O
and	CC	O
stably	RB	O
by	IN	O
utilizing	VBG	O
said	VBD	O
gene,	,	O
for	IN	O
example	NN	O
inserting	VBG	O
it	PRP	O
into	IN	O
a	DT	O
vector	NN	O
for	IN	O
use	NN	O
with	IN	O
a	DT	O
microorganism	NN	O
and	CC	O
cultivating	VBG	O
the	DT	O
microorganism	NN	O
thus	RB	O
transformed.	.	O
The	DT	O
protein	NN	O
obtained	VBN	O
by	IN	O
utilizing	VBG	O
the	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
used	VBN	O
in	IN	O
specific	JJ	O
antibody	NN	O
production.	.	O
In	IN	O
this	DT	O
case,	,	O
the	DT	O
protein	NN	O
producible	NN	O
in	IN	O
large	JJ	O
quantities	NNS	O
by	IN	O
the	DT	O
genetic	JJ	O
engineering	NN	O
technique	NN	O
mentioned	VBN	O
above	IN	O
can	MD	O
be	VB	O
used	VBN	O
as	IN	O
the	DT	O
component	NN	O
to	TO	O
serve	VB	O
as	IN	O
an	DT	O
antigen.	.	O
The	DT	O
antibody	NN	O
obtained	VBD	O
may	MD	O
be	VB	O
polyclonal	JJ	O
or	CC	O
monoclonal	JJ	O
and	CC	O
can	MD	O
be	VB	O
advantageously	RB	O
used	VBN	O
in	IN	O
the	DT	O
purification,	,	O
assay,	,	O
discrimination	NN	O
or	CC	O
identification	NN	O
of	IN	O
the	DT	O
corresponding	JJ	O
protein.	.	O
The	DT	O
gene	NN	O
of	IN	O
the	DT	O
present	JJ	O
invention	NN	O
can	MD	O
be	VB	O
readily	RB	O
produced	VBN	O
based	VBN	O
on	IN	O
the	DT	O
sequence	NN	O
information	NN	O
thereof	NN	O
disclosed	VBD	O
herein	NN	O
by	IN	O
using	VBG	O
general	JJ	O
genetic	JJ	O
engineering	NN	O
techniques	NNS	O
[cf.	.	O
e.g.	.	O
Molecular	JJ	B
Cloning,	,	I
2nd	CD	I
Ed.,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor	NNP	I
Laboratory	NNP	I
Press	NNP	I
(1989);	:	I
Zoku	NNP	B
Seikagaku	NNP	I
Jikken	NNP	I
Koza,	,	I
“Idenshi	NNP	I
Kenkyu-ho	NNP	I
I,	,	I
II	NNP	I
and	CC	I
III”,	,	I
edited	VBN	I
by	IN	I
the	DT	I
Japan	NNP	I
Biochemical	NNP	I
Society	NNP	I
(1986)].This	.	O
can	DT	O
be	MD	O
achieved,	VB	O
for	,	O
example,	IN	O
by	,	O
selecting	IN	O
a	VBG	O
desired	DT	O
clone	VBN	O
from	NN	O
a	IN	O
human	DT	O
cDNA	JJ	O
library	NN	O
(prepared	NN	O
in	VBN	O
the	IN	O
conventional	DT	O
manner	JJ	O
from	NN	O
appropriate	IN	O
cells	JJ	O
of	NNS	O
origin	IN	O
in	NN	O
which	IN	O
the	WDT	O
gene	DT	O
is	NN	O
expressed)	VBZ	O
using	)	O
a	VBG	O
probe	DT	O
or	NN	O
antibody	CC	O
specific	NN	O
to	JJ	O
the	TO	O
gene	DT	O
of	NN	O
the	IN	O
present	DT	O
invention	JJ	O
[e.g.	NN	O
Proc.	.	B
Natl.	.	I
Acad.	.	I
Sci.	.	I
USA,	.	I
78,	,	I
6613	,	I
(1981);	CD	I
Science,	:	B
222,	,	I
778	,	I
(1983)].The	CD	O
cells	.	O
of	DT	O
origin	NNS	O
to	IN	O
be	NN	O
used	TO	O
in	VB	O
the	VBN	O
above	IN	O
method	DT	O
are,	JJ	O
for	NN	O
example,	,	O
cells	IN	O
or	,	O
tissues	NNS	O
in	CC	O
which	NNS	O
the	IN	O
gene	WDT	O
in	DT	O
question	NN	O
is	IN	O
expressed,	NN	O
or	VBZ	O
cultured	,	O
cells	CC	O
derived	VBD	O
therefrom.	NNS	O
Separation	VBN	O
of	.	O
total	NN	O
RNA,	IN	O
separation	JJ	O
and	,	O
purification	NN	O
of	CC	O
mRNA,	NN	O
conversion	IN	O
to	,	O
(synthesis	NN	O
of)	TO	O
cDNA,	NN	O
cloning	)	O
thereof	,	O
and	VBG	O
so	NN	O
on	CC	O
can	RB	O
be	IN	O
carried	MD	O
out	VB	O
by	VBN	O
conventional	RP	O
methods.	IN	O
cDNA	JJ	O
libraries	.	O
are	NN	O
also	NNS	O
commercially	VBP	O
available	RB	O
and	RB	O
such	JJ	O
cDNA	CC	O
libraries,	JJ	O
for	NN	O
example	,	O
various	IN	O
cDNA	NN	O
libraries	JJ	O
available	NN	O
from	NNS	O
Clontech	JJ	O
Lab.	IN	O
Inc.	NNP	O
can	.	O
also	NNP	O
be	MD	O
used	RB	O
in	VB	O
the	VBN	O
above	IN	O
method.	DT	O
Screening	JJ	O
of	.	O
the	NN	O
gene	IN	O
of	DT	O
the	NN	O
present	IN	O
invention	DT	O
from	JJ	O
these	NN	O
cDNA	IN	O
libraries	DT	O
can	NN	O
be	NNS	O
carried	MD	O
out	VB	O
by	VBN	O
the	RP	O
conventional	IN	O
method	DT	O
mentioned	JJ	O
above.	NN	O
These	VBN	O
screening	.	O
methods	DT	O
include,	VBG	O
for	NNS	O
example,	,	O
the	IN	O
method	,	O
comprising	DT	O
selecting	NN	O
a	VBG	O
cDNA	VBG	O
clone	DT	O
by	NN	O
immunological	NN	O
screening	IN	O
using	JJ	O
an	VBG	O
antibody	VBG	O
specific	DT	O
to	NN	O
the	JJ	O
protein	TO	O
produced	DT	O
by	NN	O
the	VBN	O
corresponding	IN	O
cDNA,	DT	O
the	JJ	O
technique	,	O
of	DT	O
plaque	NN	O
or	IN	O
colony	NN	O
hybridization	CC	O
using	NN	O
probes	NN	O
selectively	VBG	O
binding	NNS	O
to	RB	O
the	VBG	O
desired	TO	O
DNA	DT	O
sequence,	VBN	O
or	NNP	O
a	,	O
combination	CC	O
of	DT	O
these.	NN	O
As	IN	O
regards	.	O
the	IN	O
probe	NNS	O
to	DT	O
be	NN	O
used	TO	O
here,	VB	O
a	VBN	O
DNA	,	O
sequence	DT	O
chemically	NN	O
synthesized	NN	O
based	RB	O
on	VBD	O
the	VBN	O
information	IN	O
about	DT	O
the	NN	O
DNA	IN	O
sequence	DT	O
of	NNP	O
the	NN	O
present	IN	O
invention	DT	O
is	JJ	O
generally	NN	O
used.	VBZ	O
It	RB	O
is	.	O
of	PRP	O
course	VBZ	O
possible	IN	O
to	NN	O
use	JJ	O
the	TO	O
gene	VB	O
of	DT	O
the	NN	O
present	IN	O
invention	DT	O
or	JJ	O
fragments	NN	O
thereof	CC	O
as	NNS	O
the	CC	O
proble.	IN	O
Furthermore,	DT	O
a	.	O
sense	,	O
primer	DT	O
and	NN	O
an	NN	O
antisense	CC	O
primer	DT	O
designed	JJ	O
based	NN	O
on	VBN	O
the	VBN	O
information	IN	O
about	DT	O
the	NN	O
partial	IN	O
amino	DT	O
acid	JJ	O
sequence	NN	O
of	JJ	O
a	NN	O
natural	IN	O
extract	DT	O
isolated	JJ	O
and	NN	O
purified	VBN	O
from	CC	O
cells	VBN	O
or	IN	O
a	NNS	O
tissue	CC	O
can	DT	O
be	NN	O
used	MD	O
as	VB	O
probes	VBN	O
for	IN	O
screening.	NNS	O
For	IN	O
obtaining	.	O
the	IN	O
gene	VBG	O
of	DT	O
the	NN	O
present	IN	O
invention,	DT	O
the	JJ	O
technique	,	O
of	DT	O
DNA/RNA	NN	O
amplification	IN	O
by	NNP	O
the	NN	O
PCR	IN	O
method	DT	O
Science,	NNP	B
230,	NN	I
1350-1354	,	I
(1984)]	,	I
[can	CD	O
suitably	NN	O
be	MD	O
employed.	RB	O
Particularly	VB	O
when	.	O
the	RB	O
full-length	WRB	O
cDNA	DT	O
can	JJ	O
hardly	NN	O
be	MD	O
obtained	RB	O
from	VB	O
the	VBN	O
library,	IN	O
the	DT	O
RACE	,	O
method	DT	O
(rapid	NNP	O
amplification	NN	O
of	JJ	O
cDNA	NN	O
ends;	IN	O
Jikken	NN	B
Igaku	:	I
(Experimental	NNP	I
Medicine),	NNP	I
12	NNP	I
(6),	,	I
35-38	CD	I
(1994)],in	,	O
particular	JJ	O
the	,	O
5′RACE	IN	O
method	JJ	O
Frohman,	DT	B
M.	CD	I
A.,	NN	I
et	,	I
al.,	NNP	I
Proc.	,	I
Natl.	FW	I
Acad.	,	I
Sci.	.	I
USA,	.	I
85,	.	I
8998-9002	.	I
(1988)]	,	I
[is	,	O
preferably	CD	O
employed.	NN	O
The	VBZ	O
primers	RB	O
to	.	O
be	DT	O
used	NNS	O
in	TO	O
such	VB	O
PCR	VBN	O
method	IN	O
can	JJ	O
be	NNP	O
appropriately	NN	O
designed	MD	O
based	VB	O
on	RB	O
the	VBN	O
sequence	VBN	O
information	IN	O
of	DT	O
the	NN	O
gene	NN	O
of	IN	O
the	DT	O
present	NN	O
invention	IN	O
as	DT	O
disclosed	JJ	O
herein	NN	O
and	IN	O
can	VBN	O
be	NN	O
synthesized	CC	O
by	MD	O
a	VB	O
conventional	VBN	O
method.	IN	O
The	DT	O
amplified	JJ	O
DNA/RNA	.	O
fragment	DT	O
can	JJ	O
be	NNP	O
isolated	NN	O
and	MD	O
purified	VB	O
by	VBN	O
a	CC	O
conventional	VBN	O
method	IN	O
as	DT	O
mentioned	JJ	O
above,	NN	O
for	IN	O
example	VBN	O
by	,	O
gel	IN	O
electrophoresis.	NN	O
The	IN	O
nucleotide	JJ	O
sequence	.	O
of	DT	O
the	JJ	O
thus-obtained	NN	O
gene	IN	O
of	DT	O
the	JJ	O
present	NN	O
invention	IN	O
or	DT	O
any	JJ	O
of	NN	O
various	CC	O
DNA	DT	O
fragments	IN	O
can	JJ	O
be	NNP	O
determined	NNS	O
by	MD	O
a	VB	O
conventional	VBN	O
method,	IN	O
for	DT	O
example	JJ	O
the	,	O
dideoxy	IN	O
method	NN	O
Proc.	DT	B
Natl.	NN	I
Acad.	NN	I
Sci.	.	I
USA,	.	I
74,	.	I
5463-5467	.	I
(1977)]	,	I
[or	,	O
the	CD	O
Maxam-Gilbert	NN	O
method	CC	O
[Methods	DT	B
in	JJ	I
Enzymology,	NN	I
65,	NNP	I
499	IN	I
(1980)].Such	,	O
nucleotide	,	O
sequence	CD	O
determination	.	O
can	JJ	O
be	JJ	O
readily	NN	O
performed	NN	O
using	MD	O
a	VB	O
commercially	RB	O
available	VBN	O
sequence	VBG	O
kit	DT	O
as	RB	O
well.	JJ	O
When	NN	O
the	NN	O
gene	RB	O
of	.	O
the	WRB	O
present	DT	O
invention	NN	O
is	IN	O
used	DT	O
and	JJ	O
conventional	NN	O
techniques	VBZ	O
of	VBN	O
recombinant	CC	O
DNA	JJ	O
technology	NNS	O
[see	IN	O
e.g.	JJ	O
Science,	NNP	B
224,	NN	I
p.	VBP	I
1431	.	I
(1984);	,	I
Biochem.	,	B
Biophys.	NN	I
Res.	CD	I
Comm.,	:	I
130,	.	I
p.	.	I
692	.	I
(1985);	,	I
Proc.	,	B
Natl.	NN	I
Acad.	CD	I
Sci.	:	I
USA,	.	I
80,	.	I
p.	.	I
5990	.	I
(1983)	,	I
and	,	O
the	NN	O
references	CD	O
cited	)	O
above]	CC	O
are	DT	O
followed,	NNS	O
a	VBD	O
recombinant	NN	O
protein	VBP	O
can	,	O
be	DT	O
obtained.	JJ	O
More	NN	O
detailedly,	MD	O
said	VB	O
protein	.	O
can	RBR	O
be	,	O
produced	VBD	O
by	NN	O
constructing	MD	O
a	VB	O
recombinant	VBN	O
DNA	IN	O
enabling	VBG	O
the	DT	O
gene	JJ	O
of	NN	O
the	VBG	O
present	DT	O
invention	NN	O
to	IN	O
be	DT	O
expressed	JJ	O
in	NN	O
host	TO	O
cells,	VB	O
introducing	VBN	O
it	IN	O
into	NN	O
host	,	O
cells	VBG	O
for	PRP	O
transformation	IN	O
thereof	NN	O
and	NNS	O
cultivating	IN	O
the	NN	O
resulting	NN	O
transformant.	CC	O
In	VBG	O
that	DT	O
case,	VBG	O
the	.	O
host	IN	O
cells	DT	O
may	,	O
be	DT	O
eukaryotic	NN	O
or	NNS	O
prokaryotic.	MD	O
The	VB	O
eukaryotic	JJ	O
cells	CC	O
include	.	O
vertebrate	DT	O
cells,	JJ	O
yeast	NNS	O
cells	VBP	O
and	JJ	O
so	,	O
on,	NN	O
and	NNS	O
the	CC	O
vertebrate	RB	O
cells	,	O
include,	CC	O
but	DT	O
are	NN	O
not	NNS	O
limited	,	O
to,	CC	O
simian	VBP	O
cells	RB	O
named	VBN	O
COS	,	O
cells	JJ	O
Cell,	NNS	B
23,	VBN	I
175-182	NNP	I
(1981)],[	NNS	O
Chinese	,	O
hamster	,	O
ovary	CD	O
cells	,	O
and	JJ	O
a	NN	O
dihydrofolate	JJ	O
reductase-deficient	NNS	O
cell	CC	O
line	DT	O
derived	JJ	O
therefrom	NN	O
Proc.	NN	B
Natl.	NN	I
Acad.	VBN	I
Sci.	IN	I
USA,	.	I
77,	.	I
4216-4220	.	I
(1980)]	.	I
[and	,	O
the	,	O
like,	CD	O
which	NN	O
are	CC	O
frequently	DT	O
used.	,	O
As	WDT	O
regards	VBP	O
the	RB	O
expression	.	O
vector	IN	O
to	NNS	O
be	DT	O
used	NN	O
with	NN	O
vertebrate	TO	O
cells,	VB	O
an	VBN	O
expression	IN	O
vector	JJ	O
having	,	O
a	DT	O
promoter	NN	O
located	NN	O
upstream	VBG	O
of	DT	O
the	NN	O
gene	VBN	O
to	NN	O
be	IN	O
expressed,	DT	O
RNA	NN	O
splicing	TO	O
sites,	VB	O
a	,	O
polyadenylation	NNP	O
site	VBG	O
and	,	O
a	DT	O
transcription	NN	O
termination	NN	O
sequence	CC	O
can	DT	O
be	NN	O
generally	NN	O
used.	NN	O
This	MD	O
may	VB	O
further	RB	O
have	.	O
an	DT	O
origin	MD	O
of	RB	O
replication	VB	O
as	DT	O
necessary.	NN	O
As	IN	O
an	NN	O
example	IN	O
of	.	O
said	IN	O
expression	DT	O
vector,	NN	O
there	IN	O
may	VBD	O
be	NN	O
mentioned	,	O
pSV2dhfr	EX	O
Mol.	MD	B
Cell.	VB	I
Biol.,	VBN	I
1,	JJ	I
854	.	I
(1981)],[	.	O
which	,	O
has	,	O
the	CD	O
SV40	,	O
early	WDT	O
promoter.	VBZ	O
As	DT	O
for	NNP	O
the	JJ	O
eukaryotic	.	O
microorganisms,	IN	O
yeasts	IN	O
are	DT	O
generally	JJ	O
and	,	O
frequently	NNS	O
used	VBP	O
and,	RB	O
among	CC	O
them,	RB	O
yeasts	VBN	O
of	,	O
the	IN	O
genus	,	O
Saccharomyces	NNS	O
can	IN	O
be	DT	O
used	NN	O
with	NNS	O
advantage.	MD	O
As	VB	O
regards	VBN	O
the	IN	O
expression	.	O
vector	IN	O
for	NNS	O
use	DT	O
with	NN	O
said	NN	O
yeasts	IN	O
and	NN	O
other	IN	O
eukaryotic	VBD	O
microorganisms,	NNS	O
pAM82	CC	O
Proc.	JJ	B
Natl.	JJ	I
Acad.	,	I
Sci.	NN	I
USA,	.	I
80,	.	I
1-5	.	I
(1983)],[	.	O
which	,	O
has	,	O
the	CD	O
acid	,	O
phosphatase	WDT	O
gene	VBZ	O
promoter,	DT	O
for	JJ	O
instance,	NN	O
can	NN	O
be	,	O
used.	IN	O
Furthermore,	,	O
a	MD	O
prokaryotic	VB	O
gene	.	O
fused	,	O
vector	DT	O
can	JJ	O
be	NN	O
preferably	VBD	O
used	NN	O
as	MD	O
the	VB	O
expression	RB	O
vector	VBN	O
for	IN	O
the	DT	O
gene	NN	O
of	NN	O
the	IN	O
present	DT	O
invention.	NN	O
As	IN	O
specific	DT	O
examples	JJ	O
of	.	O
said	IN	O
vector,	JJ	O
there	NNS	O
may	IN	O
be	VBD	O
mentioned	,	O
pGEX-2TK	EX	O
and	MD	O
pGEX-4T-2	VB	O
which	VBN	O
have	JJ	O
a	CC	O
GST	JJ	O
domain	WDT	O
(derived	VBP	O
from	DT	O
S.	NNP	O
japonicum)	NN	O
with	VBN	O
a	IN	O
molecular	NNP	O
weight	)	O
of	IN	O
26,000.	DT	O
Escherichia	JJ	O
coli	NN	O
and	IN	O
Bacillus	.	O
subtilis	NNP	O
are	NNS	O
generally	CC	O
and	NNP	O
preferably	NNS	O
used	VBP	O
as	RB	O
prokaryotic	CC	O
hosts.	RB	O
When	VBD	O
these	IN	O
are	JJ	O
used	.	O
as	WRB	O
hosts	DT	O
in	VBP	O
the	VBN	O
practice	IN	O
of	NNS	O
the	IN	O
present	DT	O
invention,	NN	O
an	IN	O
expression	DT	O
plasmid	JJ	O
derived	,	O
from	DT	O
a	NN	O
plasmid	NN	O
vector	VBN	O
capable	IN	O
of	DT	O
replicating	JJ	O
in	NN	O
said	JJ	O
host	IN	O
organisms	VBG	O
and	IN	O
provided	VBD	O
in	NN	O
this	NNS	O
vector	CC	O
with	VBN	O
a	IN	O
promoter	DT	O
and	NN	O
the	IN	O
SD	DT	O
(Shine	NN	O
and	CC	O
Dalgarno)	DT	O
sequence	NNP	O
upstream	NNP	O
of	CC	O
said	)	O
gene	NN	O
for	NN	O
enabling	IN	O
the	VBD	O
expression	NN	O
of	IN	O
the	VBG	O
gene	DT	O
of	NN	O
the	IN	O
present	DT	O
invention	NN	O
and	IN	O
further	DT	O
provided	JJ	O
with	NN	O
an	CC	O
initiation	RB	O
codon	VBN	O
(e.g.	IN	O
ATG)	DT	O
necessary	NN	O
for	NN	O
the	.	O
initiation	)	O
of	JJ	O
protein	IN	O
synthesis	DT	O
is	NN	O
preferably	IN	O
used.	JJ	O
The	NN	O
Escherichia	VBZ	O
coli	RB	O
strain	.	O
K12,	DT	O
among	NNP	O
others,	NN	O
is	NN	O
preferably	,	O
used	IN	O
as	,	O
the	VBZ	O
host	RB	O
Escherichia	VBN	O
coli,	IN	O
and	DT	O
pBR322	NN	O
and	NNP	O
modified	,	O
vectors	CC	O
derived	NN	O
therefrom	CC	O
are	VBD	O
generally	NNS	O
and	VBN	O
preferably	NNS	O
used	VBP	O
as	RB	O
the	CC	O
vector,	RB	O
while	VBD	O
various	IN	O
known	DT	O
strains	,	O
and	IN	O
vectors	JJ	O
can	JJ	O
also	NNS	O
be	CC	O
used.	NNS	O
Examples	MD	O
of	RB	O
the	VB	O
promoter	.	O
which	NNS	O
can	IN	O
be	DT	O
used	NN	O
are	WDT	O
the	MD	O
tryptophan	VB	O
(trp)	VBN	O
promoter,	VBP	O
lpp	DT	O
promoter,	NN	O
lac	)	O
promoter	,	O
and	JJ	O
PL/PR	,	O
promoter.	NN	O
The	NN	O
thus-obtained	CC	O
desired	NNP	O
recombinant	.	O
DNA	DT	O
can	JJ	O
be	JJ	O
introduced	NN	O
into	NN	O
host	MD	O
cells	VB	O
for	VBN	O
transformation	IN	O
by	NN	O
using	NNS	O
various	IN	O
general	NN	O
methods.	IN	O
The	VBG	O
transformant	JJ	O
obtained	JJ	O
can	.	O
be	DT	O
cultured	NN	O
by	VBD	O
a	MD	O
conventional	VB	O
method	VBN	O
and	IN	O
the	DT	O
culture	JJ	O
leads	NN	O
to	CC	O
expression	DT	O
and	NN	O
production	VBZ	O
of	TO	O
the	NN	O
desired	CC	O
protein	NN	O
encoded	IN	O
by	DT	O
the	JJ	O
gene	NN	O
of	VBN	O
the	IN	O
present	DT	O
invention.	NN	O
The	IN	O
medium	DT	O
to	JJ	O
be	.	O
used	DT	O
in	NN	O
said	TO	O
culture	VB	O
can	VBN	O
suitably	IN	O
be	VBD	O
selected	NN	O
from	MD	O
among	RB	O
various	VB	O
media	VBN	O
in	IN	O
conventional	IN	O
use	JJ	O
according	NNS	O
to	IN	O
the	JJ	O
host	NN	O
cells	VBG	O
employed.	TO	O
The	DT	O
host	NN	O
cells	NNS	O
can	.	O
be	DT	O
cultured	NN	O
under	NNS	O
conditions	MD	O
suited	VB	O
for	VBN	O
the	IN	O
growth	NNS	O
thereof.	VBN	O
In	IN	O
the	DT	O
above	NN	O
manner,	.	O
the	IN	O
desired	DT	O
recombinant	JJ	O
protein	,	O
is	DT	O
expressed	VBN	O
and	NN	O
produced	NN	O
and	VBZ	O
accumulated	VBN	O
or	CC	O
secreted	VBN	O
within	CC	O
the	VBN	O
transformant	CC	O
cells	VBN	O
or	IN	O
extracellularly	DT	O
or	JJ	O
on	NNS	O
the	CC	O
cell	RB	O
membrane.	CC	O
The	IN	O
recombinant	DT	O
protein	NN	O
can	.	O
be	DT	O
separated	JJ	O
and	NN	O
purified	MD	O
as	VB	O
desired	VBN	O
by	CC	O
various	VBN	O
separation	IN	O
procedures	VBN	O
utilizing	IN	O
the	JJ	O
physical,	NN	O
chemical	NNS	O
and	VBG	O
other	DT	O
properties	,	O
thereof	NN	O
[cf.	CC	O
e.g.	JJ	O
“Seikagaku	NNS	B
(Biochemistry)	VBP	I
Data	.	I
Book	.	I
II”,	NN	I
pages	)	I
1175-1259,	NNP	I
1st	NNP	I
Edition,	,	I
1st	VBZ	I
Printing,	,	I
published	CD	I
Jun.	,	I
23,	CD	I
1980	,	I
by	VBN	I
Tokyo	.	I
Kagaku	,	I
Dojin;	CD	I
Biochemistry,	IN	B
25	NNP	I
(25),	NNP	I
8274-8277	:	I
(1986);	,	I
Eur.	CD	B
J.	,	I
Biochem.,	JJ	I
163,	:	I
313-321	.	I
(1987)].Specifically,	.	O
said	,	O
procedures	,	O
include,	CD	O
among	.	O
others,	,	O
ordinary	VBD	O
reconstitution	NNS	O
treatment,	,	O
treatment	IN	O
with	,	O
a	JJ	O
protein	NN	O
precipitating	,	O
agent	NN	O
(salting	IN	O
out),	DT	O
centrifugation,	NN	O
osmotic	VBG	O
shock	NN	O
treatment,	VBG	O
sonication,	,	O
ultrafiltration,	,	O
various	JJ	O
liquid	NN	O
chromatography	,	O
techniques	,	O
such	,	O
as	JJ	O
molecular	JJ	O
sieve	NN	O
chromatography	NNS	O
(gel	JJ	O
filtration),	IN	O
adsorption	JJ	O
chromatography,	NN	O
ion	NN	O
exchange	JJ	O
chromatography,	,	O
affinity	NN	O
chromatography	,	O
and	NN	O
high-performance	NN	O
liquid	,	O
chromatography	NN	O
(HPLC),	NN	O
dialysis	CC	O
and	NN	O
combinations	NN	O
thereof.	NN	O
Among	,	O
them,	NN	O
affinity	CC	O
chromatography	NNS	O
utilizing	.	O
a	IN	O
column	,	O
with	NN	O
the	NN	O
desired	VBG	O
protein	DT	O
bound	NN	O
thereto	IN	O
is	DT	O
particularly	JJ	O
preferred.	NN	O
Furthermore,	NN	O
on	NN	O
the	VBZ	O
basis	RB	O
of	.	O
the	,	O
sequence	IN	O
information	DT	O
about	NN	O
the	IN	O
gene	DT	O
of	NN	O
the	NN	O
present	IN	O
invention	DT	O
as	NN	O
revealed	IN	O
by	DT	O
the	JJ	O
present	NN	O
invention,	IN	O
for	VBN	O
example	IN	O
by	DT	O
utilizing	JJ	O
part	,	O
or	IN	O
the	NN	O
whole	IN	O
of	VBG	O
said	NN	O
gene,	CC	O
it	DT	O
is	NN	O
possible	IN	O
to	VBD	O
detect	,	O
the	PRP	O
expression	VBZ	O
of	JJ	O
the	TO	O
gene	VB	O
of	DT	O
the	NN	O
present	IN	O
invention	DT	O
in	NN	O
various	IN	O
human	DT	O
tissues.	JJ	O
This	NN	O
can	IN	O
be	JJ	O
performed	JJ	O
by	.	O
a	DT	O
conventional	MD	O
method,	VB	O
for	VBN	O
example	IN	O
by	DT	O
RNA	JJ	O
amplification	,	O
by	IN	O
RT-PCR	NN	O
(reverse	IN	O
transcribed-polymerase	NNP	O
chain	NN	O
reaction)	IN	O
Kawasaki,	NNP	B
E.	JJ	I
S.,	NN	I
et	NN	I
al.,	)	I
Amplification	,	I
of	NNP	I
RNA,	,	I
in	FW	I
PCR	,	I
Protocol,	NNP	I
A	IN	I
guide	,	I
to	IN	I
methods	NNP	I
and	,	I
applications,	NNP	I
Academic	NN	I
Press,	TO	I
Inc.,	NNS	I
San	CC	I
Diego,	,	I
21-27	NNP	I
(1991)],[	,	O
or	,	O
by	NNP	O
northern	,	O
blotting	CD	O
analysis	,	O
[Molecular	CC	O
Cloning,	IN	O
Cold	JJ	O
Spring	VBG	O
Harbor	NN	O
Laboratory	NNP	O
(1989)],	,	O
with	NNP	O
good	NNP	O
results.	NNP	O
The	NNP	O
primers	,	O
to	IN	O
be	JJ	O
used	.	O
in	DT	O
employing	NNS	O
the	TO	O
above-mentioned	VB	O
PCR	VBN	O
method	IN	O
are	VBG	O
not	DT	O
limited	JJ	O
to	NNP	O
any	NN	O
particular	VBP	O
ones	RB	O
provided	VBN	O
that	TO	O
they	DT	O
are	JJ	O
specific	NNS	O
to	VBD	O
the	IN	O
gene	PRP	O
of	VBP	O
the	JJ	O
present	TO	O
invention	DT	O
and	NN	O
enable	IN	O
the	DT	O
gene	JJ	O
of	NN	O
the	CC	O
present	VB	O
invention	DT	O
alone	NN	O
to	IN	O
be	DT	O
specifically	JJ	O
amplified.	NN	O
They	RB	O
can	TO	O
be	VB	O
designed	RB	O
or	.	O
selected	PRP	O
appropriately	MD	O
based	VB	O
on	VBN	O
the	CC	O
gene	VBN	O
information	RB	O
provided	VBN	O
by	IN	O
the	DT	O
present	NN	O
invention.	NN	O
They	VBN	O
can	IN	O
have	DT	O
a	JJ	O
partial	.	O
sequence	PRP	O
comprising	MD	O
about	VB	O
20	DT	O
to	JJ	O
30	NN	O
nucleotides	VBG	O
according	RB	O
to	CD	O
the	TO	O
established	CD	O
practice.	NNS	O
Suitable	VBG	O
examples	TO	O
are	DT	O
as	VBN	O
shown	.	O
in	JJ	O
Examples	NNS	O
1	VBP	O
to	IN	O
11.	VBN	O
Thus,	IN	O
the	NNP	O
present	CD	O
invention	TO	O
also	.	O
provides	,	O
primers	DT	O
and/or	JJ	O
probes	NN	O
useful	RB	O
in	VBZ	O
specifically	NNS	O
detecting	VBP	O
such	NNS	O
novel	JJ	O
gene.	IN	O
By	RB	O
using	VBG	O
the	JJ	O
novel	JJ	O
gene	.	O
provided	IN	O
by	VBG	O
the	DT	O
present	JJ	O
invention,	NN	O
it	VBN	O
is	IN	O
possible	DT	O
to	JJ	O
detect	,	O
the	PRP	O
expression	VBZ	O
of	JJ	O
said	TO	O
gene	VB	O
in	DT	O
various	NN	O
tissues,	IN	O
analyze	VBD	O
the	NN	O
structure	IN	O
and	JJ	O
function	,	O
thereof	VBP	O
and,	DT	O
further,	NN	O
produce	CC	O
the	NN	O
human	NN	O
protein	,	O
encoded	,	O
by	VBP	O
said	DT	O
gene	JJ	O
in	NN	O
the	VBN	O
manner	IN	O
of	VBD	O
genetic	NN	O
enginnering.	IN	O
These	DT	O
make	NN	O
it	IN	O
possible	JJ	O
to	.	O
analyze	DT	O
the	VBP	O
expression	PRP	O
product,	JJ	O
reveal	TO	O
the	VB	O
pathology	DT	O
of	NN	O
a	,	O
disease	VB	O
associated	DT	O
therewith,	NN	O
for	IN	O
example	DT	O
a	NN	O
genopathy	VBN	O
or	,	O
cancer,	IN	O
and	NN	O
diagnose	DT	O
and	NN	O
treat	CC	O
the	,	O
disease.	CC	O
The	RB	O
following	CC	O
drawings	VB	O
are	DT	O
referred	.	O
to	DT	O
in	JJ	O
the	NNS	O
examples.	VBP	O
FIG.	VBN	O
1	TO	O
shows	IN	O
the	DT	O
result	.	O
obtained	.	O
by	CD	O
testing	VBZ	O
the	DT	O
PI4	NN	O
kinase	VBN	O
activity	IN	O
of	VBG	O
NPIK	DT	O
in	NNP	O
Example	NN	O
9.	NN	O
FIG.	IN	O
2	NNP	O
shows	IN	O
the	NNP	O
effect	.	O
of	.	O
Triton	CD	O
X-100	VBZ	O
and	DT	O
adenosine	NN	O
on	IN	O
NPIK	NNP	O
activity.	NNP	O
EXAMPLES	CC	O
The	VB	O
following	IN	O
examples	NNP	O
illustrate	.	O
the	IN	O
present	DT	O
invention	JJ	O
in	NNS	O
further	VBP	O
detail.	DT	O
Example	JJ	O
1	NN	O
GDP	IN	O
Dissociation	JJ	O
Stimulator	.	O
Gene	RB	O
(1)	CD	O
Cloning	NNP	O
and	NNP	O
DNA	NNP	O
Sequencing	NNP	O
of	)	O
GDP	NN	O
Dissociation	CC	O
Stimulator	NNP	O
Gene	NNP	O
mRNAs	IN	O
extracted	NNP	O
from	NNP	O
the	NNP	O
tissues	NNP	O
of	NN	O
human	VBD	O
fetal	IN	O
brain,	DT	O
adult	NNS	O
blood	IN	O
vessels	JJ	O
and	JJ	O
placenta	,	O
were	NN	O
purchased	NN	O
from	NNS	O
Clontech	CC	O
and	NN	O
used	VBD	O
as	VBN	O
starting	IN	O
materials.	NNP	O
cDNA	CC	O
was	VBN	O
synthesized	IN	O
from	VBG	O
each	.	O
mRNA	NN	O
and	VBD	O
inserted	VBN	O
into	IN	O
the	DT	O
vector	NN	O
λZAPII	CC	O
(Stratagene)	VBN	O
to	IN	O
thereby	DT	O
construct	NN	O
a	NNP	O
cDNA	)	O
library	TO	O
(Otsuka	VB	O
GEN	VB	O
Research	DT	O
Institute,	NN	O
Otsuka	NN	O
Pharmaceutical	NNP	O
Co.,	NNP	O
Ltd.)	NNP	O
Human	,	O
gene-containing	NNP	O
Escherichia	NNP	O
coli	,	O
colonies	)	O
were	NNP	O
allowed	JJ	O
to	NNP	O
form	NN	O
on	NNS	O
agar	VBD	O
medium	VBN	O
by	TO	O
the	VB	O
in	IN	O
vivo	JJ	O
excision	NN	O
technique	IN	O
Short,	DT	B
J.	IN	I
M.,	JJ	I
et	NN	I
al.,	NN	I
Nucleic	,	I
Acids	NNP	I
Res.,	,	I
16,	FW	I
7583-7600	,	I
(1988)].[	NNP	O
Colonies	NNP	O
were	,	O
picked	,	O
up	CD	O
at	.	O
random	NNS	O
and	VBD	O
human	VBN	O
gene-containing	RP	O
Escherichia	IN	O
coli	NN	O
clones	CC	O
were	JJ	O
registered	NN	O
on	NNP	O
96-well	NN	O
micro	NNS	O
plates.	VBD	O
The	VBN	O
clones	IN	O
registered	NNP	O
were	NN	O
stored	.	O
at	DT	O
−80°	NNS	O
C.	VBN	O
Each	VBD	O
of	VBN	O
the	IN	O
clones	NNP	O
registered	NNP	O
was	DT	O
cultured	IN	O
overnight	DT	O
in	NNS	O
1.5	VBD	O
ml	VBD	O
of	VBN	O
LB	RB	O
medium,	IN	O
and	CD	O
DNA	NN	O
was	IN	O
extracted	NNP	O
and	,	O
purified	CC	O
using	NNP	O
a	VBD	O
model	VBN	O
PI-100	CC	O
automatic	VBN	O
plasmid	VBG	O
extractor	DT	O
(Kurabo).	NN	O
Contaminant	NNP	O
Escherichia	JJ	O
coli	NN	O
RNA	NN	O
was	.	O
decomposed	NNP	O
and	NNP	O
removed	VBD	O
by	NNP	O
RNase	VBD	O
treatment.	VBN	O
The	CC	O
DNA	VBN	O
was	IN	O
dissolved	NNP	O
to	.	O
a	DT	O
final	NN	O
volume	VBD	O
of	VBN	O
30	TO	O
μl.	DT	O
A	JJ	O
2-μl	NN	O
portion	IN	O
was	CD	O
used	.	O
for	DT	O
roughly	JJ	O
checking	NN	O
the	VBD	O
DNA	VBN	O
size	IN	O
and	RB	O
quantity	VBG	O
using	DT	O
a	NN	O
minigel,	NN	O
7	CC	O
μl	NN	O
was	VBG	O
used	DT	O
for	,	O
sequencing	CD	O
reactions	NN	O
and	VBD	O
the	VBN	O
remaining	IN	O
portion	VBG	O
(21	NNS	O
μl	CC	O
)	DT	O
was	VBG	O
stored	NN	O
as	CD	O
plasmid	NN	O
DNA	)	O
at	VBD	O
4°	VBN	O
C.	IN	O
This	JJ	O
method,	NNP	O
after	IN	O
slight	CD	O
changes	NNP	O
in	DT	O
the	,	O
program,	IN	O
enables	JJ	O
extraction	NNS	O
of	IN	O
the	DT	O
cosmid,	,	O
which	VBZ	O
is	NN	O
useful	IN	O
also	DT	O
as	,	O
a	WDT	O
probe	VBZ	O
for	JJ	O
FISH	RB	O
(fluorescence	IN	O
in	DT	O
situ	NN	O
hybridization)	IN	O
shown	NNP	O
later	NN	O
in	IN	O
the	JJ	O
examples.	)	O
Then,	VBN	O
the	RB	O
dideoxy	IN	O
terminator	DT	O
method	.	O
of	,	O
Sanger	DT	O
et	JJ	O
al.	NN	O
Sanger,	NN	B
F.,	IN	I
et	NNP	I
al.,	FW	I
Proc.	.	I
Natl.	,	I
Acad.	,	I
Sci.	NN	I
USA,	,	I
74,	.	I
5463-5467	.	I
(1977)]	.	I
[using	.	O
T3,	,	O
T7	,	O
or	CD	O
a	FW	O
synthetic	VBG	O
oligonucleotide	,	O
primer	NNP	O
or	CC	O
the	DT	O
cycle	JJ	O
sequence	NN	O
method	NN	O
Carothers,	CC	B
A.	DT	I
M.,	NN	I
et	NN	I
al.,	NN	I
Bio.	,	I
Techniques,	NNP	I
7,	,	I
494-499	FW	I
(1989)]	,	I
[comprising	.	O
the	,	O
dideoxy	,	O
chain	CD	O
terminator	NN	O
method	VBG	O
plus	DT	O
PCR	NN	O
method	NN	O
was	NN	O
carried	NN	O
out.	CC	O
These	NNP	O
are	NN	O
methods	VBD	O
of	VBN	O
terminating	.	O
the	DT	O
extension	VBP	O
reaction	NNS	O
specifically	IN	O
to	VBG	O
the	DT	O
four	NN	O
bases	NN	O
using	RB	O
a	TO	O
small	DT	O
amount	CD	O
of	NNS	O
plasmid	VBG	O
DNA	DT	O
(about	JJ	O
0.1	NN	O
to	IN	O
0.5	NN	O
μg)	NNP	O
as	IN	O
a	CD	O
template.	TO	O
The	CD	O
sequence	)	O
primers	IN	O
used	DT	O
were	.	O
FITC	DT	O
(fluorescein	NN	O
isothiocyanate)-labeled	NNS	O
ones.	VBN	O
Generally,	VBD	O
about	NNP	O
25	JJ	O
cycles	VBD	O
of	.	O
reaction	,	O
were	IN	O
performed	CD	O
using	NNS	O
Taq	IN	O
polymerase.	NN	O
The	VBD	O
PCR	VBN	O
products	VBG	O
were	NNP	O
separated	.	O
on	DT	O
a	NNP	O
polyacrylamide	NNS	O
urea	VBD	O
gel	VBN	O
and	IN	O
the	DT	O
fluorescence-labeled	JJ	O
DNA	JJ	O
fragments	NN	O
were	CC	O
submitted	DT	O
to	JJ	O
an	NN	O
automatic	NNS	O
DNA	VBD	O
sequencer	VBN	O
(ALF™	TO	O
DNA	DT	O
Sequencer;	JJ	O
Pharmacia)	NN	O
for	NN	O
determining	NNP	O
the	NNP	O
sequence	:	O
of	)	O
about	IN	O
400	VBG	O
bases	DT	O
from	NN	O
the	IN	O
5′	IN	O
terminus	CD	O
side	NNS	O
of	IN	O
cDNA.	DT	O
Since	CD	O
the	JJ	O
3′	NN	O
nontranslational	IN	O
region	.	O
is	IN	O
high	DT	O
in	CD	O
heterogeneity	JJ	O
for	NN	O
each	VBZ	O
gene	JJ	O
and	IN	O
therefore	NN	O
suited	IN	O
for	DT	O
discriminating	NN	O
individual	CC	O
genes	RB	O
from	VBD	O
one	IN	O
another,	VBG	O
sequencing	JJ	O
was	NNS	O
performed	IN	O
on	CD	O
the	,	O
3′	NN	O
side	VBD	O
as	VBN	O
well	IN	O
depending	DT	O
on	JJ	O
the	NN	O
situation.	RB	O
The	RB	O
vast	VBG	O
sum	IN	O
of	DT	O
nucleotide	.	O
sequence	DT	O
information	JJ	O
obtained	NN	O
from	IN	O
the	JJ	O
DNA	NN	O
sequencer	NN	O
was	VBN	O
transferred	IN	O
to	DT	O
a	NNP	O
64-bit	NN	O
DEC	VBD	O
3400	VBN	O
computer	TO	O
for	DT	O
homology	JJ	O
analysis	NN	O
by	CD	O
the	NN	O
computer.	IN	O
In	NN	O
the	NN	O
homology	IN	O
analysis,	DT	O
a	.	O
data	IN	O
base	DT	O
(GenBank,	NN	O
EMBL)	,	O
was	DT	O
used	NN	O
for	NN	O
searching	,	O
according	)	O
to	VBD	O
the	VBN	O
UWGCG	IN	O
FASTA	VBG	O
program	VBG	O
Pearson,	TO	B
W.	DT	I
R.	NNP	I
and	NNP	I
Lipman,	NN	I
D.	,	I
J.,	NNP	I
Proc.	NNP	I
Natl.	CC	I
Acad.	,	I
Sci.	NNP	I
USA,	,	I
85,	.	I
2444-2448	.	I
(1988)].[	.	O
As	.	O
a	,	O
result	,	O
of	CD	O
arbitrary	.	O
selection	IN	O
by	DT	O
the	NN	O
above	IN	O
method	JJ	O
and	NN	O
of	IN	O
cDNA	DT	O
sequence	JJ	O
analysis,	NN	O
a	CC	O
clone	IN	O
designated	NN	O
as	NN	O
GEN-501D08	,	O
and	DT	O
having	NN	O
a	VBN	O
0.8	IN	O
kilobase	NNP	O
insert	CC	O
was	VBG	O
found	DT	O
to	CD	O
show	NN	O
a	NN	O
high	VBD	O
level	VBN	O
of	TO	O
homology	VB	O
to	DT	O
the	JJ	O
C	NN	O
terminal	IN	O
region	NN	O
of	TO	O
the	DT	O
human	NNP	O
Ral	JJ	O
guanine	NN	O
nucleotide	IN	O
dissociation	DT	O
stimulator	JJ	O
(RalGDS)	NNP	O
gene.	NN	O
Since	IN	O
RalGDS	NN	O
is	NN	O
considered	)	O
to	.	O
play	IN	O
a	NNP	O
certain	VBZ	O
role	VBN	O
in	TO	O
signal	VB	O
transmission	DT	O
pathways,	JJ	O
the	NN	O
whole	IN	O
nucleotide	JJ	O
sequence	NN	O
of	,	O
the	DT	O
cDNA	JJ	O
insert	JJ	O
portion	NN	O
providing	IN	O
the	DT	O
human	NN	O
homolog	JJ	O
was	NN	O
further	VBG	O
determined.	DT	O
Low-molecular	JJ	O
GTPases	NN	O
play	VBD	O
an	RBR	O
important	.	O
role	JJ	O
in	NNP	O
transmitting	VBP	O
signals	DT	O
for	JJ	O
a	NN	O
number	IN	O
of	VBG	O
cell	NNS	O
functions	IN	O
including	DT	O
cell	NN	O
proliferation,	IN	O
differentiation	NN	O
and	NNS	O
transformation	VBG	O
Bourne,	NN	B
H.	,	I
R.	NN	I
et	CC	I
al.,	NN	I
Nature,	,	I
348,	NNP	I
125-132	NNP	I
(1990);	FW	I
Bourne	,	B
et	,	I
al.,	,	I
Nature,	CD	I
349,	:	I
117-127	NNP	I
(1991)].[	FW	O
It	,	O
is	,	O
well	,	O
known	CD	O
that,	.	O
among	PRP	O
them,	VBZ	O
those	RB	O
proteins	VBN	O
encoded	,	O
by	IN	O
the	,	O
ras	DT	O
gene	NNS	O
family	VBN	O
function	IN	O
as	DT	O
molecular	NNS	O
switches	NN	O
or,	NN	O
in	NN	O
other	IN	O
words,	JJ	O
the	NNS	O
functions	,	O
of	IN	O
the	JJ	O
ras	,	O
gene	DT	O
family	NNS	O
are	IN	O
regulated	DT	O
by	NNS	O
different	NN	O
conditions	NN	O
of	VBP	O
binding	VBN	O
proteins	IN	O
such	JJ	O
as	NNS	O
biologically	IN	O
inactive	VBG	O
GDP-binding	NNS	O
proteins	JJ	O
or	IN	O
active	RB	O
GDP-binding	JJ	O
proteins,	JJ	O
and	NNS	O
that	CC	O
these	JJ	O
two	JJ	O
conditions	,	O
are	CC	O
induced	IN	O
by	DT	O
GTPase	CD	O
activating	NNS	O
proteins	VBP	O
(GAPs)	VBN	O
or	IN	O
GDS.	NNP	O
The	VBG	O
former	NNS	O
enzymes	)	O
induce	CC	O
GDP	.	O
binding	DT	O
by	JJ	O
stimulating	NNS	O
the	VBP	O
hydrolysis	NNP	O
of	NN	O
bound	IN	O
GTP	VBG	O
and	DT	O
the	NN	O
latter	IN	O
enzyme	NN	O
induces	NNP	O
the	CC	O
regular	DT	O
GTP	JJ	O
binding	NN	O
by	VBZ	O
releasing	DT	O
bound	JJ	O
GDP	NNP	O
Bogusuki,	NN	B
M.	IN	I
S,	VBG	I
and	NN	I
McCormick,	NNP	I
F.,	,	I
Nature,	NNP	I
366,	,	I
643-654	CC	I
(1993)].[	,	O
RalGDS	,	O
was	,	O
first	,	O
discovered	CD	O
as	.	O
a	NNP	O
member	VBD	O
of	RB	O
the	VBN	O
ras	IN	O
gene	DT	O
family	NN	O
lacking	IN	O
in	DT	O
transforming	NNS	O
activity	NN	O
and	NN	O
as	VBG	O
a	IN	O
GDP	VBG	O
dissociation	NN	O
stimulator	CC	O
specific	IN	O
to	DT	O
RAS	NNP	O
Chardin,	NN	B
P.	NN	I
and	JJ	I
Tavitian,	TO	I
A.,	NNP	I
EMBO	,	I
J.,	NNP	I
5,	CC	I
2203-2208	,	I
(1986);	,	I
Albright,	NNP	B
C.	,	I
F.,	,	I
et	CD	I
al.,	:	I
EMBO	,	I
J.,	NNP	I
12,	,	I
339-347	NN	I
(1993)].[	,	O
In	NNP	O
addition	,	O
to	,	O
Ral,	CD	O
RalGDS	.	O
was	IN	O
found	NN	O
to	TO	O
function,	,	O
through	NNP	O
interaction	VBD	O
with	VBN	O
these	TO	O
proteins,	,	O
as	IN	O
an	NN	O
effector	IN	O
molecule	DT	O
for	,	O
N-ras,	IN	O
H-ras,	DT	O
K-ras	NN	O
and	NN	O
Rap	IN	O
Spaargaren,	,	B
M.	,	I
and	NNP	I
Bischoff,	CC	I
J.	NNP	I
R.,	,	I
Proc.	NNP	I
Natl.	CC	I
Acad.	,	I
Sci.	NNP	I
USA,	,	I
91,	.	I
12609-12613	.	I
(1994)].[	.	O
The	.	O
nucleotide	,	O
sequence	,	O
of	CD	O
the	.	O
cDNA	DT	O
clone	JJ	O
designated	NN	O
as	IN	O
GEN-501D08	DT	O
is	NN	O
shown	NN	O
under	VBN	O
SEQ	IN	O
ID	NNP	O
NO:3,	VBZ	O
the	VBN	O
nucleotide	IN	O
sequence	NNP	O
of	NNP	O
the	,	O
coding	DT	O
region	JJ	O
of	NN	O
said	IN	O
clone	DT	O
under	VBG	O
SEQ	NN	O
ID	IN	O
NO:2,	VBD	O
and	NN	O
the	IN	O
amino	NNP	O
acid	NNP	O
sequence	,	O
encoded	CC	O
by	DT	O
said	NN	O
nucleotide	JJ	O
sequence	NN	O
under	VBN	O
SEQ	IN	O
ID	VBD	O
NO:1.	JJ	O
This	NN	O
cDNA	IN	O
comprises	NNP	O
842	NNP	O
nucleotides,	.	O
including	DT	O
an	NN	O
open	VBZ	O
reading	CD	O
frame	,	O
comprising	VBG	O
366	DT	O
nucleotides	JJ	O
and	NN	O
coding	NN	O
for	VBG	O
122	CD	O
amino	NNS	O
acids.	CC	O
The	VBG	O
translation	IN	O
initiation	CD	O
codon	JJ	O
was	.	O
found	DT	O
to	NN	O
be	NN	O
located	NN	O
at	VBD	O
the	VBN	O
28th	TO	O
nucleotide	VB	O
residue.	VBN	O
Comparison	IN	O
between	DT	O
the	CD	O
RalGDS	RB	O
protein	.	O
known	NNP	O
among	IN	O
conventional	DT	O
databases	NNP	O
and	NN	O
the	VBN	O
amino	IN	O
acid	JJ	O
sequence	NNS	O
deduced	CC	O
from	DT	O
said	NN	O
cDNA	JJ	O
revealed	NN	O
that	VBD	O
the	IN	O
protein	VBD	O
encoded	NN	O
by	VBD	O
this	IN	O
cDNA	DT	O
is	NN	O
homologous	VBN	O
to	IN	O
the	DT	O
C	NN	O
terminal	VBZ	O
domain	JJ	O
of	TO	O
human	DT	O
RalGDS.	NNP	O
The	NN	O
amino	NN	O
acid	IN	O
sequence	JJ	O
encoded	.	O
by	DT	O
this	NN	O
novel	JJ	O
gene	NN	O
was	VBN	O
found	IN	O
to	DT	O
be	JJ	O
39.5%	NN	O
identical	VBD	O
with	VBN	O
the	TO	O
C	VB	O
terminal	NN	O
domain	JJ	O
of	IN	O
RalGDS	DT	O
which	NNP	O
is	NN	O
thought	NN	O
to	IN	O
be	NNP	O
necessary	WDT	O
for	VBZ	O
binding	VBN	O
to	TO	O
ras.	VB	O
Therefore,	JJ	O
it	IN	O
is	VBG	O
presumable,	TO	O
as	.	O
mentioned	,	O
above,	PRP	O
that	VBZ	O
this	,	O
gene	IN	O
product	VBN	O
might	,	O
interact	IN	O
with	DT	O
the	NN	O
ras	NN	O
family	MD	O
proteins	VB	O
or	IN	O
have	DT	O
influence	NNS	O
on	NN	O
the	NNS	O
ras-mediated	CC	O
signal	VBP	O
transduction	VBN	O
pathways.	IN	O
However,	DT	O
this	JJ	O
novel	JJ	O
gene	NN	O
is	.	O
lacking	,	O
in	DT	O
the	JJ	O
region	NN	O
coding	VBZ	O
for	VBG	O
the	IN	O
GDS	DT	O
activity	NN	O
domain	VBG	O
and	IN	O
the	DT	O
corresponding	NNP	O
protein	NN	O
seems	NN	O
to	CC	O
be	DT	O
different	JJ	O
in	NN	O
function	VBZ	O
from	TO	O
the	VB	O
GDS	JJ	O
protein.	IN	O
This	NN	O
gene	IN	O
was	DT	O
named	NNP	O
human	.	O
RalGDS	DT	O
by	NN	O
the	VBD	O
present	VBN	O
inventors.	JJ	O
(2)	NNP	O
Northern	IN	O
Blot	DT	O
Analysis	JJ	O
The	.	O
expression	)	O
of	NNP	O
the	NNP	O
RalGDS	NNP	O
protein	DT	O
mRNA	NN	O
in	IN	O
normal	DT	O
human	NNP	O
tissues	NN	O
was	NN	O
evaluated	IN	O
by	JJ	O
Northern	JJ	O
blotting	NNS	O
using,	VBD	O
as	VBN	O
a	IN	O
probe,	NNP	O
the	VBG	O
human	,	O
cDNA	IN	O
clone	DT	O
labeled	,	O
by	DT	O
the	JJ	O
random	NN	O
oligonucleotide	NN	O
priming	VBN	O
method.	IN	O
The	DT	O
Northern	NN	O
blot	IN	O
analysis	VBG	O
was	.	O
carried	DT	O
out	NNP	O
with	NN	O
a	NN	O
human	VBD	O
MTN	VBN	O
blot	RP	O
(Human	IN	O
Multiple	DT	O
Tissue	JJ	O
Northern	NNP	O
blot;	NN	O
Clontech,	NNP	O
Palo	NNP	O
Alto,	NNP	O
Calif.,	NNP	O
USA)	:	O
according	,	O
to	NNP	O
the	,	O
manufacturer's	,	O
protocol.	)	O
Thus,	VBG	O
the	TO	O
PCR	DT	O
amplification	POS	O
product	.	O
from	,	O
the	DT	O
above	NNP	O
GEN-501D08	NN	O
clone	NN	O
was	IN	O
labeled	DT	O
with	JJ	O
[32P]-dCTP	NNP	O
(random-primed	NN	O
DNA	VBD	O
labeling	VBN	O
kit,	IN	O
Boehringer-Mannheim)	NNP	O
for	JJ	O
use	NNP	O
as	VBG	O
a	,	O
probe.	)	O
For	IN	O
blotting,	NN	O
hybridization	IN	O
was	DT	O
performed	.	O
overnight	IN	O
at	,	O
42°	NN	O
C.	VBD	O
in	VBN	O
a	RB	O
solution	IN	O
comprising	CD	O
50%	NNP	O
formamide/5×SSC/50×Denhardt's	IN	O
solution/0.1%	DT	O
SDS	NN	O
(containing	VBG	O
100	NN	O
μg/ml	POS	O
denatured	NN	O
salmon	NNP	O
sperm	VBG	O
DNA).	CD	O
After	NN	O
washing	VBD	O
with	JJ	O
two	JJ	O
portions	.	O
of	IN	O
2×SSC/0.01%	VBG	O
SDS	IN	O
at	CD	O
room	NNS	O
temperature,	IN	O
the	NN	O
membrane	NNP	O
filter	IN	O
was	NN	O
further	,	O
washed	DT	O
three	NN	O
times	NN	O
with	VBD	O
0.1×SSC/0.05%	RBR	O
SDS	VBD	O
at	CD	O
50°	NNS	O
C.	IN	O
for	NN	O
40	NNP	O
minutes.	IN	O
An	CD	O
X-ray	NNP	O
film	IN	O
(Kodak)	CD	O
was	.	O
exposed	DT	O
to	JJ	O
the	NN	O
filter	)	O
at	VBD	O
−70°	VBN	O
C.	TO	O
for	DT	O
18	NN	O
hours.	IN	O
As	NNP	O
a	NNP	O
result,	IN	O
it	CD	O
was	.	O
revealed	IN	O
that	DT	O
a	,	O
900-bp	PRP	O
transcript	VBD	O
had	VBN	O
been	IN	O
expressed	DT	O
in	JJ	O
all	NN	O
the	VBD	O
human	VBN	O
tissues	VBN	O
tested.	IN	O
In	PDT	O
addition,	DT	O
a	JJ	O
3.2-kb	NNS	O
transcript	.	O
was	IN	O
observed	,	O
specifically	DT	O
in	JJ	O
the	NN	O
heart	VBD	O
and	VBN	O
skeletal	RB	O
muscle.	IN	O
The	DT	O
expression	NN	O
of	CC	O
these	JJ	O
transcripts	.	O
differing	DT	O
in	NN	O
size	IN	O
may	DT	O
be	NNS	O
due	VBG	O
either	IN	O
to	NN	O
alternative	MD	O
splicing	VB	O
or	JJ	O
to	DT	O
cross	TO	O
hybridization	JJ	O
with	NN	O
homologous	CC	O
genes.	TO	O
(3)	VB	O
Cosmid	NN	O
Clone	IN	O
and	JJ	O
Chromosome	.	O
Localization	)	O
by	NNP	O
FISH	NNP	O
FISH	CC	O
was	NNP	O
performed	NNP	O
by	IN	O
screening	NNP	O
a	NNP	O
library	VBD	O
of	VBN	O
human	IN	O
chromosomes	VBG	O
cloned	DT	O
in	NN	O
the	IN	O
cosmid	JJ	O
vector	NNS	O
pWE15	VBN	O
using,	IN	O
as	DT	O
a	NN	O
probe,	NN	O
the	NN	O
0.8-kb	,	O
insert	IN	O
of	DT	O
the	,	O
cDNA	DT	O
clone	JJ	O
Sambrook,	NN	B
J.,	IN	I
et	DT	I
al.,	NN	I
Molecular	NN	I
Cloning,	,	I
2nd	,	I
Ed.,	FW	I
pp.	,	I
3.1-3.58,	NNP	I
Cold	,	I
Spring	CD	I
Harbor	,	I
Laboratory	.	I
Press,	,	I
Cold	NNP	I
Spring	NNP	I
Harbor,	NNP	I
N.Y.	NNP	I
(1989)].[	,	O
FISH	NNP	O
for	NNP	O
chromosome	,	O
assignment	NNP	O
was	.	O
carried	NN	O
out	IN	O
by	NN	O
the	NN	O
method	VBD	O
of	VBN	O
Inazawa	RP	O
et	IN	O
al.	DT	O
which	NN	O
comprises	IN	O
G-banding	NNP	O
pattern	FW	O
comparison	.	O
for	WDT	O
confirmation	VBZ	O
Inazawa,	NNP	B
J.,	NN	I
et	NN	I
al.,	IN	I
Genomics,	NN	I
17,	,	I
153-162	,	I
(1993)].[	FW	O
For	,	O
use	,	O
as	,	O
a	CD	O
probe,	.	O
the	IN	O
cosmid	NN	O
DNA	IN	O
(0.5	DT	O
μg)	,	O
obtained	DT	O
from	NN	O
chromosome	NNP	O
screening	CD	O
and	)	O
corresponding	VBD	O
to	IN	O
GEN-501D08	NN	O
was	NN	O
labeled	CC	O
with	VBG	O
biotin-16-dUTP	TO	O
by	NNP	O
nick	VBD	O
translation.	VBN	O
To	IN	O
eliminate	NN	O
the	IN	O
background	JJ	O
noise	.	O
due	TO	O
to	VB	O
repetitive	DT	O
sequences,	NN	O
0.5	NN	O
μl	JJ	O
of	TO	O
sonicated	JJ	O
human	,	O
placenta	CD	O
DNA	NN	O
(10	IN	O
mg/ml)	JJ	O
was	JJ	O
added	NN	O
to	NNP	O
9.5	CD	O
μl	)	O
of	VBD	O
the	VBN	O
probe	TO	O
solution.	CD	O
The	NN	O
mixture	IN	O
was	DT	O
denatured	NN	O
at	.	O
80°	DT	O
C.	NN	O
for	VBD	O
5	VBN	O
minutes	IN	O
and	CD	O
admixed	NNP	O
with	IN	O
an	CD	O
equal	NNS	O
volume	CC	O
of	JJ	O
4×SSC	IN	O
containing	DT	O
20%	JJ	O
dextransulfate.	NN	O
Then,	IN	O
a	CD	O
denatured	VBG	O
slide	NN	O
was	.	O
sown	,	O
with	DT	O
the	JJ	O
hybridization	NN	O
mixture	VBD	O
and,	VBN	O
after	IN	O
covering	DT	O
with	NN	O
paraffin,	NN	O
incubated	,	O
in	IN	O
a	VBG	O
wet	IN	O
chamber	,	O
at	VBN	O
37°	IN	O
C.	DT	O
for	JJ	O
16	NN	O
to	IN	O
18	CD	O
hours.	NNP	O
After	IN	O
washing	CD	O
with	TO	O
50%	CD	O
formamide/2×SSC	.	O
at	IN	O
37°	VBG	O
C.	IN	O
for	NN	O
15	NN	O
minutes,	IN	O
the	CD	O
slide	NNP	O
was	IN	O
washed	CD	O
with	,	O
2×SSC	DT	O
for	NN	O
15	VBD	O
minutes	VBN	O
and	IN	O
further	CD	O
with	IN	O
1×SSC	CD	O
for	NNS	O
15	CC	O
minutes.	RB	O
The	IN	O
slide	CD	O
was	IN	O
then	CD	O
incubated	.	O
in	DT	O
4×SSC	NN	O
supplemented	VBD	O
with	RB	O
“1%	VBN	O
Block	IN	O
Ace”	CD	O
(trademark;	JJ	O
Dainippon	IN	O
Pharmaceutical)	NN	O
containing	NNP	O
avidin-FITC	NNP	O
(5	:	O
μg/ml)	NNP	O
at	)	O
37°	VBG	O
C.	JJ	O
for	CD	O
40	)	O
minutes.	IN	O
Then,	CD	O
the	NNP	O
slide	IN	O
was	CD	O
washed	.	O
with	,	O
4×SSC	DT	O
for	NN	O
10	VBD	O
minutes	VBN	O
and	IN	O
with	CD	O
4×SSC	IN	O
containing	CD	O
0.05%	NNS	O
Triton	CC	O
X-100	IN	O
for	CD	O
10	VBG	O
minutes	NN	O
and	NNP	O
immersed	NNP	O
in	IN	O
an	CD	O
antifading	NNS	O
PPD	CC	O
solution	VBN	O
[prepared	IN	O
by	DT	O
adjusting	NN	O
100	NNP	O
mg	NN	O
of	VBN	O
PPD	IN	O
(Wako	VBG	O
Catalog	CD	O
No.	NN	O
164-015321)	IN	O
and	NNP	O
10	NNP	O
ml	NNP	O
of	.	O
PBS(−)	)	O
(pH	CC	O
7.4)	CD	O
to	NN	O
pH	IN	O
8.0	)	O
with	$	O
0.5	)	O
M	TO	O
Na2CO3/0.5	VB	O
M	CD	O
NaHCO3	IN	O
(9:1,	CD	O
v/v)	NNP	O
buffer	NNP	O
(pH	NNP	O
9.0)	NNP	O
and	,	O
adding	)	O
glycerol	NN	O
to	JJ	O
make	)	O
a	CC	O
total	VBG	O
volume	NN	O
of	TO	O
100	VB	O
ml]	DT	O
containing	JJ	O
1%	NN	O
DABCO	IN	O
[1%	CD	O
DABCO	VBD	O
(Sigma)	VBG	O
in	NN	O
PBS(−):glycerol	NNP	O
1:9	NN	O
(v:v)],	NNP	O
followed	)	O
by	IN	O
counter	NN	O
staining	CD	O
with	,	O
DAPI	VBN	O
(4,6-diamino-2-phenylindole;	IN	O
Sigma).	NN	O
With	VBG	O
more	IN	O
than	NNP	O
100	:	O
tested	.	O
cells	IN	O
in	JJR	O
the	IN	O
metaphase,	CD	O
a	JJ	O
specific	NNS	O
hybridization	IN	O
signal	DT	O
was	,	O
observed	DT	O
on	JJ	O
the	NN	O
chromosome	NN	O
band	VBD	O
at	VBN	O
6p21.3,	IN	O
without	DT	O
any	NN	O
signal	NN	O
on	IN	O
other	,	O
chromosomes.	IN	O
It	DT	O
was	NN	O
thus	IN	O
confirmed	JJ	O
that	.	O
the	PRP	O
RalGDS	VBD	O
gene	RB	O
is	VBN	O
located	IN	O
on	DT	O
the	NNP	O
chromosome	NN	O
6p21.3.	VBZ	O
By	VBN	O
using	IN	O
the	DT	O
novel	NN	O
human	.	O
RalGDS-associated	IN	O
gene	VBG	O
of	DT	O
the	JJ	O
present	JJ	O
invention	JJ	O
as	NN	O
obtained	IN	O
in	DT	O
this	JJ	O
example,	NN	O
the	IN	O
expression	VBN	O
of	IN	O
said	DT	O
gene	,	O
in	DT	O
various	NN	O
tissues	IN	O
can	VBD	O
be	NN	O
detected	IN	O
and	JJ	O
the	NNS	O
human	MD	O
RalGDS	VB	O
protein	VBN	O
can	CC	O
be	DT	O
produced	JJ	O
in	NNP	O
the	NN	O
manner	MD	O
of	VB	O
genetic	VBN	O
engineering.	IN	O
These	DT	O
are	NN	O
expected	IN	O
to	JJ	O
enable	.	O
studies	DT	O
on	VBP	O
the	VBN	O
roles	TO	O
of	VB	O
the	NNS	O
expression	IN	O
product	DT	O
protein	NNS	O
and	IN	O
ras-mediated	DT	O
signals	NN	O
in	NN	O
transduction	NN	O
pathways	CC	O
as	JJ	O
well	NNS	O
as	IN	O
pathological	NN	O
investigations	NNS	O
of	RB	O
diseases	RB	O
in	IN	O
which	JJ	O
these	NNS	O
are	IN	O
involved,	NNS	O
for	IN	O
example	WDT	O
cancer,	DT	O
and	VBP	O
the	,	O
diagnosis	IN	O
and	NN	O
treatment	,	O
of	CC	O
such	DT	O
diseases.	NN	O
Furthermore,	CC	O
it	NN	O
becomes	IN	O
possible	JJ	O
to	.	O
study	,	O
the	PRP	O
development	VBZ	O
and	JJ	O
progress	TO	O
of	VB	O
diseases	DT	O
involving	NN	O
the	CC	O
same	NN	O
chromosomal	IN	O
translocation	NNS	O
of	VBG	O
the	DT	O
RalGDS	JJ	O
protein	JJ	O
gene	NN	O
of	IN	O
the	DT	O
present	NNP	O
invention,	NN	O
for	NN	O
example	IN	O
tonic	DT	O
spondylitis,	JJ	O
atrial	,	O
septal	IN	O
defect,	NN	O
pigmentary	JJ	O
retinopathy,	,	O
aphasia	JJ	O
and	NN	O
the	,	O
like.	JJ	O
Example	,	O
2	NN	O
Cytoskeleton-Associated	CC	O
Protein	DT	O
2	.	O
Gene	JJ	O
(CKAP2	CD	O
Gene)	JJ	O
(1)	NNP	O
Cytoskeleton-Associated	CD	O
Protein	NNP	O
2	NNP	O
Gene	)	O
Cloning	)	O
and	JJ	O
DNA	NNP	O
Sequencing	CD	O
cDNA	NNP	O
clones	NNP	O
were	CC	O
arbitrarily	NNP	O
chosen	NNP	O
from	NN	O
a	NNS	O
human	VBD	O
fetal	RB	O
brain	VBN	O
cDNA	IN	O
library	DT	O
in	JJ	O
the	NN	O
same	NN	O
manner	NN	O
as	NN	O
in	IN	O
Example	DT	O
1	JJ	O
were	NN	O
subjected	IN	O
to	IN	O
sequence	NNP	O
analysis	CD	O
and,	VBD	O
as	VBN	O
a	TO	O
result,	VB	O
a	NN	O
clone	,	O
having	IN	O
a	DT	O
base	,	O
sequence	DT	O
containing	NN	O
the	VBG	O
CAP-glycine	DT	O
domain	NN	O
of	NN	O
the	VBG	O
human	DT	O
cytoskeleton-associated	NNP	O
protein	NN	O
(CAP)	IN	O
gene	DT	O
and	JJ	O
highly	JJ	O
homologous	NN	O
to	)	O
several	NN	O
CAP	CC	O
family	RB	O
genes	JJ	O
was	TO	O
found	JJ	O
and	NNP	O
named	NN	O
GEN-080G01.	NNS	O
Meanwhile,	VBD	O
the	VBN	O
cytoskeleton	CC	O
occurs	VBN	O
in	.	O
the	,	O
cytoplasm	DT	O
and	NN	O
just	VBZ	O
inside	IN	O
the	DT	O
cell	NN	O
membrane	CC	O
of	RB	O
eukaryotic	IN	O
cells	DT	O
and	NN	O
is	NN	O
a	IN	O
network	JJ	O
structure	NNS	O
comprising	CC	O
complicatedly	VBZ	O
entangled	DT	O
filaments.	NN	O
Said	NN	O
cytoskeleton	VBG	O
is	RB	O
constituted	JJ	O
of	.	O
microtubules	NNP	O
composed	NN	O
of	VBZ	O
tubulin,	VBN	O
microfilaments	IN	O
composed	NNS	O
of	VBN	O
actin,	IN	O
intermediate	,	O
filaments	NNS	O
composed	VBD	O
of	IN	O
desmin	,	O
and	JJ	O
vimentin,	NNS	O
and	VBN	O
so	IN	O
on.	NN	O
The	CC	O
cytoskeleton	,	O
not	CC	O
only	RB	O
acts	.	O
as	DT	O
supportive	NN	O
cellular	RB	O
elements	RB	O
but	VBZ	O
also	IN	O
isokinetically	JJ	O
functions	JJ	O
to	NNS	O
induce	CC	O
morphological	RB	O
changes	RB	O
of	NNS	O
cells	TO	O
by	VB	O
polymerization	JJ	O
and	NNS	O
depolymerization	IN	O
in	NNS	O
the	IN	O
fibrous	NN	O
system.	CC	O
The	NN	O
cytoskeleton	IN	O
binds	DT	O
to	JJ	O
intracellular	.	O
organelles,	DT	O
cell	NN	O
membrane	VBZ	O
receptors	TO	O
and	VB	O
ion	,	O
channels	NN	O
and	NN	O
thus	NNS	O
plays	CC	O
an	NN	O
important	NNS	O
role	CC	O
in	RB	O
intracellular	VBZ	O
movement	DT	O
and	JJ	O
locality	NN	O
maintenance	IN	O
thereof	JJ	O
and,	NN	O
in	CC	O
addition,	NN	O
is	NN	O
said	NN	O
to	,	O
have	IN	O
functions	,	O
in	VBZ	O
activity	VBD	O
regulation	TO	O
and	VB	O
mutual	NNS	O
information	IN	O
transmission.	NN	O
Thus	NN	O
it	CC	O
supposedly	JJ	O
occupies	NN	O
a	.	O
very	RB	O
important	PRP	O
position	RB	O
in	VBZ	O
physiological	DT	O
activity	RB	O
regulation	JJ	O
of	NN	O
the	IN	O
whole	JJ	O
cell.	NN	O
In	NN	O
particular,	IN	O
the	DT	O
relation	JJ	O
between	.	O
canceration	IN	O
of	,	O
cells	DT	O
and	NN	O
qualitative	IN	O
changes	NN	O
of	IN	O
the	NNS	O
cytoskeleton	CC	O
attracts	JJ	O
attention	NNS	O
since	IN	O
cancer	DT	O
cells	NN	O
differ	VBZ	O
in	NN	O
morphology	IN	O
and	NN	O
recognition	NNS	O
response	VBP	O
from	IN	O
normal	NN	O
cells.	CC	O
The	NN	O
activity	NN	O
of	IN	O
this	JJ	O
cytoskeleton	.	O
is	DT	O
modulated	NN	O
by	IN	O
a	DT	O
number	NN	O
of	VBZ	O
cytoskeleton-associated	VBN	O
proteins	IN	O
(CAPs).	DT	O
One	NN	O
group	IN	O
of	JJ	O
CAPs	NNS	O
is	.	O
characterized	CD	O
by	NN	O
a	IN	O
glycine	NNP	O
motif	VBZ	O
highly	VBN	O
conserved	IN	O
and	DT	O
supposedly	JJ	O
contributing	NN	O
to	RB	O
association	VBN	O
with	CC	O
microtubules	RB	O
[CAP-GLY	VBG	O
domain;	TO	O
Riehemann,	NN	B
K.	IN	I
and	NNS	I
Song,	NNP	I
C.,	:	I
Trends	,	I
Biochem.	NNP	I
Sci.,	CC	I
18,	,	I
82-83	,	I
(1993)].Among	NNP	O
the	.	O
members	,	O
of	,	O
this	CD	O
group	.	O
of	IN	O
CAPs,	DT	O
there	NNS	O
are	IN	O
CLIP-170,	DT	O
150	NN	O
kDa	IN	O
DAP	,	O
(dynein-associated	EX	O
protein,	VBP	O
or	,	O
dynactin),	CD	O
D.	NN	O
melanogaster	NNP	O
GLUED,	JJ	O
S.	,	O
cerevisiae	CC	O
BIK1,	,	O
restin	NNP	O
Bilbe,	NN	B
G.,	,	I
et	NNP	I
al.,	NN	I
EMBO	,	I
J.,	NN	I
11,	,	I
2103-2113	,	I
(1992)];[	FW	O
Hilliker,	,	B
C.,	NNP	I
et	,	I
al.,	,	I
Cytogenet.	CD	I
Cell	:	I
Genet.,	,	I
65,	,	I
172-176	FW	I
(1994)]	,	I
and	.	O
C.	NNP	O
elegans	,	O
13.5	,	O
kDa	CD	O
protein	NN	O
Wilson,	CC	B
R.,	NNP	I
et	VBZ	I
al.,	CD	I
Nature,	NN	I
368,	NN	I
32-38	,	I
(1994)].[	,	O
Except	FW	O
for	,	O
the	,	O
last	,	O
two	CD	O
proteins,	.	O
direct	IN	O
or	IN	O
indirect	DT	O
evidences	JJ	O
have	CD	O
suggested	,	O
that	JJ	O
they	CC	O
could	JJ	O
interact	NNS	O
with	VBP	O
microtublues.	VBN	O
The	IN	O
above-mentioned	PRP	O
CLIP-170	MD	O
is	VB	O
essential	IN	O
for	.	O
the	DT	O
in	JJ	O
vitro	NNP	O
binding	VBZ	O
of	JJ	O
endocytic	IN	O
vesicles	DT	O
to	IN	O
microtubules	JJ	O
and	NN	O
colocalizes	IN	O
with	JJ	O
endocytic	NNS	O
organelles	TO	O
Rickard,	NNS	B
J.	CC	I
E.	NNS	I
and	IN	I
Kreis,	JJ	I
T.	NNS	I
E.,	,	I
J.	NNP	I
Biol.	NNP	I
Chem.,	CC	I
18,	,	I
82-83	NNP	I
(1990);	,	I
Pierre,	NNP	B
P.,	.	I
et	,	I
al.,	,	I
Cell,	CD	I
70,	:	I
887-900	,	I
(1992)].[	,	O
The	FW	O
above-mentioned	,	O
dynactin	,	O
is	,	O
one	CD	O
of	.	O
the	DT	O
factors	JJ	O
constituting	NN	O
the	VBZ	O
cytoplasmic	CD	O
dynein	IN	O
motor,	DT	O
which	NNS	O
functions	VBG	O
in	DT	O
retrograde	JJ	O
vesicle	NN	O
transport	,	O
Schroer,	WDT	B
T.	NNS	I
A.	IN	I
and	NN	I
Sheetz,	NN	I
M.	NN	I
P.,	,	I
J.	NNP	I
Cell	NN	I
Biol.,	CC	I
115,	,	I
1309-1318	NNP	I
(1991)]	,	I
[or	.	O
probably	NNP	O
in	,	O
the	,	O
movement	CD	O
of	NN	O
chromosomes	CC	O
during	RB	O
mitosis	IN	O
Pfarr,	DT	B
C.	NN	I
M.,	IN	I
et	NNS	I
al.,	IN	I
Nature,	NN	I
345,	,	I
263-265	NNP	I
(1990);	,	I
Steuer,	FW	B
E.	,	I
R.,	,	I
et	,	I
al.,	CD	I
Nature,	:	I
345,	,	I
266-268	NNP	I
(1990);	,	I
Wordeman,	FW	B
L.,	,	I
et	,	I
al.,	,	I
J.	CD	I
Cell	:	I
Biol.,	,	I
114,	,	I
285-294	FW	I
(1991)].[	,	O
GLUED,	.	O
the	NNP	O
Drosophila	,	O
homolog	,	O
of	CD	O
mammalian	.	O
dynactin,	,	O
is	DT	O
essential	NNP	O
for	NN	O
the	IN	O
viability	JJ	O
of	,	O
almost	VBZ	O
all	JJ	O
cells	IN	O
and	DT	O
for	NN	O
the	IN	O
proper	RB	O
organization	DT	O
of	NNS	O
some	CC	O
neurons	IN	O
Swaroop,	DT	B
A.,	JJ	I
et	NN	I
al.,	IN	I
Proc.	DT	I
Natl.	NNS	I
Acad.	,	I
Sci.	,	I
USA,	FW	I
84,	,	I
6501-6505	.	I
(1987);	.	I
Holzbaur,	.	B
E.	.	I
L.	,	I
P.,	,	I
et	CD	I
al.,	:	I
Nature,	,	I
351,	NNP	I
579-583	NNP	I
(1991)].[	,	O
BIK1	FW	O
interacts	,	O
with	,	O
microtubules	,	O
and	CD	O
plays	.	O
an	NNP	O
important	VBZ	O
role	IN	O
in	NNS	O
spindle	CC	O
formation	VBZ	O
during	DT	O
mitosis	JJ	O
in	NN	O
yeasts	IN	O
Trueheart,	JJ	B
J.,	NN	I
et	IN	I
al.,	NN	I
Mol.	IN	I
Cell.	NNS	I
Biol.,	,	I
7,	,	I
2316-2326	FW	I
(1987);	,	I
Berlin,	.	B
V.,	.	I
et	,	I
al.,	,	I
J.	CD	I
Cell	:	I
Biol.,	,	I
111,	,	I
2573-2586	FW	I
(1990)].[	,	O
At	.	O
present,	NNP	O
these	,	O
genes	,	O
are	CD	O
classified	.	O
under	IN	O
the	,	O
term	DT	O
CAP	NNS	O
family	VBP	O
(CAPS).	VBN	O
As	IN	O
a	DT	O
result	NN	O
of	NNP	O
database	NN	O
searching,	.	O
the	IN	O
above-mentioned	DT	O
cDNA	NN	O
clone	IN	O
of	NN	O
463-bp	,	O
(excluding	DT	O
the	JJ	O
poly-A	NN	O
signal)	NN	O
showed	IN	O
significant	JJ	O
homology	VBG	O
in	DT	O
nucleotide	JJ	O
sequence	)	O
with	VBD	O
the	JJ	O
restin	NN	O
and	IN	O
CLIP-170	JJ	O
encoding	NN	O
genes.	IN	O
However,	DT	O
said	NN	O
clone	CC	O
was	NNP	O
lacking	VBG	O
in	.	O
the	,	O
5′	VBD	O
region	NN	O
as	VBD	O
compared	VBG	O
with	IN	O
the	DT	O
restin	JJ	O
gene	NN	O
and,	IN	O
therefore,	VBN	O
the	IN	O
technique	DT	O
of	NN	O
5′	NN	O
RACE	,	O
Frohman,	,	B
M.	DT	I
A.,	NN	I
et	IN	I
al.,	CD	I
Proc.	NNP	I
Natl.	,	I
Acad.	NNP	I
Sci.	,	I
USA,	FW	I
85,	,	I
8998-9002	.	I
(1988)]	.	I
[was	.	O
used	.	O
to	,	O
isolate	,	O
this	CD	O
missing	NN	O
segment.	VBD	O
(2)	VBN	O
5′	TO	O
RACE	VB	O
(5′	DT	O
Rapid	VBG	O
Amplification	.	O
of	)	O
cDNA	CD	O
Ends)	NNP	O
A	CD	O
cDNA	NNP	O
clone	NNP	O
containing	IN	O
the	NN	O
5′	)	O
portion	NNP	O
of	NN	O
the	NN	O
gene	VBG	O
of	DT	O
the	CD	O
present	NN	O
invention	IN	O
was	DT	O
isolated	NN	O
for	IN	O
analysis	DT	O
by	JJ	O
the	NN	O
5′	VBD	O
RACE	VBN	O
technique	IN	O
using	NN	O
a	IN	O
commercial	DT	O
kit	CD	O
(5′-Rapid	NNP	O
AmpliFinder	NN	O
RACE	VBG	O
kit,	DT	O
Clontech)	JJ	O
according	NN	O
to	JJ	O
the	NNP	O
manufacturer's	NNP	O
protocol	,	O
with	)	O
minor	VBG	O
modifications,	TO	O
as	DT	O
follows.	POS	O
The	NN	O
gene-specific	IN	O
primer	JJ	O
P1	,	O
and	IN	O
primer	.	O
P2	DT	O
used	JJ	O
here	NN	O
were	NNP	O
synthesized	CC	O
by	NN	O
the	NNP	O
conventional	VBD	O
method	RB	O
and	VBD	O
their	VBN	O
nucleotide	IN	O
sequences	DT	O
are	JJ	O
as	NN	O
shown	CC	O
below	PRP$	O
in	JJ	O
Table	NNS	O
1.	VBP	O
The	IN	O
anchor	VBN	O
primer	IN	O
used	IN	O
was	JJ	O
the	.	O
one	DT	O
attached	NN	O
to	NN	O
the	VBN	O
commercial	VBD	O
kit.	DT	O
cDNA	CD	O
was	VBN	O
obtained	TO	O
by	DT	O
reverse	JJ	O
transcription	.	O
of	NN	O
0.1	VBD	O
μg	VBN	O
of	IN	O
human	JJ	O
fetal	NN	O
brain	IN	O
poly(A)+RNA	CD	O
by	NN	O
the	IN	O
random	JJ	O
hexamer	JJ	O
technique	NN	O
using	NN	O
reverse	IN	O
transcriptase	DT	O
(Superscript™	JJ	O
II,	NN	O
Life	NN	O
Technologies)	VBG	O
and	JJ	O
the	NN	O
cDNA	NNP	O
was	,	O
amplified	NNP	O
by	)	O
the	CC	O
first	DT	O
PCR	NN	O
using	VBD	O
the	VBN	O
P1	IN	O
primer	DT	O
and	JJ	O
anchor	NNP	O
primer	VBG	O
according	DT	O
to	NNP	O
Watanabe	NN	O
et	CC	O
al.	NN	O
Watanabe,	NN	B
T.,	VBG	I
et	TO	I
al.,	NNP	I
Cell	FW	I
Genet.,	.	I
in	,	I
press).[	,	O
Thus,	FW	O
to	,	O
0.1	NNP	O
μg	,	O
of	IN	O
the	.	O
above-mentioned	,	O
cDNA	TO	O
were	CD	O
added	NN	O
2.5	IN	O
mM	DT	O
dNTP/1×Taq	JJ	O
buffer	NN	O
(Takara	VBD	O
Shuzo)/0.2	VBN	O
μM	CD	O
P1	JJ	O
primer,	NN	O
0.2	NN	O
μM	NNP	O
adaptor	VBP	O
primer/0.25	JJ	O
unit	NNP	O
ExTaq	,	O
enzyme	CD	O
(Takara	NN	O
Shuzo)	NN	O
to	NN	O
make	NN	O
a	NNP	O
total	NN	O
volume	NNP	O
of	)	O
50	TO	O
μl,	VB	O
followed	DT	O
by	JJ	O
addition	NN	O
of	IN	O
the	CD	O
anchor	,	O
primer.	VBN	O
The	IN	O
mixture	NN	O
was	IN	O
subjected	DT	O
to	NN	O
PCR.	.	O
Thus,	DT	O
35	NN	O
cycles	VBD	O
of	VBN	O
amplification	TO	O
were	.	O
performed	,	O
under	CD	O
the	NNS	O
conditions:	IN	O
94°	NN	O
C.	VBD	O
for	VBN	O
45	IN	O
seconds,	DT	O
60°	:	O
C.	CD	O
for	NNP	O
45	IN	O
seconds,	CD	O
and	,	O
72°	CD	O
C.	NNP	O
for	IN	O
2	CD	O
minutes.	,	O
Finally,	CC	O
the	CD	O
mixture	NNP	O
was	IN	O
heated	CD	O
at	.	O
72°	,	O
C.	DT	O
for	NN	O
5	VBD	O
minutes.	VBN	O
Then,	IN	O
1	CD	O
μl	NNP	O
of	IN	O
the	CD	O
50-μl	.	O
first	,	O
PCR	CD	O
product	NN	O
was	IN	O
subjected	DT	O
to	JJ	O
amplification	JJ	O
by	NNP	O
the	NN	O
second	VBD	O
PCR	VBN	O
using	TO	O
the	NN	O
specific	IN	O
nested	DT	O
P2	JJ	O
primer	NNP	O
and	VBG	O
anchor	DT	O
primer.	NN	O
The	VBD	O
second	NNP	O
PCR	NN	O
product	CC	O
was	NN	O
analyzed	.	O
by	DT	O
1.5%	JJ	O
agarose	NNP	O
gel	NN	O
electrophoresis.	VBD	O
Upon	VBN	O
agarose	IN	O
gel	NN	O
electrophoresis,	JJ	O
a	JJ	O
single	.	O
band,	IN	O
about	JJ	O
650	JJ	O
nucleotides	,	O
in	DT	O
size,	JJ	O
was	,	O
detected.	RB	O
The	CD	O
product	NNS	O
from	IN	O
this	,	O
band	VBD	O
was	.	O
inserted	DT	O
into	NN	O
a	IN	O
vector	DT	O
(pT7Blue(R)T-Vector,	NN	O
Novagen)	VBD	O
and	VBN	O
a	IN	O
plurality	DT	O
of	NN	O
clones	,	O
with	)	O
an	CC	O
insert	DT	O
having	NN	O
an	IN	O
appropriate	NNS	O
size	IN	O
were	DT	O
selected.	NN	O
Six	VBG	O
of	DT	O
the	JJ	O
5′	NN	O
RACE	VBD	O
clones	.	O
obtained	CD	O
from	IN	O
the	DT	O
PCR	CD	O
product	NNP	O
had	NNS	O
the	VBN	O
same	IN	O
sequence	DT	O
but	NNP	O
had	NN	O
different	VBD	O
lengths.	DT	O
By	JJ	O
sequencing	NN	O
two	CC	O
overlapping	VBD	O
cDNA	JJ	O
clones,	.	O
GEN-080G01	IN	O
and	VBG	O
GEN-080G0149,	CD	O
the	VBG	O
protein-encoding	NN	O
sequence	,	O
and	NNP	O
5′	CC	O
and	,	O
3′	DT	O
flanking	JJ	O
sequences,	NN	O
1015	CC	O
nucleotides	CD	O
in	CC	O
total	CD	O
length,	NN	O
were	,	O
determined.	CD	O
Said	NNS	O
gene	IN	O
was	JJ	O
named	,	O
cytoskeleton-associated	VBD	O
protein	.	O
2	NNP	O
gene	NN	O
(CKAP2	VBD	O
gene).	VBN	O
The	JJ	O
nucleotide	NN	O
sequence	CD	O
obtained	NN	O
from	NNP	O
the	.	O
above-mentioned	DT	O
two	JJ	O
overlapping	NN	O
cDNA	VBN	O
clones	IN	O
GEN-080G01	DT	O
and	JJ	O
GEN-080G0149	CD	O
is	VBG	O
shown	NN	O
under	NNS	O
SEQ	NNP	O
ID	CC	O
NO:6,	NNP	O
the	VBZ	O
nucleotide	VBN	O
sequence	IN	O
of	NNP	O
the	NNP	O
coding	,	O
region	DT	O
of	JJ	O
said	NN	O
clone	IN	O
under	DT	O
SEQ	VBG	O
ID	NN	O
NO:5,	IN	O
and	VBD	O
the	NN	O
amino	IN	O
acid	NNP	O
sequence	NNP	O
encoded	,	O
by	CC	O
said	DT	O
nucleotide	NN	O
sequence	JJ	O
under	NN	O
SEQ	VBN	O
ID	IN	O
NO:4.	VBD	O
As	JJ	O
shown	NN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:6,	.	O
the	IN	O
CKAP2	VBN	O
gene	IN	O
had	NNP	O
a	NNP	O
relatively	,	O
GC-rich	DT	O
5′	NNP	O
noncoding	NN	O
region,	VBD	O
with	DT	O
incomplete	RB	O
triplet	JJ	O
repeats,	CD	O
(CAG)4(CGG)4(CTG)(CGG),	JJ	O
occurring	,	O
at	IN	O
nucleotides	JJ	O
40-69.	NN	O
ATG	,	O
located	,	O
at	VBG	O
nucleotides	IN	O
274-276	JJ	O
is	.	O
the	NNP	O
presumable	VBN	O
start	IN	O
codon.	JJ	O
A	JJ	O
stop	VBZ	O
codon	DT	O
(TGA)	JJ	O
was	NN	O
situated	.	O
at	DT	O
nucleotides	JJ	O
853-855.	NN	O
A	)	O
polyadenylation	VBD	O
signal	VBN	O
(ATTAAA)	IN	O
was	JJ	O
followed	.	O
by	DT	O
16	NN	O
nucleotides	NN	O
before	)	O
the	VBD	O
poly(A)	VBN	O
start.	IN	O
The	CD	O
estimated	NNS	O
open	IN	O
reading	DT	O
frame	)	O
comprises	.	O
579	DT	O
nucleotides	VBN	O
coding	JJ	O
for	NN	O
193	NN	O
amino	VBZ	O
acid	CD	O
residues	NNS	O
with	VBG	O
a	IN	O
calculated	CD	O
molecular	NN	O
weight	NN	O
of	NNS	O
21,800	IN	O
daltons.	DT	O
The	JJ	O
coding	JJ	O
region	NN	O
was	IN	O
further	CD	O
amplified	.	O
by	DT	O
RT-PCR,	VBG	O
to	NN	O
eliminate	VBD	O
the	RB	O
possibility	VBN	O
of	IN	O
the	,	O
synthetic	TO	O
sequence	VB	O
obtained	DT	O
being	NN	O
a	IN	O
cDNA	DT	O
chimera.	JJ	O
(2)	NN	O
Similarity	VBD	O
of	VBG	O
CKAP2	DT	O
to	NN	O
Other	.	O
CAPs	)	O
While	NN	O
sequencing	IN	O
of	NNP	O
CKAP2	TO	O
revealed	JJ	O
homology	NNP	O
with	IN	O
the	VBG	O
sequences	IN	O
of	NNP	O
restin	VBD	O
and	NN	O
CLIP-170,	IN	O
the	DT	O
homologous	NNS	O
region	IN	O
was	NN	O
limited	CC	O
to	,	O
a	DT	O
short	JJ	O
sequence	NN	O
corresponding	VBD	O
to	VBN	O
the	TO	O
CAP-GLY	DT	O
domain.	JJ	O
On	NN	O
the	VBG	O
amino	TO	O
acid	DT	O
level,	NNP	O
the	.	O
deduced	IN	O
CKAP2	DT	O
was	NN	O
highly	JJ	O
homologous	,	O
to	DT	O
five	JJ	O
other	NNP	O
CAPs	VBD	O
in	RB	O
this	JJ	O
domain.	TO	O
CKAP2	CD	O
was	JJ	O
lacking	NNPS	O
in	IN	O
such	DT	O
other	.	O
motif	NNP	O
characteristics	VBD	O
of	VBG	O
some	IN	O
CAPs	JJ	O
as	JJ	O
the	NN	O
alpha	NNS	O
helical	IN	O
rod	DT	O
and	NNP	O
zinc	IN	O
finger	DT	O
motif.	JJ	O
The	JJ	O
alpha	NN	O
helical	CC	O
rod	NN	O
is	NN	O
thought	.	O
to	DT	O
contribute	JJ	O
to	JJ	O
dimerization	NN	O
and	VBZ	O
to	VBN	O
increase	TO	O
the	VB	O
microtubule	TO	O
binding	NN	O
capacity	CC	O
Pierre,	TO	B
P.,	VB	I
et	DT	I
al.,	NN	I
Cell,	VBG	I
70,	NN	I
887-900	,	I
(1992)].[	,	O
The	FW	O
lack	,	O
of	,	O
the	,	O
alpha	CD	O
helical	.	O
domain	DT	O
might	NN	O
mean	IN	O
that	DT	O
CKAP2	JJ	O
be	JJ	O
incapable	NN	O
of	MD	O
homo	VB	O
or	IN	O
hetero	NNP	O
dimer	VB	O
formation.	JJ	O
Paralleling	IN	O
of	NN	O
the	CC	O
CAP-GLY	NN	O
domains	NN	O
of	.	O
these	VBG	O
proteins	IN	O
revealed	DT	O
that	NNP	O
other	NNS	O
conserved	IN	O
residues	DT	O
other	NNS	O
than	VBD	O
glycine	IN	O
residues	JJ	O
are	VBD	O
also	NNS	O
found	JJ	O
in	IN	O
CKAP2.	JJ	O
CAPs	NNS	O
having	VBP	O
a	RB	O
CAP-GLY	VBN	O
domain	IN	O
are	.	O
thought	NNP	O
to	VBG	O
be	DT	O
associated	JJ	O
with	NN	O
the	VBP	O
activities	VBN	O
of	TO	O
cellular	VB	O
organelles	VBN	O
and	IN	O
the	DT	O
interactions	NNS	O
thereof	IN	O
with	JJ	O
microtubules.	NNS	O
Since	CC	O
it	DT	O
contains	NNS	O
a	VBP	O
CAP-GLY	IN	O
domain,	.	O
as	IN	O
mentioned	PRP	O
above,	VBZ	O
CKAP2	DT	O
is	JJ	O
placed	,	O
in	IN	O
the	VBN	O
family	,	O
of	NNP	O
CAPs.	VBZ	O
Studies	VBN	O
with	IN	O
mutants	DT	O
of	NN	O
Glued	IN	O
have	.	O
revealed	NNS	O
that	IN	O
the	NNS	O
Glued	IN	O
product	NNP	O
plays	VBP	O
an	VBN	O
important	IN	O
role	DT	O
in	NNP	O
almost	NN	O
all	VBZ	O
cells	DT	O
Swaroop,	JJ	B
A.,	NN	I
et	IN	I
al.,	RB	I
Proc.	DT	I
Natl.	NNS	I
Acad.	,	I
Sci.	,	I
USA,	FW	I
84,	,	I
6501-6505	.	I
(1987)]	.	I
[and	.	O
that	.	O
it	,	O
has	,	O
other	CD	O
neuron-specific	NN	O
functions	CC	O
in	IN	O
neuronal	PRP	O
cells	VBZ	O
Meyerowitz,	JJ	B
E.	JJ	I
M.	NNS	I
and	IN	I
Kankel,	JJ	I
D.	NNS	I
R.,	,	I
Dev.	NNP	I
Biol.,	NNP	I
62,	CC	I
112-142	,	I
(1978)].[	NNP	O
These	,	O
microtubule-associated	.	O
proteins	,	O
are	,	O
thought	CD	O
to	.	O
function	DT	O
in	JJ	O
vesicle	NNS	O
transport	VBP	O
and	VBN	O
mitosis.	TO	O
Because	VB	O
of	IN	O
the	NN	O
importance	NN	O
of	CC	O
the	.	O
vesicle	IN	O
transport	IN	O
system	DT	O
in	NN	O
neuronal	IN	O
cells,	DT	O
defects	NN	O
in	NN	O
these	NN	O
components	IN	O
might	JJ	O
lead	,	O
to	NNS	O
aberrant	IN	O
neuronal	DT	O
systems.	NNS	O
In	MD	O
view	VB	O
of	TO	O
the	JJ	O
above,	JJ	O
CKAP2	.	O
might	IN	O
be	NN	O
involved	IN	O
in	DT	O
specific	,	O
neuronal	NNP	O
functions	MD	O
as	VB	O
well	VBN	O
as	IN	O
in	JJ	O
fundamental	JJ	O
cellular	NNS	O
functions.	RB	O
(3)	RB	O
Northern	IN	O
Blot	IN	O
Analysis	JJ	O
The	JJ	O
expression	.	O
of	)	O
human	NNP	O
CKAP2	NNP	O
mRNA	NNP	O
in	DT	O
normal	NN	O
human	IN	O
tissues	JJ	O
was	NNP	O
examined	NN	O
by	IN	O
Northern	JJ	O
blotting	JJ	O
in	NNS	O
the	VBD	O
same	VBN	O
manner	IN	O
as	NNP	O
in	VBG	O
Example	IN	O
1	DT	O
(2)	JJ	O
using	NN	O
the	IN	O
GEN-080G01	IN	O
clone	NNP	O
(corresponding	CD	O
to	)	O
nucleotides	VBG	O
553-1015)	DT	O
as	NNP	O
a	NN	O
probe.	VBG	O
As	TO	O
a	VB	O
result,	)	O
in	IN	O
all	DT	O
the	.	O
eight	IN	O
tissues	DT	O
tested,	,	O
namely	IN	O
human	PDT	O
heart,	DT	O
brain,	CD	O
placenta,	NNS	O
lung,	,	O
liver,	RB	O
skeletal	JJ	O
muscle,	,	O
kidney	,	O
and	,	O
pancreas,	,	O
a	,	O
1.0	JJ	O
kb	,	O
transcript	NN	O
agreeing	CC	O
in	,	O
size	DT	O
with	CD	O
the	NN	O
CKAP2	NN	O
cDNA	VBG	O
was	IN	O
detected.	NN	O
Said	IN	O
1.0	DT	O
kb	NNP	O
transcript	NN	O
was	VBD	O
expressed	.	O
at	VBD	O
significantly	CD	O
higher	NN	O
levels	NN	O
in	VBD	O
heart	VBN	O
and	IN	O
brain	RB	O
than	JJR	O
in	NNS	O
the	IN	O
other	NN	O
tissues	CC	O
examined.	NN	O
Two	IN	O
weak	IN	O
bands,	DT	O
3.4	JJ	O
kb	NNS	O
and	.	O
4.6	CD	O
kb,	JJ	O
were	,	O
also	CD	O
detected	NN	O
in	CC	O
all	CD	O
the	,	O
tissues	VBD	O
examined.	RB	O
According	VBN	O
to	IN	O
the	PDT	O
Northern	DT	O
blot	NNS	O
analysis,	.	O
the	VBG	O
3.4	TO	O
kb	DT	O
and	NNP	O
4.6	NN	O
kb	,	O
transcripts	DT	O
might	CD	O
possibly	NN	O
be	CC	O
derived	CD	O
from	NNS	O
the	NNS	O
same	MD	O
gene	RB	O
coding	VB	O
for	VBN	O
the	IN	O
1.0	DT	O
kb	JJ	O
CKAP2	NN	O
by	VBG	O
alternative	IN	O
splicing	DT	O
or	CD	O
transcribed	NNS	O
from	NNP	O
other	IN	O
related	JJ	O
genes.	NN	O
These	CC	O
characteristics	VBN	O
of	IN	O
the	JJ	O
transcripts	VBN	O
may	.	O
indicate	DT	O
that	NNS	O
CKAP2	IN	O
might	DT	O
also	NNS	O
code	MD	O
for	VB	O
a	DT	O
protein	NNP	O
having	MD	O
a	RB	O
CAP-GLY	VB	O
domain	IN	O
as	DT	O
well	NN	O
as	VBG	O
an	DT	O
alpha	JJ	O
helix.	NN	O
(4)	RB	O
Cosmid	RB	O
Cloning	IN	O
and	DT	O
Chromosomal	JJ	O
Localization	.	O
by	)	O
Direct	NNP	O
R-Banding	NNP	O
FISH	CC	O
Two	NNP	O
cosmids	NNP	O
corresponding	IN	O
to	NNP	O
the	NNP	O
CKAP2	NNP	O
cDNA	CD	O
were	NNS	O
obtained.	VBG	O
These	TO	O
two	DT	O
cosmid	NNP	O
clones	NN	O
were	VBD	O
subjected	.	O
to	DT	O
direct	CD	O
R-banding	NN	O
FISH	NNS	O
in	VBD	O
the	VBN	O
same	TO	O
manner	VB	O
as	NNP	O
in	NNP	O
Example	IN	O
1	DT	O
(3)	JJ	O
for	NN	O
chromosomal	IN	O
locus	IN	O
mapping	NNP	O
of	CD	O
CKAP2.	)	O
For	IN	O
suppressing	JJ	O
the	NN	O
background	NN	O
due	IN	O
to	.	O
repetitive	IN	O
sequences,	VBG	O
a	DT	O
20-fold	NN	O
excessive	JJ	O
amount	TO	O
of	JJ	O
human	,	O
Cot-I	DT	O
DNA	JJ	O
(BRL)	JJ	O
was	NN	O
added	IN	O
as	JJ	O
described	NNP	O
by	NNP	O
Lichter	)	O
et	VBD	O
al.	VBN	O
Lichter,	IN	B
P.,	VBN	I
et	IN	I
al.,	NNP	I
Proc.	CC	I
Natl.	.	I
Acad.	,	I
Sci.	,	I
USA,	FW	I
87,	,	I
6634-6638	.	I
(1990)].[	.	O
A	.	O
Provia	.	O
100	,	O
film	,	O
(Fuji	CD	O
ISO	.	O
100;	DT	O
Fuji	NNP	O
Photo	CD	O
Film)	NN	O
was	NNP	O
used	NNP	O
for	:	O
photomicrography.	NNP	O
As	NNP	O
a	)	O
result,	VBD	O
CKAP2	VBN	O
was	IN	O
mapped	.	O
on	IN	O
chromosome	DT	O
bands	,	O
19q13.11-q13.12.	NNP	O
Two	VBD	O
autosomal	VBN	O
dominant	IN	O
neurological	NN	O
diseases	NNS	O
have	.	O
been	CD	O
localized	JJ	O
to	JJ	O
this	JJ	O
region	NNS	O
by	VBP	O
linkage	VBN	O
analysis:	VBN	O
CADASIL	TO	O
(cerebral	DT	O
autosomal	NN	O
dominant	IN	O
arteriopathy	NN	O
with	:	O
subcortical	NNP	O
infarcts	JJ	O
and	NN	O
leukoencephalopathy)	JJ	O
between	JJ	O
the	IN	O
DNA	JJ	O
markers	NNS	O
D195221	CC	O
and	)	O
D195222,	IN	O
and	DT	O
FHM	NNP	O
(familial	NNS	O
hemiplegic	NNP	O
migraine)	CC	O
between	,	O
D195215	CC	O
and	NNP	O
D195216.	JJ	O
These	NN	O
two	)	O
diseases	IN	O
may	NNP	O
be	CC	O
allelic	.	O
disorders	DT	O
in	CD	O
which	NNS	O
the	MD	O
same	VB	O
gene	JJ	O
is	NNS	O
involved	IN	O
Tournier-Lasserve,	WDT	B
E.,	DT	I
et	JJ	I
al.,	NN	I
Nature	VBZ	I
Genet.,	VBN	I
3,	,	I
256-259	,	I
(1993);	FW	I
Joutel,	,	B
A.,	NNP	I
et	,	I
al.,	,	I
Nature	CD	I
Genet.,	:	I
5,	,	I
40-45	,	I
(1993)].[	FW	O
Although	,	O
no	NNP	O
evidence	,	O
is	,	O
available	CD	O
to	.	O
support	IN	O
CKAP2	DT	O
as	NN	O
a	VBZ	O
candidate	JJ	O
gene	TO	O
for	VB	O
FHM	NNP	O
or	IN	O
CADASIL,	DT	O
it	NN	O
is	NN	O
conceivable	IN	O
that	NNP	O
its	CC	O
mutation	,	O
might	PRP	O
lead	VBZ	O
to	JJ	O
some	IN	O
or	PRP$	O
other	NN	O
neurological	MD	O
disease.	VB	O
By	TO	O
using	DT	O
the	CC	O
novel	JJ	O
human	JJ	O
CKAP2	.	O
gene	IN	O
of	VBG	O
the	DT	O
present	JJ	O
invention	JJ	O
as	NNP	O
obtained	NN	O
in	IN	O
this	DT	O
example,	JJ	O
it	NN	O
is	IN	O
possible	VBN	O
to	IN	O
detect	DT	O
the	,	O
expression	PRP	O
of	VBZ	O
said	JJ	O
gene	TO	O
in	VB	O
various	DT	O
tissues	NN	O
or	IN	O
produce	VBD	O
the	NN	O
human	IN	O
CKAP2	JJ	O
gene	NNS	O
in	CC	O
the	VB	O
manner	DT	O
of	JJ	O
genetic	NNP	O
engineering.	NN	O
Through	IN	O
these,	DT	O
it	NN	O
becomes	IN	O
possible	JJ	O
to	.	O
analyze	IN	O
the	,	O
functions	PRP	O
of	VBZ	O
the	JJ	O
human	TO	O
CKAP2	VB	O
system	DT	O
or	NNS	O
human	IN	O
CKAP2,	DT	O
which	JJ	O
is	NNP	O
involved	NN	O
in	CC	O
diverse	JJ	O
activities	,	O
essential	WDT	O
to	VBZ	O
cells,	VBN	O
as	IN	O
mentioned	JJ	O
above,	NNS	O
to	JJ	O
diagnose	TO	O
various	,	O
neurological	IN	O
diseases	VBN	O
in	,	O
which	TO	O
said	VB	O
system	JJ	O
or	JJ	O
gene	NNS	O
is	IN	O
involved,	WDT	O
for	VBD	O
example	NN	O
familial	CC	O
migraine,	NN	O
and	VBZ	O
to	,	O
screen	IN	O
out	NN	O
and	JJ	O
evaluate	,	O
a	CC	O
therapeutic	TO	O
or	VB	O
prophylactic	RP	O
drug	CC	O
therefor.	VB	O
Example	DT	O
3	JJ	O
OTK27	CC	O
Gene	JJ	O
(1)	NN	O
OTK27	.	O
Gene	RB	O
Cloning	CD	O
and	NNP	O
DNA	NNP	O
Sequencing	)	O
As	NNP	O
a	NNP	O
result	NNP	O
of	CC	O
sequence	NNP	O
analysis	NNP	O
of	IN	O
cDNA	DT	O
clones	NN	O
arbitraily	IN	O
selected	NN	O
from	NN	O
a	IN	O
human	NN	O
fetal	NNS	O
brain	RB	O
cDNA	VBN	O
library	IN	O
in	DT	O
the	JJ	O
same	NN	O
manner	NN	O
as	NN	O
in	NN	O
Example	IN	O
1	DT	O
(1)	JJ	O
and	NN	O
database	IN	O
searching,	IN	O
a	NNP	O
cDNA	CD	O
clone,	)	O
GEN-025F07,	CC	O
coding	NN	O
for	,	O
a	DT	O
protein	NN	O
highly	,	O
homologous	,	O
to	VBG	O
NHP2,	IN	O
a	DT	O
yeast	NN	O
nucleoprotein	RB	O
Saccharomyces	JJ	B
cerevisiae;	TO	I
Kolodrubetz,	,	I
D.	DT	I
and	NN	I
Burgum,	NN	I
A.,	NNP	I
YEAST,	:	I
7,	,	I
79-90	NNP	I
(1991)],[	CC	O
was	,	O
found	,	O
and	,	O
named	,	O
OTK27.	CD	O
Nucleoproteins	,	O
are	VBD	O
fundamental	VBN	O
cellular	CC	O
constituents	VBN	O
of	.	O
chromosomes,	NNS	O
ribosomes	VBP	O
and	JJ	O
so	JJ	O
forth	NNS	O
and	IN	O
are	,	O
thought	NNS	O
to	CC	O
play	RB	O
an	JJ	O
essential	CC	O
role	VBP	O
in	VBN	O
cell	TO	O
multiplication	VB	O
and	DT	O
viability.	JJ	O
The	NN	O
yeast	IN	O
nucleoprotein	NN	O
NHP2,	NN	O
a	CC	O
high-mobility	.	O
group	DT	O
(HMG)-like	NN	O
protein,	NN	O
like	,	O
HMG,	DT	O
has	NN	O
reportedly	NN	O
a	IN	O
function	,	O
essential	IN	O
for	,	O
cell	VBZ	O
viability	RB	O
Kolodrubetz,	DT	B
D.	NN	I
and	NN	I
Burgum,	IN	I
A.,	NN	I
YEAST,	NN	I
7,	,	I
79-90	NNP	I
(1991)].[	CC	O
The	,	O
novel	,	O
human	,	O
gene,	,	O
OTK27	CD	O
gene,	.	O
of	DT	O
the	JJ	O
present	JJ	O
invention,	,	O
which	NNP	O
is	,	O
highly	IN	O
homologous	DT	O
to	JJ	O
the	,	O
above-mentioned	WDT	O
yeast	VBZ	O
NHP2	RB	O
gene,	JJ	O
is	TO	O
supposed	DT	O
to	JJ	O
be	NN	O
similar	NNP	O
in	,	O
function.	VBZ	O
The	VBN	O
nucleotide	TO	O
sequence	VB	O
of	JJ	O
said	IN	O
GEN-025F07	.	O
clone	DT	O
was	JJ	O
found	NN	O
to	IN	O
comprise	VBD	O
1493	NNP	O
nucleotides,	NN	O
as	VBD	O
shown	VBN	O
under	TO	O
SEQ	VB	O
ID	CD	O
NO:9,	,	O
and	IN	O
contain	VBN	O
an	IN	O
open	NNP	O
reading	NNP	O
frame	,	O
comprising	CC	O
384	VBP	O
nucleotides,	DT	O
as	JJ	O
shown	NN	O
under	NN	O
SEQ	VBG	O
ID	CD	O
NO:8,	,	O
coding	IN	O
for	VBN	O
an	IN	O
amino	NNP	O
acid	NNP	O
sequence	,	O
comprising	VBG	O
128	IN	O
amino	DT	O
acid	NN	O
residues,	NN	O
as	NN	O
shown	VBG	O
under	CD	O
SEQ	JJ	O
ID	NN	O
NO:7.	,	O
The	IN	O
initiation	VBN	O
codon	IN	O
was	NNP	O
located	NNP	O
at	.	O
nucleotides	DT	O
95-97	NN	O
of	NN	O
the	VBD	O
sequence	VBN	O
shown	IN	O
under	JJ	O
SEQ	CD	O
ID	IN	O
NO:9,	DT	O
and	NN	O
the	VBN	O
termination	IN	O
codon	NNP	O
at	NNP	O
nucleotides	,	O
479-481.	CC	O
At	DT	O
the	NN	O
amino	NN	O
acid	IN	O
level,	JJ	O
the	.	O
OTK27	IN	O
protein	DT	O
was	NN	O
highly	JJ	O
homologous	,	O
(38%)	DT	O
to	NNP	O
NHP2.	NN	O
It	VBD	O
was	RB	O
83%	JJ	O
identical	)	O
with	TO	O
the	.	O
protein	PRP	O
deduced	VBD	O
from	NN	O
the	JJ	O
cDNA	IN	O
from	DT	O
Arabidopsis	NN	O
thaliana;	VBD	O
Newman,	IN	O
T.,	DT	O
unpublished;	NN	O
GENEMBL	IN	O
Accession	NNP	O
No.	:	O
T14197).	,	O
(2)	,	O
Northern	:	O
Blot	NNP	O
Analysis	NNP	O
For	.	O
examining	.	O
the	)	O
expression	NNP	O
of	NNP	O
human	NNP	O
OTK27	IN	O
mRNA	VBG	O
in	DT	O
normal	NN	O
human	IN	O
tissues,	JJ	O
the	NNP	O
insert	NN	O
in	IN	O
the	JJ	O
OTK27	JJ	O
cDNA	,	O
was	DT	O
amplified	NN	O
by	IN	O
PCR,	DT	O
the	NNP	O
PCR	NN	O
product	VBD	O
was	VBN	O
purified	IN	O
and	,	O
labeled	DT	O
with	NNP	O
[32P]-dCTP	NN	O
(random-primed	VBD	O
DNA	VBN	O
labeling	CC	O
kit,	VBN	O
Boehringer	IN	O
Mannheim),	NNP	O
and	JJ	O
Northern	NNP	O
blotting	VBG	O
was	,	O
performed	NNP	O
using	,	O
the	CC	O
labeled	NNP	O
product	NN	O
as	VBD	O
a	VBN	O
probe	VBG	O
in	DT	O
the	JJ	O
same	NN	O
manner	IN	O
as	DT	O
in	NN	O
Example	IN	O
1	DT	O
(2).	JJ	O
As	NN	O
a	IN	O
result	IN	O
of	NNP	O
the	CD	O
Northern	.	O
blot	IN	O
analysis,	DT	O
two	NN	O
bands	IN	O
corresponding	DT	O
to	NNP	O
possible	NN	O
transcripts	,	O
from	CD	O
this	NNS	O
gene	VBG	O
were	TO	O
detected	JJ	O
at	NNS	O
approximately	IN	O
1.6	DT	O
kb	NN	O
and	VBD	O
0.7	VBN	O
kb.	IN	O
Both	RB	O
sizes	CD	O
of	NNS	O
transcript	CC	O
were	CD	O
expressed	.	O
in	DT	O
all	NNS	O
normal	IN	O
adult	NN	O
tissues	VBD	O
examined.	VBN	O
However,	IN	O
the	DT	O
expression	JJ	O
of	NN	O
the	NNS	O
0.7	.	O
kb	,	O
transcript	DT	O
was	NN	O
significantly	IN	O
reduced	DT	O
in	CD	O
brain	NN	O
and	NN	O
was	VBD	O
of	RB	O
higher	VBN	O
levels	IN	O
in	NN	O
heart,	CC	O
skeletal	VBD	O
muscle	IN	O
and	JJR	O
testicle	NNS	O
than	IN	O
in	,	O
other	JJ	O
tissues	NN	O
examined.	CC	O
For	NN	O
further	IN	O
examination	IN	O
of	JJ	O
these	NNS	O
two	.	O
transcripts,	IN	O
eleven	JJ	O
cDNA	NN	O
clones	IN	O
were	DT	O
isolated	CD	O
from	,	O
a	RB	O
testis	JJ	O
cDNA	NNS	O
library	VBD	O
and	VBN	O
their	IN	O
DNA	DT	O
sequences	NN	O
were	NN	O
determined	NN	O
in	CC	O
the	PRP$	O
same	NN	O
manner	NNS	O
as	VBD	O
in	VBN	O
Example	IN	O
1	DT	O
(1).	JJ	O
As	NN	O
a	IN	O
result,	IN	O
in	NNP	O
six	CD	O
clones,	.	O
the	IN	O
sequences	DT	O
were	,	O
found	IN	O
to	CD	O
be	,	O
in	DT	O
agreement	NNS	O
with	VBD	O
that	VBN	O
of	TO	O
the	VB	O
0.7	IN	O
kb	NN	O
transcript,	IN	O
with	DT	O
a	IN	O
poly(A)	DT	O
sequence	CD	O
starting	NN	O
at	,	O
around	IN	O
the	DT	O
600th	)	O
nucleotide,	NN	O
namely	VBG	O
at	IN	O
the	IN	O
598th	DT	O
nucleotide	JJ	O
in	,	O
two	RB	O
of	IN	O
the	DT	O
six	CD	O
clones,	RB	O
at	IN	O
the	CD	O
606th	IN	O
nucleotide	DT	O
in	CD	O
three	,	O
clones,	IN	O
and	DT	O
at	CD	O
the	NN	O
613th	IN	O
nucleotide	CD	O
in	,	O
one	CC	O
clone.	IN	O
In	DT	O
these	CD	O
six	NN	O
clones,	IN	O
the	CD	O
“TATAAA”	.	O
sequence	IN	O
was	DT	O
recognized	CD	O
at	,	O
nucleotides	DT	O
583-588	JJ	O
as	NN	O
a	VBD	O
probable	VBN	O
poly(A)	IN	O
signal.	NNS	O
The	JJ	O
upstream	IN	O
poly(A)	DT	O
signal	JJ	O
“TATAAA”	)	O
of	.	O
this	DT	O
gene	JJ	O
was	)	O
recognized	JJ	O
as	NN	O
little	IN	O
influencing	DT	O
in	NN	O
brain	VBD	O
and	VBN	O
more	IN	O
effective	JJ	O
in	NN	O
the	IN	O
three	NN	O
tissues	CC	O
mentioned	RBR	O
above	JJ	O
than	IN	O
in	DT	O
other	CD	O
tissues.	NNS	O
The	VBN	O
possibility	IN	O
was	IN	O
considered	IN	O
that	JJ	O
the	.	O
stability	DT	O
of	NN	O
each	VBD	O
transcript	VBN	O
vary	IN	O
from	DT	O
tissue	NN	O
to	IN	O
tissue.	DT	O
Results	NN	O
of	VBP	O
zoo	IN	O
blot	NN	O
analysis	TO	O
indicated	.	O
that	NNS	O
this	IN	O
gene	NN	O
is	NN	O
well	NN	O
conserved	VBD	O
also	IN	O
in	DT	O
other	NN	O
vertebrates.	VBZ	O
Since	RB	O
this	VBN	O
gene	RB	O
is	IN	O
expressed	JJ	O
ubiquitously	.	O
in	IN	O
normal	DT	O
adult	NN	O
tissues	VBZ	O
and	VBN	O
conserved	RB	O
among	IN	O
a	JJ	O
wide	NN	O
range	NNS	O
of	CC	O
species,	VBN	O
the	IN	O
gene	DT	O
product	JJ	O
is	NN	O
likely	IN	O
to	,	O
play	DT	O
an	NN	O
important	NN	O
physiological	VBZ	O
role.	JJ	O
The	TO	O
evidence	VB	O
that	DT	O
yeasts	JJ	O
lacking	JJ	O
in	.	O
NHP2	DT	O
are	NN	O
nonviable	IN	O
suggests	VBZ	O
that	VBG	O
the	IN	O
human	NNP	O
homolog	VBP	O
may	JJ	O
also	NNS	O
be	IN	O
essential	DT	O
to	JJ	O
cell	NN	O
viability.	MD	O
(3)	RB	O
Chromosomal	VB	O
Localization	JJ	O
of	TO	O
OTK27	VB	O
by	.	O
Direct	)	O
R-Banding	NNP	O
FISH	NNP	O
One	IN	O
cosmid	NNP	O
clone	IN	O
corresponding	NNP	O
to	NNP	O
the	NNP	O
cDNA	NNP	O
OTK27	NN	O
was	NN	O
isolated	VBG	O
from	TO	O
a	DT	O
total	NN	O
human	NNP	O
genomic	VBD	O
cosmid	VBN	O
library	IN	O
(5-genome	DT	O
equivalent)	JJ	O
using	JJ	O
the	NN	O
OTK27	NN	O
cDNA	JJ	O
insert	JJ	O
as	)	O
a	VBG	O
probe	DT	O
and	NNP	O
subjected	NN	O
to	NN	O
FISH	IN	O
in	DT	O
the	NN	O
same	CC	O
manner	VBN	O
as	TO	O
in	NNP	O
Example	IN	O
1	DT	O
(3)	JJ	O
for	NN	O
chromosomal	IN	O
localization	IN	O
of	NNP	O
OTK27.	CD	O
As	)	O
a	IN	O
result,	JJ	O
two	NN	O
distinct	IN	O
spots	.	O
were	IN	O
observed	DT	O
on	,	O
the	CD	O
chromosome	JJ	O
band	NNS	O
12q24.3.	VBD	O
The	VBN	O
OTK27	IN	O
gene	DT	O
of	NN	O
the	NN	O
present	.	O
invention	DT	O
can	NNP	O
be	NN	O
used	IN	O
in	DT	O
causing	JJ	O
expression	NN	O
thereof	MD	O
and	VB	O
detecting	VBN	O
the	IN	O
OTK27	VBG	O
protein,	NN	O
a	NN	O
human	CC	O
nucleoprotein,	VBG	O
and	DT	O
thus	NNP	O
can	,	O
be	DT	O
utilized	JJ	O
in	,	O
the	CC	O
diagnosis	RB	O
and	MD	O
pathologic	VB	O
studies	VBN	O
of	IN	O
various	DT	O
diseases	NN	O
in	CC	O
which	JJ	O
said	NNS	O
protein	IN	O
is	JJ	O
involved	NNS	O
and,	IN	O
because	WDT	O
of	VBD	O
its	NN	O
involvement	VBZ	O
in	VBN	O
cell	,	O
proliferation	IN	O
and	IN	O
differentiation,	PRP$	O
in	NN	O
screening	IN	O
out	NN	O
and	NN	O
evaluating	CC	O
therapeutic	,	O
and	IN	O
preventive	VBG	O
drugs	RP	O
for	CC	O
cancer.	VBG	O
Example	JJ	O
4	CC	O
OTK18	JJ	O
Gene	NNS	O
(1)	IN	O
OTK18	.	O
Gene	RB	O
Cloning	CD	O
and	NNP	O
DNA	NNP	O
Sequencing	)	O
Zinc	NNP	O
finger	NNP	O
proteins	NNP	O
are	CC	O
defined	NNP	O
as	NNP	O
constituing	NNP	O
a	NN	O
large	NNS	O
family	VBP	O
of	VBN	O
transcription-regulating	IN	O
proteins	VBG	O
in	DT	O
eukaryotes	JJ	O
and	NN	O
carry	IN	O
evolutionally	JJ	O
conserved	NNS	O
structural	IN	O
motifs	NNS	O
Kadonaga,	CC	B
J.	VBP	I
T.,	RB	I
et	VBN	I
al.,	JJ	I
Cell,	NNS	I
51,	,	I
1079-1090	NNP	I
(1987);	,	I
Klung,	FW	B
A.	,	I
and	,	I
Rhodes,	,	I
D.,	CD	I
Trends	:	I
Biol.	,	I
Sci.,	NNP	I
12,	CC	I
464-469	,	I
(1987);	,	I
Evans,	NNP	B
R.	.	I
M.	,	I
and	,	I
Hollenberg,	CD	I
S.	:	I
M.,	,	I
Cell,	NNP	I
52,	NNP	I
1-3	CC	I
(1988)].[	,	O
The	NNP	O
zinc	,	O
finger,	,	O
a	,	O
loop-like	CD	O
motif	.	O
formed	DT	O
by	NN	O
the	,	O
interaction	DT	O
between	JJ	O
the	NN	O
zinc	VBN	O
ion	IN	O
and	DT	O
two	NN	O
residues,	IN	O
cysteine	DT	O
and	NN	O
histidine	NN	O
residues,	CC	O
is	CD	O
involved	,	O
in	NN	O
the	CC	O
sequence-specific	NN	O
binding	,	O
of	VBZ	O
a	VBN	O
protein	IN	O
to	DT	O
RNA	JJ	O
or	NN	O
DNA.	IN	O
The	DT	O
zinc	NN	O
finger	TO	O
motif	NNP	O
was	CC	O
first	.	O
identified	DT	O
within	NN	O
the	NN	O
amino	NN	O
acid	VBD	O
sequence	RB	O
of	VBN	O
the	IN	O
Xenopus	DT	O
transcription	NN	O
factor	JJ	O
IIIA	NN	O
Miller,	IN	B
J.,	DT	I
et	NNP	I
al.,	NN	I
EMBO	NN	I
J.,	NNP	I
4,	,	I
1609-1614	,	I
(1986)].[	FW	O
The	,	O
C2H2	NNP	O
finger	,	O
motif	,	O
is	CD	O
in	.	O
general	DT	O
tandemly	NNP	O
repeated	NN	O
and	NN	O
contains	VBZ	O
an	IN	O
evolutionally	JJ	O
conserved	NN	O
intervening	VBN	O
sequence	CC	O
of	VBZ	O
7	DT	O
or	RB	O
8	VBN	O
amino	VBG	O
acids.	NN	O
This	IN	O
intervening	CD	O
stretch	CC	O
was	CD	O
first	JJ	O
identified	.	O
in	DT	O
the	NN	O
Kruppel	NN	O
segmentation	VBD	O
gene	RB	O
of	VBN	O
Drosophila	IN	O
Rosenberg,	DT	B
U.	NNP	I
B.,	NN	I
et	NN	I
al.,	IN	I
Nature,	NNP	I
319,	,	I
336-339	.	I
(1986)].[	,	O
Since	FW	O
then,	,	O
hundreds	,	O
of	,	O
C2H2	CD	O
zinc	.	O
finger	IN	O
protein-encoding	,	O
genes	NNS	O
have	IN	O
been	NNP	O
found	NNP	O
invertebrate	VBD	O
genomes.	JJ	O
As	NNS	O
a	VBP	O
result	VBN	O
of	VBN	O
sequence	JJ	O
analysis	.	O
of	IN	O
cDNA	DT	O
clones	NN	O
arbitrarily	IN	O
selected	NN	O
from	NN	O
a	IN	O
human	NN	O
fetal	NNS	O
brain	RB	O
cDNA	VBN	O
library	IN	O
in	DT	O
the	JJ	O
same	NN	O
manner	NN	O
as	NN	O
in	NN	O
Example	IN	O
1	DT	O
(1)	JJ	O
and	NN	O
database	IN	O
searching,	IN	O
several	NNP	O
zinc	CD	O
finger	)	O
structure-containing	CC	O
clones	NN	O
were	,	O
identified	JJ	O
and,	CD	O
further,	JJR	O
a	JJ	O
clone	NNS	O
having	VBD	O
a	VBN	O
zinc	,	O
finger	,	O
structure	DT	O
of	NN	O
the	VBG	O
Kruppel	DT	O
type	NN	O
was	NN	O
found.	NN	O
Since	IN	O
this	DT	O
clone	NNP	O
lacked	NN	O
the	VBD	O
5′	.	O
portion	IN	O
of	DT	O
the	NN	O
transcript,	VBD	O
plaque	DT	O
hybridization	CD	O
was	NN	O
performed	IN	O
with	DT	O
a	,	O
fetal	JJ	O
brain	NN	O
cDNA	VBD	O
library	VBN	O
using,	IN	O
as	DT	O
a	JJ	O
probe,	NN	O
an	NN	O
approximately	JJ	O
1.8	,	O
kb	IN	O
insert	DT	O
in	,	O
the	DT	O
cDNA	RB	O
clone,	CD	O
whereby	NNS	O
three	NN	O
clones	IN	O
were	DT	O
isolated.	NN	O
The	,	O
nucleotide	WRB	O
sequences	CD	O
of	NNS	O
these	VBD	O
were	.	O
determined	DT	O
in	JJ	O
the	NNS	O
same	IN	O
manner	DT	O
as	VBD	O
in	VBN	O
Example	IN	O
1	DT	O
(1).	JJ	O
Among	NN	O
the	IN	O
three	IN	O
clones,	NNP	O
the	CD	O
one	.	O
having	IN	O
the	DT	O
largest	CD	O
insert	,	O
spans	DT	O
3,754	CD	O
nucleotides	VBG	O
including	DT	O
an	JJS	O
open	NN	O
reading	VBZ	O
frame	CD	O
of	NNS	O
2,133	VBG	O
nucleotides	DT	O
coding	JJ	O
for	NN	O
711	NN	O
amino	IN	O
acids.	CD	O
It	NNS	O
was	VBG	O
found	IN	O
that	CD	O
said	JJ	O
clone	.	O
contains	PRP	O
a	VBD	O
novel	VBN	O
human	IN	O
gene	VBD	O
coding	NN	O
for	VBZ	O
a	DT	O
peptide	JJ	O
highly	JJ	O
homologous	NN	O
in	VBG	O
the	IN	O
zinc	DT	O
finger	NN	O
domain	RB	O
to	JJ	O
those	IN	O
encoded	DT	O
by	NN	O
human	NN	O
ZNF41	NN	O
and	TO	O
the	DT	O
Drosophila	VBN	O
Kruppel	IN	O
gene.	JJ	O
This	NNP	O
gene	CC	O
was	DT	O
named	NNP	O
OTK18	NNP	O
gene	.	O
(derived	DT	O
from	NN	O
the	VBD	O
clone	VBN	O
GEN-076C09).	NNP	O
The	NN	O
nucleotide	VBN	O
sequence	IN	O
of	DT	O
the	NN	O
cDNA	.	O
clone	DT	O
of	JJ	O
the	NN	O
OTK18	IN	O
gene	DT	O
is	NN	O
shown	NN	O
under	IN	O
SEQ	DT	O
ID	NNP	O
NO:12,	NN	O
the	VBZ	O
coding	VBN	O
region-containing	IN	O
nucleotide	NNP	O
sequence	NNP	O
under	,	O
SEQ	DT	O
ID	VBG	O
NO:11,	JJ	O
and	JJ	O
the	NN	O
predicted	IN	O
amino	NNP	O
acid	NNP	O
sequence	,	O
encoded	CC	O
by	DT	O
said	VBN	O
OTK18	NN	O
gene	JJ	O
under	NN	O
SEQ	VBN	O
ID	IN	O
NO:10.	VBD	O
It	NNP	O
was	NN	O
found	IN	O
that	NNP	O
the	NNP	O
amino	.	O
acid	PRP	O
sequence	VBD	O
of	VBN	O
OTK18	IN	O
as	DT	O
deduced	NN	O
from	JJ	O
SEQ	NN	O
ID	IN	O
NO:12	NNP	O
contains	IN	O
13	VBN	O
finger	IN	O
motifs	NNP	O
on	NNP	O
its	NNP	O
carboxy	VBZ	O
side.	CD	O
(2)	NN	O
Comparison	NNS	O
with	IN	O
Other	PRP$	O
Zinc	JJ	O
Finger	.	O
Motif-Containing	)	O
Genes	NN	O
Comparison	IN	O
among	JJ	O
OTK18,	NNP	O
human	NNP	O
ZNF41	NNP	O
and	NNP	O
the	NNP	O
Drosophila	IN	O
Kruppel	,	O
gene	JJ	O
revealed	NNP	O
that	CC	O
each	DT	O
finger	NNP	O
motif	NNP	O
is	NN	O
for	VBD	O
the	IN	O
most	DT	O
part	NN	O
conserved	NN	O
in	VBZ	O
the	IN	O
consensus	DT	O
sequence	JJS	O
CXECGKAFXQKSXLX2HQRXH.	NN	O
Comparison	VBN	O
of	IN	O
the	DT	O
consensus	NN	O
sequence	NN	O
of	.	O
the	NNP	O
zinc	IN	O
finger	DT	O
motifs	NN	O
of	NN	O
OTK18	IN	O
with	DT	O
those	NN	O
of	NN	O
human	NNS	O
ZNF41	IN	O
and	NNP	O
the	IN	O
Drosophila	DT	O
Kruppel	IN	O
gene	JJ	O
revealed	NNP	O
that	CC	O
the	DT	O
Kruppel	NNP	O
type	NNP	O
motif	NN	O
is	VBD	O
well	IN	O
conserved	DT	O
in	NNP	O
the	NN	O
OTK18-encoded	NN	O
protein.	VBZ	O
However,	RB	O
the	VBN	O
sequence	IN	O
similarities	DT	O
were	JJ	O
limited	.	O
to	,	O
zinc	DT	O
finger	NN	O
domains	NNS	O
and	VBD	O
no	VBN	O
significant	TO	O
homologies	VB	O
were	NN	O
found	NNS	O
with	CC	O
regard	DT	O
to	JJ	O
other	NNS	O
regions.	VBD	O
The	VBN	O
zinc	IN	O
finger	NN	O
domain	TO	O
interacts	JJ	O
specifically	.	O
with	DT	O
the	NN	O
target	NN	O
DNA,	NN	O
recognizing	NNS	O
an	RB	O
about	IN	O
5	DT	O
by	NN	O
sequence	,	O
to	VBG	O
thereby	DT	O
bind	IN	O
to	CD	O
the	IN	O
DNA	NN	O
helix	TO	O
Rhodes,	VB	B
D.	VB	I
and	TO	I
Klug,	DT	I
A.,	NNP	I
Cell,	NN	I
46,	,	I
123-132	NNP	I
(1986)].[	CC	O
Based	,	O
on	,	O
the	,	O
idea	,	O
that,	CD	O
in	.	O
view	VBN	O
of	IN	O
the	DT	O
above,	NN	O
the	,	O
multiple	IN	O
module	NN	O
(tandem	IN	O
repetitions	DT	O
of	,	O
zinc	DT	O
finger)	JJ	O
can	NN	O
interact	JJ	O
with	NNS	O
long	IN	O
stretches	NNP	O
of	)	O
DNA,	MD	O
it	VB	O
is	IN	O
presumable	JJ	O
that	NNS	O
the	IN	O
target	,	O
DNA	PRP	O
of	VBZ	O
this	JJ	O
gene	IN	O
product	DT	O
containing	NN	O
13	NN	O
repeated	IN	O
zinc	DT	O
finger	NN	O
units	NN	O
would	VBG	O
be	CD	O
a	VBN	O
DNA	NN	O
fragment	NN	O
with	NNS	O
a	MD	O
length	VB	O
of	DT	O
approximately	NNP	O
65	NN	O
bp.	IN	O
(3)	DT	O
Northern	NN	O
Blot	IN	O
Analysis	RB	O
Northern	CD	O
blot	.	O
analysis	)	O
was	NNP	O
performed	NNP	O
as	NNP	O
described	NNP	O
in	NN	O
Example	NN	O
1	VBD	O
(2)	VBN	O
for	IN	O
checking	VBN	O
normal	IN	O
human	NNP	O
tissues	CD	O
for	)	O
expression	IN	O
of	VBG	O
the	JJ	O
human	JJ	O
OTK18	NNS	O
mRNA	IN	O
therein	NN	O
by	IN	O
amplifying	DT	O
the	JJ	O
insert	NNP	O
of	NN	O
the	NN	O
OTK18	IN	O
cDNA	VBG	O
by	DT	O
PCR,	NN	O
purifying	IN	O
the	DT	O
PCR	NNP	O
product,	NN	O
labeling	IN	O
the	,	O
same	VBG	O
with	DT	O
[32P]-dCTP	NNP	O
(random-primed	,	O
DNA	VBG	O
labeling	DT	O
kit,	JJ	O
Boehringer	IN	O
Mannheim)	NNP	O
and	JJ	O
using	NNP	O
an	VBG	O
MTN	,	O
blot	NNP	O
with	)	O
the	CC	O
labeled	VBG	O
product	DT	O
as	NNP	O
a	NN	O
probe.	IN	O
The	DT	O
results	JJ	O
of	NN	O
Northern	IN	O
blot	DT	O
analysis	.	O
revealed	DT	O
that	NNS	O
the	IN	O
transcript	NNP	O
of	NN	O
OTK18	NN	O
is	VBD	O
approximately	IN	O
4.3	DT	O
kb	NN	O
long	IN	O
and	NNP	O
is	VBZ	O
expressed	RB	O
ubiquitously	JJ	O
in	NNS	O
various	JJ	O
normal	CC	O
adult	VBZ	O
tissues.	VBN	O
However,	RB	O
the	IN	O
expression	JJ	O
level	JJ	O
in	NN	O
the	.	O
liver	,	O
and	DT	O
in	NN	O
peripheral	NN	O
blood	IN	O
lymphocytes	DT	O
seemed	NN	O
to	CC	O
be	IN	O
lower	JJ	O
than	NN	O
in	NNS	O
other	VBD	O
organs	TO	O
tested.	VB	O
(4)	JJR	O
Cosmid	IN	O
Cloning	IN	O
and	JJ	O
Chromosomal	NNS	O
Localization	.	O
by	)	O
Direct	NNP	O
R-Banding	NNP	O
FISH	CC	O
Chromosomal	NNP	O
localization	NNP	O
of	IN	O
OTK18	NNP	O
was	NNP	O
carried	NNP	O
out	NNP	O
as	NN	O
described	IN	O
in	NNP	O
Example	VBD	O
1	VBN	O
(3).	RP	O
As	IN	O
a	VBN	O
result,	IN	O
complete	NNP	O
twin	CD	O
spots	.	O
were	IN	O
identified	DT	O
with	,	O
8	JJ	O
samples	JJ	O
while	NNS	O
23	VBD	O
samples	VBN	O
showed	IN	O
an	CD	O
incomplete	NNS	O
signal	IN	O
or	CD	O
twin	NNS	O
spots	VBD	O
on	DT	O
either	JJ	O
or	NN	O
both	CC	O
homologs.	JJ	O
All	NNS	O
signals	IN	O
appeared	DT	O
at	CC	O
the	DT	O
q13.4	.	O
band	DT	O
of	NNS	O
chromosome	VBD	O
19.	IN	O
No	DT	O
twin	JJ	O
spots	NN	O
were	IN	O
observed	NN	O
on	.	O
any	DT	O
other	JJ	O
chromosomes.	NNS	O
The	VBD	O
results	VBN	O
of	IN	O
FISH	DT	O
thus	JJ	O
revealed	.	O
that	DT	O
this	NNS	O
gene	IN	O
is	NNP	O
localized	RB	O
on	VBD	O
chromosomal	IN	O
band	DT	O
19q13.4.	NN	O
This	VBZ	O
region	VBN	O
is	IN	O
known	JJ	O
to	NN	O
contain	.	O
many	DT	O
DNA	NN	O
segments	VBZ	O
that	VBN	O
hybridize	TO	O
with	VB	O
oligonucleotides	JJ	O
corresponding	NNP	O
to	NNS	O
zinc	WDT	O
finger	VBP	O
domains	IN	O
Hoovers,	NNS	B
J.	VBG	I
M.	TO	I
N.,	VB	I
et	NN	I
al.,	NNS	I
Genomics,	,	I
12,	NNP	I
254-263	NNP	I
(1992)].[	,	O
In	FW	O
addition,	,	O
at	,	O
least	,	O
one	CD	O
other	.	O
gene	IN	O
coding	,	O
for	IN	O
a	JJS	O
zinc	CD	O
finger	JJ	O
domain	NN	O
has	VBG	O
been	IN	O
identified	DT	O
in	NN	O
this	NN	O
region	NN	O
Marine,	VBZ	B
J.-C.,	VBN	I
et	VBN	I
al.,	IN	I
Genomics,	DT	I
21,	NN	I
285-286	,	I
(1994)].[	,	O
Hence,	FW	O
the	,	O
chromosome	,	O
19q13	,	O
is	CD	O
presumably	.	O
a	,	O
site	DT	O
of	NN	O
grouping	CD	O
of	VBZ	O
multiple	RB	O
genes	DT	O
coding	NN	O
for	IN	O
transcription-regulating	NN	O
proteins.	IN	O
When	JJ	O
the	NNS	O
novel	VBG	O
human	IN	O
OTK18	JJ	O
gene	.	O
provided	WRB	O
by	DT	O
this	JJ	O
example	JJ	O
is	NNP	O
used,	NN	O
it	VBN	O
becomes	IN	O
possible	DT	O
to	NN	O
detect	VBZ	O
expression	,	O
of	PRP	O
said	VBZ	O
gene	JJ	O
in	TO	O
various	VB	O
tissues	NN	O
and	IN	O
produce	VBD	O
the	NN	O
human	IN	O
OTK18	JJ	O
protein	NNS	O
in	CC	O
the	VB	O
manner	DT	O
of	JJ	O
genetic	NNP	O
engineering.	NN	O
Through	IN	O
these,	DT	O
it	NN	O
is	IN	O
possible	JJ	O
to	.	O
analyze	IN	O
the	,	O
functions	PRP	O
of	VBZ	O
the	JJ	O
human	TO	O
transcription	VB	O
regulating	DT	O
protein	NNS	O
gene	IN	O
system	DT	O
or	JJ	O
human	NN	O
transcription	VBG	O
regulating	JJ	O
proteins,	NN	O
which	NN	O
are	CC	O
deeply	JJ	O
involved	NN	O
in	NN	O
diverse	,	O
activities	WDT	O
fundamental	VBP	O
to	RB	O
cells,	VBN	O
as	IN	O
mentioned	JJ	O
above,	NNS	O
to	VBP	O
diagnose	TO	O
various	,	O
diseases	IN	O
with	VBN	O
which	,	O
said	TO	O
gene	VB	O
is	JJ	O
associated,	NNS	O
for	IN	O
example	WDT	O
malformation	VBD	O
or	NN	O
cancer	VBZ	O
resulting	,	O
from	IN	O
a	NN	O
developmental	NN	O
or	CC	O
differentiation	NN	O
anomaly,	VBG	O
and	IN	O
mental	DT	O
or	NN	O
nervous	CC	O
disorder	NN	O
resulting	,	O
from	CC	O
a	JJ	O
developmental	CC	O
anomaly	JJ	O
in	NN	O
the	VBG	O
nervous	IN	O
system,	DT	O
and	JJ	O
further	NN	O
to	IN	O
screen	DT	O
out	JJ	O
and	,	O
evaluate	CC	O
therapeutic	RB	O
or	TO	O
prophylactic	VB	O
drugs	RP	O
for	CC	O
these	VB	O
diseases.	JJ	O
Example	CC	O
5	JJ	O
Genes	NNS	O
Encoding	IN	O
Human	DT	O
26S	.	O
Proteasome	JJ	O
Constituent	CD	O
P42	NNPS	O
Protein	NNP	O
and	NNP	O
P27	CD	O
Protein	NNP	O
(1)	NNP	O
Cloning	NNP	O
and	NNP	O
DNA	CC	O
Sequencing	NNP	O
of	NNP	O
Genes	)	O
Respectively	NN	O
Encoding	CC	O
Human	NNP	O
26S	NNP	O
Proteasome	IN	O
Constituent	NNP	O
P42	NNP	O
Protein	NNP	O
and	NNP	O
P27	CD	O
Protein	NNP	O
Proteasome,	NNP	O
which	NNP	O
is	NNP	O
a	CC	O
multifunctional	NNP	O
protease,	NNP	O
is	,	O
an	WDT	O
enzyme	VBZ	O
occurring	DT	O
widely	JJ	O
in	,	O
eukaryotes	VBZ	O
from	DT	O
yeasts	JJ	O
to	VBG	O
humans	RB	O
and	IN	O
decomposing	NNS	O
ubiquitin-binding	IN	O
proteins	NNS	O
in	TO	O
cells	NNS	O
in	CC	O
an	VBG	O
energy-dependent	JJ	O
manner.	NNS	O
Structurally,	IN	O
said	NNS	O
proteasome	IN	O
is	DT	O
constituted	JJ	O
of	.	O
20S	,	O
proteasome	VBD	O
composed	NN	O
of	VBZ	O
various	VBN	O
constituents	IN	O
with	CD	O
a	NN	O
molecular	VBN	O
weight	IN	O
of	JJ	O
21	NNS	O
to	IN	O
31	DT	O
kilodaltons	JJ	O
and	NN	O
a	IN	O
group	CD	O
of	TO	O
PA700	CD	O
regulatory	NNS	O
proteins	CC	O
composed	DT	O
of	NN	O
various	IN	O
constituents	NNP	O
with	JJ	O
a	NNS	O
molecular	VBN	O
weight	IN	O
of	JJ	O
30	NNS	O
to	IN	O
112	DT	O
kilodaltons	JJ	O
and	NN	O
showing	IN	O
a	CD	O
sedimentation	TO	O
coefficient	CD	O
of	NNS	O
22S	CC	O
and,	VBG	O
as	DT	O
a	NN	O
whole,	NN	O
occurs	IN	O
as	CD	O
a	,	O
macromolecule	IN	O
with	DT	O
a	,	O
molecular	VBZ	O
weight	IN	O
of	DT	O
about	NN	O
2	IN	O
million	DT	O
daltons	JJ	O
and	NN	O
a	IN	O
sedimentation	IN	O
coefficient	CD	O
of	CD	O
26S	NNS	O
Rechsteiner,	CC	B
M.,	DT	I
et	NN	I
al.,	NN	I
J.	IN	I
Biol.	CD	I
Chem.,	,	I
268,	,	I
6065-6068	FW	I
(1993);	,	I
Yoshimura,	NNP	B
T.,	.	I
et	,	I
al.,	,	I
J.	CD	I
Struct.	:	I
Biol.,	,	I
111,	,	I
200-211	FW	I
(1993);	,	I
Tanaka,	NNP	B
K.,	.	I
et	,	I
al.,	,	I
New	CD	I
Biologist,	:	I
4,	,	I
173-187	,	I
(1992)].[	FW	O
Despite	,	O
structural	NNP	O
and	,	O
mechanical	,	O
analyses	CD	O
thereof,	.	O
the	IN	O
whole	JJ	O
picture	CC	O
of	JJ	O
proteasome	NNS	O
is	,	O
not	DT	O
yet	JJ	O
fully	NN	O
clear.	IN	O
However,	NN	O
according	VBZ	O
to	RB	O
studies	RB	O
using	RB	O
yeasts	.	O
and	,	O
mice	VBG	O
in	TO	O
the	NNS	O
main,	VBG	O
it	NNS	O
reportedly	CC	O
has	NN	O
the	IN	O
functions	DT	O
mentioned	,	O
below	PRP	O
and	RB	O
its	VBZ	O
functions	DT	O
are	NNS	O
becoming	VBN	O
more	IN	O
and	CC	O
more	PRP$	O
elucidated.	NNS	O
The	VBP	O
mechanism	VBG	O
of	JJR	O
energy-dependent	CC	O
proteolysis	RBR	O
in	.	O
cells	DT	O
starts	NN	O
with	IN	O
selection	JJ	O
of	NN	O
proteins	IN	O
by	NNS	O
ubiquitin	NNS	O
binding.	IN	O
It	NN	O
is	IN	O
not	NNS	O
20S	IN	O
proteasome	JJ	O
but	.	O
26S	PRP	O
proteasome	VBZ	O
that	RB	O
has	CD	O
ubiquitin-conjugated	NN	O
protein	CC	O
decomposing	CD	O
activity	NN	O
which	WDT	O
is	VBZ	O
ATP-dependent	JJ	O
Chu-Ping	NNS	B
et	VBG	I
al.,	NN	I
J.	WDT	I
Biol.	VBZ	I
Chem.,	JJ	I
269,	NNP	I
3539-3547	NN	I
(1994)].[	,	O
Hence,	NNP	O
human	.	O
26S	,	O
proteasome	,	O
is	CD	O
considered	.	O
to	,	O
be	JJ	O
useful	CD	O
in	NN	O
elucidating	VBZ	O
the	VBN	O
mechanism	TO	O
of	VB	O
energy-dependent	JJ	O
proteolysis.	IN	O
Factors	VBG	O
involved	DT	O
in	NN	O
the	IN	O
cell	JJ	O
cycle	.	O
regulation	NNS	O
are	VBN	O
generally	IN	O
short	DT	O
in	NN	O
half-life	NN	O
and	NN	O
in	VBP	O
many	RB	O
cases	JJ	O
they	IN	O
are	JJ	O
subject	CC	O
to	IN	O
strict	JJ	O
quantitative	NNS	O
control.	PRP	O
In	VBP	O
fact,	JJ	O
it	TO	O
has	VB	O
been	JJ	O
made	.	O
clear	IN	O
that	,	O
the	PRP	O
oncogene	VBZ	O
products	VBN	O
Mos,	VBN	O
Myc,	JJ	O
Fos	IN	O
and	DT	O
so	NN	O
forth	NNS	O
can	,	O
be	,	O
decomposed	NNP	O
by	CC	O
26S	RB	O
proteasome	JJ	O
in	MD	O
an	VB	O
energy-	VBN	O
and	IN	O
ubiquitin-dependent	CD	O
manner	NN	O
Ishida,	IN	B
N.,	DT	I
et	JJ	I
al.,	CC	I
FEBS	JJ	I
Lett.,	NN	I
324,	,	I
345-348	,	I
(1993);	FW	I
Hershko,	,	B
A.	NNP	I
and	,	I
Ciechanover,	,	I
A.,	CD	I
Annu.	:	I
Rev.	,	I
Biochem.,	NNP	I
61,	CC	I
761-807	,	I
(1992)]	,	I
[and	.	O
the	.	O
importance	,	O
of	,	O
proteasone	CD	O
in	NN	O
cell	CC	O
cycle	DT	O
control	NN	O
is	IN	O
being	NN	O
recognized.	IN	O
Its	NN	O
importance	NN	O
in	NN	O
the	VBZ	O
immune	VBG	O
system	.	O
has	PRP$	O
also	NN	O
been	IN	O
pointed	DT	O
out.	NN	O
It	NN	O
is	VBZ	O
suggested	RB	O
that	VBN	O
proteasome	VBN	O
is	.	O
positively	PRP	O
involved	VBZ	O
in	VBN	O
class	IN	O
I	NN	O
major	VBZ	O
histocompatible	RB	O
complex	VBN	O
antigen	IN	O
presentation	NN	O
Michalek,	PRP	B
M.	JJ	I
T.,	JJ	I
et	JJ	I
al.,	NN	I
Nature,	NN	I
363,	,	I
552-554	NNP	I
(1993)]	,	I
[and	FW	O
it	,	O
is	,	O
further	,	O
suggested	CD	O
that	NN	O
proteasome	CC	O
may	PRP	O
be	VBZ	O
involved	RBR	O
in	VBD	O
Alzheimer	IN	O
disease,	NN	O
since	MD	O
the	VB	O
phenomena	VBN	O
of	IN	O
abnormal	NNP	O
accumulation	,	O
of	IN	O
ubiquitin-conjugated	DT	O
proteins	NN	O
in	IN	O
the	JJ	O
brain	NN	O
of	IN	O
patients	JJ	O
with	NNS	O
Alzheimer	IN	O
disease	DT	O
Kitaguchi,	NN	B
N.,	IN	I
et	NNS	I
al.,	IN	I
Nature,	NNP	I
361,	NN	I
530-532	,	I
(1988)].[	,	O
Because	FW	O
of	,	O
its	,	O
diverse	,	O
functions	CD	O
such	.	O
as	IN	O
those	IN	O
mentioned	PRP$	O
above,	JJ	O
proteasome	NNS	O
attracts	JJ	O
attention	IN	O
from	DT	O
the	VBN	O
viewpoint	,	O
of	JJ	O
its	NNS	O
utility	NN	O
in	IN	O
the	DT	O
diagnosis	NN	O
and	IN	O
treatment	PRP$	O
of	NN	O
various	IN	O
diseases.	DT	O
A	NN	O
main	CC	O
function	NN	O
of	IN	O
26S	JJ	O
proteasome	.	O
is	DT	O
ubiquitin-conjugated	JJ	O
protein	NN	O
decomposing	IN	O
activity.	CD	O
In	NN	O
particular,	VBZ	O
it	JJ	O
is	JJ	O
known	NN	O
that	.	O
cell	IN	O
cycle-related	,	O
gene	PRP	O
products	VBZ	O
such	VBN	O
as	IN	O
oncogene	NN	O
products	JJ	O
and	NN	O
cyclins,	NNS	O
typically	JJ	O
c-Myc,	IN	O
are	NN	O
degraded	NNS	O
via	CC	O
ubiquitin-dependent	,	O
pathways.	RB	O
It	,	O
has	VBP	O
also	VBN	O
been	IN	O
observed	JJ	O
that	.	O
the	PRP	O
proteasome	VBZ	O
gene	RB	O
is	VBN	O
expressed	VBN	O
abnormally	IN	O
in	DT	O
liver	JJ	O
cancer	NN	O
cells,	VBZ	O
renal	VBN	O
cancer	RB	O
cells,	IN	O
leukemia	NN	O
cells	NN	O
and	,	O
the	JJ	O
like	NN	O
as	,	O
compared	NN	O
with	NNS	O
normal	CC	O
cells	DT	O
Kanayama,	JJ	B
H.,	IN	I
et	VBN	I
al.,	IN	I
Cancer	JJ	I
Res.,	NNS	I
51,	,	I
6677-6685	,	I
(1991)]	FW	I
[and	,	O
that	NNP	O
proteasome	,	O
is	,	O
abnormally	CD	O
accumulated	NN	O
in	CC	O
tumor	DT	O
cell	NN	O
nuclei.	VBZ	O
Hence,	RB	O
constituents	VBN	O
of	IN	O
proteasome	NN	O
are	NN	O
expected	.	O
to	,	O
be	NNS	O
useful	IN	O
in	NN	O
studying	VBP	O
the	VBN	O
mechanism	TO	O
of	VB	O
such	JJ	O
canceration	IN	O
and	VBG	O
in	DT	O
the	NN	O
diagnosis	IN	O
or	JJ	O
treatment	NN	O
of	CC	O
cancer.	IN	O
Also,	DT	O
it	NN	O
is	CC	O
known	NN	O
that	IN	O
the	.	O
expression	,	O
of	PRP	O
proteasome	VBZ	O
is	VBN	O
induced	IN	O
by	DT	O
interferon	NN	O
γ	IN	O
and	NN	O
so	VBZ	O
on	VBN	O
and	IN	O
is	NN	O
deeply	NN	O
involved	CC	O
in	RB	O
antigen	IN	O
presentation	CC	O
in	VBZ	O
cells	RB	O
Aki,	VBN	B
M.,	IN	I
et	NN	I
al.,	NN	I
J.	IN	I
Biochem.,	NNS	I
115,	,	I
257-269	,	I
(1994)].[	FW	O
Hence,	,	O
constituents	.	O
of	,	O
human	,	O
proteasome	CD	O
are	.	O
expected	,	O
to	NNS	O
be	IN	O
useful	JJ	O
in	NN	O
studying	VBP	O
the	VBN	O
mechanism	TO	O
of	VB	O
antigen	JJ	O
presentation	IN	O
in	VBG	O
the	DT	O
immune	NN	O
system	IN	O
and	NN	O
in	NN	O
developing	IN	O
immunoregulating	DT	O
drugs.	NN	O
Furthermore,	NN	O
proteasome	CC	O
is	IN	O
considered	VBG	O
to	VBG	O
be	.	O
deeply	,	O
associated	NN	O
with	VBZ	O
ubiquitin	VBN	O
abnormally	TO	O
accumulated	VB	O
in	RB	O
the	VBN	O
brain	IN	O
of	JJ	O
patients	RB	O
with	VBN	O
Alzheimer	IN	O
disease.	DT	O
Hence,	NN	O
it	IN	O
is	NNS	O
suggested	IN	O
that	NNP	O
constituents	.	O
of	,	O
human	PRP	O
proteasome	VBZ	O
should	VBN	O
be	IN	O
useful	NNS	O
in	IN	O
studying	JJ	O
the	NN	O
cause	MD	O
of	VB	O
Alzheimer	JJ	O
disease	IN	O
and	VBG	O
in	DT	O
the	NN	O
treatment	IN	O
of	NNP	O
said	NN	O
disease.	CC	O
In	IN	O
addition	DT	O
to	NN	O
the	IN	O
utilization	VBD	O
of	.	O
expectedly	IN	O
multifunctional	NN	O
proteasome	TO	O
as	DT	O
such	NN	O
in	IN	O
the	JJ	O
above	JJ	O
manner,	NN	O
it	IN	O
is	JJ	O
probably	IN	O
possible	DT	O
to	JJ	O
produce	,	O
antibodies	PRP	O
using	VBZ	O
constituents	RB	O
of	JJ	O
proteasome	TO	O
as	VB	O
antigens	NNS	O
and	VBG	O
use	NNS	O
such	IN	O
antibodies	NN	O
in	IN	O
diagnosing	NNS	O
various	CC	O
diseases	VB	O
by	JJ	O
immunoassay.	NNS	O
Its	IN	O
utility	VBG	O
in	JJ	O
this	NNS	O
field	IN	O
of	.	O
diagnosis	PRP$	O
is	NN	O
thus	IN	O
also	DT	O
a	NN	O
focus	IN	O
of	NN	O
interest.	VBZ	O
Meanwhile,	RB	O
a	RB	O
protein	DT	O
having	NN	O
the	IN	O
characteristics	.	O
of	,	O
human	DT	O
26S	NN	O
proteasome	VBG	O
is	DT	O
disclosed,	NNS	O
for	IN	O
example	JJ	O
in	CD	O
Japanese	NN	O
Unexamined	VBZ	O
Patent	,	O
Publication	IN	O
No.	NN	O
292964/1993	IN	O
and	JJ	O
rat	JJ	O
proteasome	NNP	O
constituents	NNP	O
are	.	O
disclosed	CD	O
in	CC	O
Japanese	VB	O
Unexamined	JJ	O
Patent	NNS	O
Publication	VBP	O
Nos.	VBN	O
268957/1993	IN	O
and	JJ	O
317059/1993.	JJ	O
However,	NNP	O
no	NNP	O
human	.	O
26S	CD	O
proteasome	CC	O
constituents	.	O
are	,	O
known.	DT	O
Therefore,	JJ	O
the	CD	O
present	NN	O
inventors	NNS	O
made	VBP	O
a	.	O
further	,	O
search	DT	O
for	JJ	O
human	NNS	O
26S	VBD	O
proteasome	DT	O
constituents	JJ	O
and	NN	O
successfully	IN	O
obtained	JJ	O
two	CD	O
novel	NN	O
human	NNS	O
26S	CC	O
proteasome	RB	O
constituents,	VBN	O
namely	CD	O
human	JJ	O
26S	JJ	O
proteasome	CD	O
constituent	NN	O
P42	,	O
protein	RB	O
and	JJ	O
human	CD	O
S26	JJ	O
proteasome	NN	O
constituent	NNP	O
P27	NN	O
protein,	CC	O
and	JJ	O
performed	NNP	O
cloning	NN	O
and	NN	O
DNA	NNP	O
sequencing	,	O
of	CC	O
the	VBD	O
corresponding	NN	O
genes	CC	O
in	NNP	O
the	NN	O
following	IN	O
manner.	DT	O
(1)	JJ	O
Purification	NNS	O
of	IN	O
Human	DT	O
26S	JJ	O
Proteasome	.	O
Constituents	)	O
P42	NN	O
Protein	IN	O
and	NNP	O
P27	CD	O
Protein	NNP	O
Human	NNP	O
proteasome	NNP	O
was	NNP	O
purified	CC	O
using	NNP	O
about	NNP	O
100	NNP	O
g	NN	O
of	VBD	O
fresh	VBN	O
human	VBG	O
kidney	IN	O
and	CD	O
following	NNS	O
the	IN	O
method	JJ	O
of	JJ	O
purifying	NN	O
human	CC	O
proteasome	VBG	O
as	DT	O
described	NN	O
in	IN	O
Japanese	VBG	O
Unexamined	JJ	O
Patent	NN	O
Publication	IN	O
No.	VBN	O
292964/1993,	IN	O
namely	JJ	O
by	JJ	O
column	NNP	O
chromatography	NNP	O
using	.	O
BioGel	,	O
A-1.5	RB	O
m	IN	O
(5×90	NN	O
cm,	NN	O
Bio-Rad),	VBG	O
hydroxyapatite	NNP	O
(1.5×15	NNP	O
cm,	NN	O
Bio-Rad)	CD	O
and	,	O
Q-Sepharose	,	O
(1.5×15	JJ	O
cm,	CD	O
Pharmacia)	,	O
and	)	O
glycerol	CC	O
density	NNP	O
gradient	CD	O
centrifugation.	,	O
The	)	O
thus-obtained	CC	O
human	JJ	O
proteasome	NN	O
was	NN	O
subjected	.	O
to	DT	O
reversed	JJ	O
phase	JJ	O
high	NN	O
performance	VBD	O
liquid	VBN	O
chromatography	TO	O
(HPLC)	VBN	O
using	NN	O
a	JJ	O
Hitachi	NN	O
model	NN	O
L6200	NN	O
HPLC	)	O
system.	VBG	O
A	DT	O
Shodex	NNP	O
RS	NN	O
Pak	NNP	O
D4-613	NNP	O
(0.6×15	.	O
cm,	DT	O
Showa	NNP	O
Denko)	NNP	O
was	NNP	O
used	NNP	O
and	CD	O
gradient	,	O
elution	NNP	O
was	)	O
performed	VBD	O
with	VBN	O
the	CC	O
following	JJ	O
two	NN	O
solutions:	VBD	O
First	VBN	O
solution:	IN	O
0.06%	DT	O
trifluoroacetic	VBG	O
acid;	CD	O
Second	:	O
solution:	JJ	O
0.05%	:	O
trifluoroacetic	NN	O
acid,	JJ	O
70%	:	O
acetonitrile.	JJ	O
An	:	O
aliquot	NN	O
of	JJ	O
each	,	O
eluate	NN	O
fraction	.	O
was	DT	O
subjected	NN	O
to	IN	O
8.5%	DT	O
SDS-polyacrylamide	NN	O
electrophoresis	NN	O
under	VBD	O
conditions	VBN	O
of	TO	O
reduction	NN	O
with	JJ	O
dithiothreitol.	NN	O
The	IN	O
P42	NNS	O
protein	IN	O
and	NN	O
P27	IN	O
protein	.	O
thus	DT	O
detected	NNP	O
were	NN	O
isolated	CC	O
and	NNP	O
purified.	VBP	O
The	RB	O
purified	VBN	O
P42	VBD	O
and	VBN	O
P27	CC	O
proteins	.	O
were	DT	O
respectively	JJ	O
digested	NNP	O
with	CC	O
1	NNP	O
μg	NNS	O
of	VBD	O
trypsin	RB	O
in	VBN	O
0.1	IN	O
M	CD	O
Tris	NNS	O
buffer	IN	O
(pH	NN	O
7.8)	IN	O
containing	CD	O
2	NNP	O
M	NNP	O
urea	NN	O
at	JJ	O
37°	)	O
C.	VBG	O
for	CD	O
8	NNP	O
hours	NN	O
and	IN	O
the	CD	O
partial	NNP	O
peptide	IN	O
fragments	CD	O
obtained	NNS	O
were	CC	O
separated	DT	O
by	JJ	O
reversed	NN	O
phase	NNS	O
HPLC	VBN	O
and	VBD	O
their	VBN	O
sequences	IN	O
were	JJ	O
determined	NN	O
by	NNP	O
Edman	CC	O
degradation.	PRP$	O
The	NNS	O
results	VBD	O
obtained	VBN	O
are	IN	O
as	NNP	O
shown	.	O
below	DT	O
in	NNS	O
Table	VBN	O
2.	VBP	O
(2)	IN	O
cDNA	VBN	O
Library	IN	O
Screening,	IN	O
Clone	JJ	O
Isolation	.	O
and	)	O
cDNA	NN	O
Nucleotide	NNP	O
Sequence	,	O
Determination	NNP	O
As	NNP	O
mentioned	CC	O
in	NN	O
Example	NNP	O
1	NNP	O
(1),	NNP	O
the	IN	O
present	VBN	O
inventors	IN	O
have	NNP	O
a	CD	O
database	,	O
comprising	DT	O
about	JJ	O
30,000	NNS	O
cDNA	VBP	O
data	DT	O
as	NN	O
constructed	VBG	O
based	IN	O
on	CD	O
large-scale	NN	O
DNA	NNS	O
sequencing	IN	O
using	VBN	O
human	VBN	O
fetal	IN	O
brain,	JJ	O
arterial	NNP	O
blood	VBG	O
vessel	VBG	O
and	JJ	O
placenta	JJ	O
cDNA	,	O
libraries.	JJ	O
Based	NN	O
on	NN	O
the	CC	O
amino	NN	O
acid	NN	O
sequences	.	O
obtained	VBN	O
as	IN	O
mentioned	DT	O
above	NN	O
in	NN	O
(1),	NNS	O
computer	VBD	O
searching	IN	O
was	VBN	O
performed	IN	O
with	IN	O
the	,	O
FASTA	NN	O
program	NN	O
(search	VBD	O
for	VBN	O
homology	IN	O
between	DT	O
said	NNP	O
amino	NN	O
acid	NN	O
sequences	IN	O
and	NN	O
the	IN	O
amino	VBD	O
acid	NN	O
sequences	NN	O
estimated	NNS	O
from	CC	O
the	DT	O
database).	NN	O
As	NN	O
regards	NNS	O
P42,	VBN	O
a	IN	O
clone	DT	O
(GEN-331G07)	.	O
showing	IN	O
identity	NNS	O
with	,	O
regard	DT	O
to	NN	O
two	)	O
amino	VBG	O
acid	NN	O
sequences	IN	O
[(2)	NN	O
and	TO	O
(7)	CD	O
shown	NN	O
in	NN	O
table	NNS	O
2]	)	O
was	CC	O
screened	)	O
out	VBN	O
and,	IN	O
as	JJ	O
regards	NN	O
P27,	VBD	O
a	VBN	O
clone	RP	O
(GEN-163D09)	,	O
showing	IN	O
identity	NNS	O
with	,	O
regard	DT	O
to	NN	O
two	)	O
amino	VBG	O
acid	NN	O
sequences	IN	O
[(1)	NN	O
and	TO	O
(8)	CD	O
shown	NN	O
in	NN	O
Table	NNS	O
2]	)	O
was	CC	O
found.	)	O
For	VBN	O
each	IN	O
of	JJ	O
these	NN	O
clones,	VBD	O
the	.	O
5′	IN	O
side	DT	O
sequence	IN	O
was	DT	O
determined	,	O
by	DT	O
5′	CD	O
RACE	NN	O
and	NN	O
the	VBD	O
whole	VBN	O
sequence	IN	O
was	CD	O
determined,	NNP	O
in	CC	O
the	DT	O
same	JJ	O
manner	NN	O
as	VBD	O
in	,	O
Example	IN	O
2	DT	O
(2).	JJ	O
As	NN	O
a	IN	O
result,	IN	O
it	NNP	O
was	CD	O
revealed	.	O
that	IN	O
the	DT	O
above-mentioned	,	O
P42	PRP	O
clone	VBD	O
GEN-331G07	VBN	O
comprises	IN	O
a	DT	O
1,566-nucleotide	JJ	O
sequence	NNP	O
as	NN	O
shown	NNP	O
under	VBZ	O
SEQ	DT	O
ID	JJ	O
NO:15,	NN	O
inclusive	IN	O
of	VBN	O
a	IN	O
1,167-nucleotide	NNP	O
open	NNP	O
reading	,	O
frame	NN	O
as	IN	O
shown	DT	O
under	JJ	O
SEQ	JJ	O
ID	NN	O
NO:14,	NN	O
and	IN	O
that	VBN	O
the	IN	O
amino	NNP	O
acid	NNP	O
sequence	,	O
encoded	CC	O
thereby	IN	O
is	DT	O
the	NN	O
one	JJ	O
shown	NN	O
under	VBD	O
SEQ	RB	O
ID	VBZ	O
NO:13	DT	O
and	CD	O
comprises	VBN	O
389	IN	O
amino	NNP	O
acid	NNP	O
residues.	NNP	O
The	CC	O
results	VBZ	O
of	CD	O
computer	NN	O
homology	NN	O
search	.	O
revealed	DT	O
that	NNS	O
the	IN	O
P42	NN	O
protein	NN	O
is	NN	O
significantly	VBD	O
homologous	IN	O
to	DT	O
the	NNP	O
AAA	NN	O
(ATPase	VBZ	O
associated	RB	O
with	JJ	O
a	TO	O
variety	DT	O
of	NNP	O
cellular	NNP	O
activities)	VBN	O
protein	IN	O
family	DT	O
(e.g.	NN	O
P45,	IN	O
TBP1,	JJ	O
TBP7,	)	O
S4,	VBP	O
MSS1,	NN	O
etc.).	.	O
It	,	O
was	,	O
thus	,	O
suggested	,	O
that	,	O
it	.	O
is	PRP	O
a	VBD	O
new	RB	O
member	VBN	O
of	IN	O
the	PRP	O
AAA	VBZ	O
protein	DT	O
family.	JJ	O
As	NN	O
for	IN	O
the	DT	O
P27	NNP	O
clone	NN	O
GEN-163D09,	.	O
it	IN	O
was	IN	O
revealed	DT	O
that	NNP	O
it	NN	O
comprises	,	O
a	PRP	O
1,128-nucleotide	VBD	O
sequence	VBN	O
as	IN	O
shown	PRP	O
under	VBZ	O
SEQ	DT	O
ID	JJ	O
NO:18,	NN	O
including	IN	O
a	VBN	O
669-nucleotide	IN	O
open	NNP	O
reading	NNP	O
frame	,	O
as	VBG	O
shown	DT	O
under	JJ	O
SEQ	JJ	O
ID	NN	O
NO:17	NN	O
and	IN	O
that	VBN	O
the	IN	O
amino	NNP	O
acid	NNP	O
sequence	NNP	O
encoded	CC	O
thereby	IN	O
is	DT	O
the	NN	O
one	JJ	O
shown	NN	O
under	VBD	O
SEQ	RB	O
ID	VBZ	O
NO:16	DT	O
and	CD	O
comprises	VBN	O
223	IN	O
amino	NNP	O
acid	NNP	O
residues.	NNP	O
As	CC	O
regards	VBZ	O
the	CD	O
P27	NN	O
protein,	NN	O
homology	.	O
search	IN	O
using	NNS	O
a	DT	O
computer	NNP	O
failed	,	O
to	NN	O
reveal	NN	O
any	VBG	O
homologous	DT	O
gene	NN	O
among	VBD	O
public	TO	O
databases.	VB	O
Thus,	DT	O
the	JJ	O
gene	NN	O
in	IN	O
question	JJ	O
is	.	O
presumably	,	O
a	DT	O
novel	NN	O
gene	IN	O
having	NN	O
an	VBZ	O
unknown	RB	O
function.	DT	O
Originally,	JJ	O
the	NN	O
above-mentioned	VBG	O
P42	DT	O
and	JJ	O
P27	.	O
gene	,	O
products	DT	O
were	JJ	O
both	NNP	O
purified	CC	O
as	NNP	O
regulatory	NN	O
subunit	NNS	O
components	VBD	O
of	DT	O
proteasome	VBN	O
complex.	IN	O
Therefore,	JJ	O
these	JJ	O
are	NNS	O
expected	IN	O
to	NN	O
play	.	O
an	,	O
important	DT	O
role	VBP	O
in	VBN	O
various	TO	O
biological	VB	O
functions	DT	O
through	JJ	O
proteolysis,	NN	O
for	IN	O
example	JJ	O
a	JJ	O
role	NNS	O
in	IN	O
energy	,	O
supply	IN	O
through	NN	O
decomposition	DT	O
of	NN	O
ATP	IN	O
and,	NN	O
hence,	NN	O
they	IN	O
are	NN	O
presumably	IN	O
useful	NNP	O
not	,	O
only	,	O
in	PRP	O
studying	VBP	O
the	RB	O
function	JJ	O
of	RB	O
human	RB	O
26S	IN	O
proteasome	VBG	O
but	DT	O
also	NN	O
in	IN	O
the	JJ	O
diagnosis	CD	O
and	NN	O
treatment	CC	O
of	RB	O
various	IN	O
diseases	DT	O
caused	NN	O
by	CC	O
lowering	NN	O
of	IN	O
said	JJ	O
biological	NNS	O
functions,	VBN	O
among	IN	O
others.	VBG	O
Example	IN	O
6	VBD	O
BNAP	JJ	O
Gene	,	O
(1)	IN	O
BNAP	.	O
Gene	RB	O
Cloning	CD	O
and	NNP	O
DNA	NNP	O
Sequencing	)	O
The	NNP	O
nucleosome	NNP	O
composed	NNP	O
of	CC	O
DNA	NNP	O
and	VBG	O
histone	DT	O
is	NN	O
a	VBD	O
fundamental	IN	O
structure	NNP	O
constituting	CC	O
chromosomes	NN	O
in	VBZ	O
eukaryotic	DT	O
cells	JJ	O
and	NN	O
is	VBG	O
well	NNS	O
conserved	IN	O
over	JJ	O
borders	NNS	O
among	CC	O
species.	VBZ	O
This	RB	O
structure	VBN	O
is	IN	O
closely	NNS	O
associated	IN	O
with	.	O
the	DT	O
processes	NN	O
of	VBZ	O
replication	RB	O
and	VBN	O
transcription	IN	O
of	DT	O
DNA.	NNS	O
However,	IN	O
the	NN	O
nucleosome	CC	O
formation	NN	O
is	IN	O
not	.	O
fully	,	O
understood	DT	O
as	JJ	O
yet.	NN	O
Only	VBZ	O
certain	RB	O
specific	RB	O
factors	JJ	O
involved	IN	O
in	.	O
nucleosome	RB	O
assembly	JJ	O
(NAPs)	JJ	O
have	NNS	O
been	VBN	O
identified.	IN	O
Thus,	JJ	O
two	NN	O
acidic	)	O
proteins,	VBP	O
nucleoplasmin	VBN	O
and	.	O
N1,	,	O
are	CD	O
already	JJ	O
known	,	O
to	NNS	O
facilitate	CC	O
nucleosome	,	O
construction	VBP	O
Kleinschmidt,	RB	B
J.	VBN	I
A.,	TO	I
et	VB	I
al.,	JJ	I
J.	NN	I
Biol.	,	I
Chem.,	.	I
260,	,	I
1166-1176	FW	I
(1985);	,	I
Dilworth,	NNP	B
S.	.	I
M.,	,	I
et	,	I
al.,	CD	I
Cell,	:	I
51,	,	I
1009-1018	NNP	I
(1987)].[	,	O
A	FW	O
yeast	,	O
gene,	,	O
NAP-I,	,	O
was	CD	O
isolated	.	O
using	DT	O
a	JJ	O
mono-clonal	,	O
antibody	,	O
and	VBD	O
recombinant	VBN	O
proteins	VBG	O
derived	DT	O
therefrom	JJ	O
were	NN	O
tested	CC	O
as	JJ	O
to	NNS	O
whether	VBN	O
they	NNS	O
have	VBD	O
nucleosome	VBN	O
assembling	IN	O
activity	TO	O
in	IN	O
vivo.	PRP	O
More	VBP	O
recently,	JJ	O
a	NN	O
mouse	NN	O
NAP-I	IN	O
gene,	.	O
which	RBR	O
is	,	O
a	DT	O
mammalian	NN	O
homolog	JJ	O
of	,	O
the	WDT	O
yeast	VBZ	O
NAP-I	DT	O
gene	JJ	O
was	NN	O
cloned	IN	O
(Okuda,	DT	O
A.;	JJ	O
registered	JJ	O
in	NN	O
database	VBD	O
under	VBN	O
the	,	O
accession	:	O
number	VBN	O
D12618).	IN	O
Also	NN	O
cloned	IN	O
were	DT	O
a	NN	O
mouse	NN	O
gene,	.	O
DN38	RB	O
Kato,	VBN	B
K.,	VBD	I
Eur.	DT	I
J.	NN	I
Neurosci.,	,	I
2,	NNP	I
704-711	,	I
(1990)]	,	I
[and	.	O
a	.	O
human	,	O
nucleosome	,	O
assembly	CD	O
protein	NN	O
(hNRP)	CC	O
Simon,	DT	B
H.	JJ	I
U.,	NN	I
et	NN	I
al.,	NN	I
Biochem.	)	I
J.,	,	I
297,	NNP	I
389-397	,	I
(1994)].[	FW	O
It	,	O
was	.	O
shown	,	O
that	,	O
the	CD	O
hNRP	.	O
gene	PRP	O
is	VBD	O
expressed	VBN	O
in	IN	O
many	DT	O
tissues	NN	O
and	NN	O
is	VBZ	O
associated	VBN	O
with	IN	O
T	JJ	O
lymphocyte	NNS	O
proliferation.	CC	O
The	VBZ	O
present	VBN	O
inventors	IN	O
performed	NNP	O
sequence	JJ	O
analysis	.	O
of	DT	O
cDNA	JJ	O
clones	NNS	O
arbitrarily	VBD	O
chosen	JJ	O
from	NN	O
a	IN	O
human	NN	O
fetal	NNS	O
brain	RB	O
cDNA	VBN	O
library	IN	O
in	DT	O
the	JJ	O
same	NN	O
manner	NN	O
as	NN	O
in	NN	O
Example	IN	O
1	DT	O
(1),	JJ	O
followed	NN	O
by	IN	O
searches	IN	O
among	NNP	O
databases	CD	O
and,	,	O
as	VBN	O
a	IN	O
result,	NNS	O
made	IN	O
it	NNS	O
clear	,	O
that	IN	O
a	DT	O
1,125-nucleotide	,	O
cDNA	VBD	O
clone	PRP	O
(free	JJ	O
of	IN	O
poly(A)),	DT	O
GEN-078D05,	JJ	O
is	NN	O
significantly	NN	O
homologous	JJ	O
to	IN	O
the	,	O
mouse	,	O
NAP-I	VBZ	O
gene,	RB	O
which	JJ	O
is	TO	O
a	DT	O
gene	NN	O
for	NNP	O
a	,	O
nucleosome	WDT	O
assembly	VBZ	O
protein	DT	O
(NAP)	NN	O
involved	IN	O
in	DT	O
nucleosome	JJ	O
construction,	NN	O
a	NN	O
mouse	)	O
partial	VBN	O
cDNA	IN	O
clone,	JJ	O
DN38,	,	O
and	DT	O
hNRP.	NN	O
Since	JJ	O
said	NN	O
clone	,	O
GEN-078D05	,	O
was	CC	O
lacking	.	O
in	IN	O
the	VBD	O
5′	NN	O
region,	NNP	O
5′	VBD	O
RACE	VBG	O
was	IN	O
performed	DT	O
in	CD	O
the	,	O
same	CD	O
manner	NNP	O
as	VBD	O
in	VBN	O
Example	IN	O
2	DT	O
(2)	JJ	O
to	NN	O
obtain	IN	O
the	IN	O
whole	NNP	O
coding	CD	O
region.	)	O
For	TO	O
this	VB	O
5′	DT	O
RACE,	JJ	O
primers	NN	O
P1	.	O
and	IN	O
P2	DT	O
respectively	CD	O
having	,	O
the	NNS	O
nucleotide	NNP	O
sequences	CC	O
shown	NNP	O
below	RB	O
in	VBG	O
Table	DT	O
3.	JJ	O
After	NNS	O
the	VBN	O
first	IN	O
5′	IN	O
RACE,	JJ	O
a	.	O
single	IN	O
band	DT	O
corresponding	JJ	O
to	CD	O
a	,	O
sequence	DT	O
length	JJ	O
of	NN	O
1,300	VBG	O
nucleotides	TO	O
was	DT	O
obtained.	NN	O
This	NN	O
product	IN	O
was	CD	O
inserted	NNS	O
into	VBD	O
pT7Blue(R)	.	O
T-Vector	DT	O
and	NN	O
several	VBD	O
clones	VBN	O
appropriate	IN	O
in	)	O
insert	NNP	O
size	CC	O
were	JJ	O
selected.	NNS	O
Ten	VBP	O
5′	IN	O
RACE	JJ	O
clones	NN	O
obtained	VBD	O
from	.	O
two	CD	O
independent	CD	O
PCR	NNP	O
reactions	NNS	O
were	VBN	O
sequenced	IN	O
and	CD	O
the	JJ	O
longest	NNP	O
clone	NNS	O
GEN-078D05TA13	VBD	O
(about	VBN	O
1,300	CC	O
nucleotides	DT	O
long)	JJS	O
was	NN	O
further	NNP	O
analyzed.	IN	O
Both	CD	O
strands	NNS	O
of	)	O
the	VBD	O
two	JJ	O
overlapping	.	O
cDNA	DT	O
clones	NNS	O
GEN-078D05	IN	O
and	DT	O
GEN-078D05TA13	CD	O
were	VBG	O
sequenced,	NN	O
whereby	NNS	O
it	NNP	O
was	CC	O
confirmed	NNP	O
that	VBD	O
the	,	O
two	WRB	O
clones	PRP	O
did	VBD	O
not	VBN	O
yet	IN	O
cover	DT	O
the	CD	O
whole	NNS	O
coding	VBD	O
region.	RB	O
Therefore,	RB	O
a	VB	O
further	DT	O
second	JJ	O
5′	NN	O
RACE	.	O
was	,	O
carried	DT	O
out.	JJ	O
For	JJ	O
the	CD	O
second	NNP	O
5′	VBD	O
RACE,	VBN	O
two	.	O
primers,	IN	O
P3	DT	O
and	JJ	O
P4,	CD	O
respectively	,	O
having	CD	O
the	,	O
sequences	NNP	O
shown	CC	O
below	,	O
in	RB	O
Table	VBG	O
4	DT	O
were	NNS	O
used.	VBN	O
A	IN	O
clone,	IN	O
GEN-078D0508,	JJ	O
obtained	CD	O
by	VBD	O
the	.	O
second	DT	O
5′	,	O
RACE	,	O
was	VBN	O
300	IN	O
nucleotides	DT	O
long.	JJ	O
This	CD	O
clone	NNP	O
contained	VBD	O
an	CD	O
estimable	NNS	O
initiation	.	O
codon	DT	O
and	NN	O
three	VBD	O
preceding	DT	O
in-frame	JJ	O
termination	NN	O
codons.	NN	O
From	CC	O
these	CD	O
three	VBG	O
overlapping	JJ	O
clones,	NN	O
it	.	O
became	IN	O
clear	DT	O
that	CD	O
the	VBG	O
whole	,	O
coding	PRP	O
region	VBD	O
comprises	JJ	O
2,636	IN	O
nucleotides.	DT	O
This	JJ	O
gene	NN	O
was	NN	O
named	VBZ	O
brain-specific	CD	O
nucleosome	.	O
assembly	DT	O
protein	NN	O
(BNAP)	VBD	O
gene.	VBN	O
The	JJ	O
BNAP	NN	O
gene	NN	O
contains	NN	O
a	)	O
1,518-nucleotide	.	O
open	DT	O
reading	NNP	O
frame	NN	O
shown	VBZ	O
under	DT	O
SEQ	JJ	O
ID	JJ	O
NO:20.	NN	O
The	NN	O
amino	VBN	O
acid	IN	O
encoded	NNP	O
thereby	NNP	O
comprises	.	O
506	DT	O
amino	NN	O
acid	NN	O
residues,	VBD	O
as	RB	O
shown	VBZ	O
under	CD	O
SEQ	NN	O
ID	NN	O
NO:19,	,	O
and	IN	O
the	VBN	O
nucleotide	IN	O
sequence	NNP	O
of	NNP	O
the	,	O
whole	CC	O
cDNA	DT	O
clone	JJ	O
of	NN	O
BNAP	IN	O
is	DT	O
as	JJ	O
shown	NN	O
under	NN	O
SEQ	IN	O
ID	NNP	O
NO:21.	VBZ	O
As	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	.	O
21,	IN	O
the	VBN	O
5′	IN	O
noncoding	NNP	O
region	NNP	O
of	:	O
said	,	O
gene	DT	O
was	CD	O
found	JJ	O
to	NN	O
be	IN	O
generally	VBD	O
rich	NN	O
in	VBD	O
GC.	VBN	O
Candidate	TO	O
initiation	VB	O
codon	RB	O
sequences	JJ	O
were	IN	O
found	.	O
at	NNP	O
nucleotides	NN	O
Nos.	NN	O
266-268,	NNS	O
287-289	VBD	O
and	VBN	O
329-331.	IN	O
These	NNS	O
three	.	O
sequences	,	O
all	JJ	O
had	CC	O
well	.	O
conserved	DT	O
sequences	CD	O
in	NNS	O
the	DT	O
vicinity	VBD	O
of	RB	O
the	VBN	O
initiation	NNS	O
codons	IN	O
Kozak,	DT	B
M.,	NN	I
J.	IN	I
Biol.	DT	I
Chem.,	NN	I
266,	NNS	I
19867-19870	,	I
(1991)].[	,	O
According	NNP	O
to	.	O
the	,	O
scanning	,	O
model,	CD	O
the	.	O
first	VBG	O
ATG	TO	O
(nucleotides	DT	O
Nos.	VBG	O
266-268)	,	O
of	DT	O
the	JJ	O
cDNA	NNP	O
clone	JJ	O
may	.	O
be	)	O
the	IN	O
initiation	DT	O
codon.	NN	O
The	NN	O
termination	MD	O
codon	VB	O
was	DT	O
located	NN	O
at	.	O
nucleotides	DT	O
Nos.	NN	O
1784-1786.	NN	O
The	VBD	O
3′	VBN	O
noncoding	IN	O
redion	NNS	O
was	.	O
generally	.	O
rich	DT	O
in	CD	O
AT	JJ	O
and	NN	O
two	VBD	O
polyadenylation	RB	O
signals	JJ	O
(AATAAA)	IN	O
were	NNP	O
located	CC	O
at	CD	O
nucleotides	NN	O
Nos.	NNS	O
2606-2611	)	O
and	VBD	O
2610-2615,	VBN	O
respectively.	IN	O
The	NNS	O
longest	.	O
open	JJ	O
reading	CC	O
frame	,	O
comprised	.	O
1,518	DT	O
nucleotides	JJS	O
coding	JJ	O
for	NN	O
506	NN	O
amino	VBD	O
acid	CD	O
residues	NNS	O
and	VBG	O
the	IN	O
calculated	CD	O
molecular	NN	O
weight	NN	O
of	NNS	O
the	CC	O
BNAP	DT	O
gene	JJ	O
product	JJ	O
was	NN	O
57,600	IN	O
daltons.	DT	O
Hydrophilic	NNP	O
plots	NN	O
indicated	NN	O
that	VBD	O
BNAP	CD	O
is	.	O
very	NNP	O
hydrophilic,	NNS	O
like	VBD	O
other	IN	O
NAPs.	NNP	O
For	VBZ	O
recombinant	RB	O
BNAP	,	O
expression	IN	O
and	JJ	O
purification	.	O
and	IN	O
for	JJ	O
eliminating	NNP	O
the	NN	O
possibility	CC	O
that	NN	O
the	CC	O
BNAP	IN	O
gene	VBG	O
sequence	DT	O
might	NN	O
give	IN	O
three	DT	O
chimera	NNP	O
clones	NN	O
in	NN	O
the	MD	O
step	VB	O
of	CD	O
5′	NN	O
RACE,	NNS	O
RT-PCR	IN	O
was	DT	O
performed	NN	O
using	IN	O
a	CD	O
sequence	,	O
comprising	NNP	O
nucleotides	VBD	O
Nos.	VBN	O
326-356	VBG	O
as	DT	O
a	NN	O
sense	VBG	O
primer	NNS	O
and	.	O
a	JJ	O
sequence	IN	O
comprising	DT	O
nucleotides	NN	O
Nos.	NN	O
1758-1786	CC	O
as	DT	O
an	NN	O
antisenses	VBG	O
primer.	NNS	O
As	.	O
a	JJ	O
result,	IN	O
a	DT	O
single	VBZ	O
product	.	O
of	IN	O
about	DT	O
1,500	,	O
by	DT	O
was	JJ	O
obtained	NN	O
and	IN	O
it	IN	O
was	CD	O
thus	IN	O
confirmed	VBD	O
that	VBN	O
said	CC	O
sequence	PRP	O
is	VBD	O
not	RB	O
a	VBN	O
chimera	IN	O
but	VBD	O
a	NN	O
single	VBZ	O
transcript.	RB	O
(2)	DT	O
Comparison	NN	O
between	CC	O
BNAP	DT	O
and	JJ	O
NAPs	.	O
The	)	O
amino	NNP	O
acid	IN	O
sequence	NNP	O
deduced	CC	O
from	NNP	O
BNAP	DT	O
showed	NN	O
46%	JJ	O
identity	NN	O
and	VBD	O
65%	IN	O
similarity	NNP	O
to	VBD	O
hNRP.	NN	O
The	NN	O
deduced	CC	O
BNAP	NN	O
gene	NN	O
product	TO	O
had	.	O
motifs	DT	O
characteristic	JJ	O
of	NNP	O
the	NN	O
NAPs	NN	O
already	VBD	O
reported	VBN	O
and	NN	O
of	IN	O
BNAP.	DT	O
In	NNP	O
general,	RB	O
half	VBD	O
of	CC	O
the	IN	O
C	.	O
terminus	IN	O
was	,	O
well	NN	O
conserved	IN	O
in	DT	O
humans	NNP	O
and	NN	O
yeasts.	VBD	O
The	RB	O
first	VBN	O
motif	IN	O
(domain	NNS	O
I)	CC	O
is	.	O
KGIPDYWLI	DT	O
(corresponding	JJ	O
to	NN	O
amino	VB	O
acid	)	O
residues	VBZ	O
Nos.	NNP	O
309-317).	VBG	O
This	TO	O
was	VB	O
observed	JJ	O
also	NNS	O
in	.	O
hNRP	.	O
(KGIPSFWLT	DT	O
(SEQ	VBD	O
ID	VBN	O
NO:75))	RB	O
and	IN	O
in	NN	O
yeast	NNP	O
NAP-I	NNP	O
(KGIPEFWLT	NNP	O
(SEQ	)	O
ID	CC	O
NO:76)).	IN	O
The	JJ	O
second	NNP	O
motif	NNP	O
(domain	NNP	O
II)	NNP	O
is	.	O
ASFFNFFSPP	DT	O
(corresponding	JJ	O
to	NN	O
amino	VB	O
acid	)	O
residues	VBZ	O
Nos.	NNP	O
437-446)	VBG	O
and	TO	O
this	VB	O
was	JJ	O
expressed	NNS	O
as	.	O
DSFFNFFAPP	)	O
(SEQ	CC	O
ID	DT	O
NO:77)	VBD	O
in	VBN	O
hNRP	IN	O
and	NNP	O
as	NNP	O
ESFFNFFSP	NNP	O
(SEQ	)	O
ID	IN	O
NO:78)	NN	O
in	CC	O
yeast	IN	O
NAP-I.	NNP	O
These	NNP	O
two	NNP	O
motifs	)	O
were	IN	O
also	JJ	O
conserved	.	O
in	DT	O
the	CD	O
deduced	NNS	O
mouse	VBD	O
NAP-I	RB	O
and	VBN	O
DN38	IN	O
peptides.	DT	O
Both	JJ	O
conserved	NN	O
motifs	NNP	O
were	CC	O
each	NNP	O
a	.	O
hydrophilic	DT	O
cluster,	VBD	O
and	NNS	O
the	VBD	O
Cys	DT	O
in	DT	O
position	JJ	O
402	,	O
was	CC	O
also	DT	O
found	NNP	O
conserved.	IN	O
Half	NN	O
of	CD	O
the	VBD	O
N	RB	O
terminus	VBN	O
had	.	O
no	NN	O
motifs	IN	O
strictly	DT	O
conserved	NNP	O
from	NN	O
yeasts	VBD	O
to	DT	O
mammalian	NNS	O
species,	RB	O
while	VBN	O
motifs	IN	O
conserved	NNS	O
among	TO	O
mammalian	JJ	O
species	,	O
were	IN	O
found.	NNS	O
For	VBN	O
instance,	IN	O
HDLERKYA	JJ	O
(corresponding	NNS	O
to	VBD	O
amino	.	O
acid	IN	O
residues	,	O
Nos.	NNP	O
130	VBG	O
to	TO	O
137)	VB	O
and	JJ	O
IINAEYEPTEEECEW	NNS	O
(corresponding	.	O
to	CD	O
amino	TO	O
acid	)	O
residues	CC	O
Nos.	NNP	O
150-164),	VBG	O
which	TO	O
may	VB	O
be	JJ	O
associated	NNS	O
with	.	O
mammal-specific	,	O
functions,	WDT	O
were	MD	O
found	VB	O
strictly	VBN	O
conserved.	IN	O
NAPs	JJ	O
had	,	O
acidic	VBD	O
stretches,	VBN	O
which	RB	O
are	.	O
believed	NNP	O
to	VBD	O
be	JJ	O
readily	,	O
capable	WDT	O
of	VBP	O
binding	VBN	O
to	TO	O
histone	VB	O
or	RB	O
other	JJ	O
basic	IN	O
proteins.	VBG	O
All	TO	O
NAPs	VB	O
had	CC	O
three	JJ	O
acidic	JJ	O
stretches	.	O
but	DT	O
the	NNP	O
locations	VBD	O
thereof	CD	O
were	JJ	O
not	NNS	O
conserved.	CC	O
BNAP	DT	O
has	NNS	O
no	WDT	O
such	VBD	O
three	RB	O
acidic	.	O
stretches	NNP	O
but,	VBZ	O
instead,	DT	O
three	JJ	O
repeated	CD	O
sequences	JJ	O
(corresponding	NNS	O
to	,	O
amino	,	O
acid	CD	O
residues	VBN	O
Nos.	NNS	O
194-207,	VBG	O
208-221	TO	O
and	VB	O
222-235)	JJ	O
with	NNS	O
a	.	O
long	,	O
acidic	JJ	O
cluster,	CC	O
inclusive	)	O
of	IN	O
41	DT	O
amino	JJ	O
acid	JJ	O
residues	,	O
out	NN	O
of	IN	O
98	CD	O
amino	NN	O
acid	NN	O
residues,	VBZ	O
the	IN	O
consensus	IN	O
sequence	CD	O
being	NN	O
ExxKExPEVKxEEK	NN	O
(SEQ	,	O
ID	DT	O
NO:79)	NN	O
(each	NN	O
x	VBG	O
being	NNP	O
a	NNP	O
nonconserved,	NNP	O
mostly	)	O
hydrophobic,	DT	O
residue).	NN	O
Furthermore,	VBG	O
it	DT	O
was	,	O
revealed	RB	O
that	,	O
the	.	O
BNAP	,	O
sequence	PRP	O
had	VBD	O
several	VBN	O
BNAP-specific	IN	O
motifs.	DT	O
Thus,	NNP	O
an	NN	O
extremely	VBD	O
serine-rich	JJ	O
doamin	NNP	O
(corresponding	.	O
to	,	O
amino	DT	O
acid	RB	O
residues	JJ	O
Nos.	NN	O
24-72)	VBG	O
with	TO	O
33	VB	O
(67%)	JJ	O
of	NNS	O
49	.	O
amino	)	O
acid	IN	O
residues	CD	O
being	)	O
serine	IN	O
residues	CD	O
was	NN	O
found	NN	O
in	NNS	O
the	VBG	O
N-terminus	JJ	O
portion.	NNS	O
On	VBD	O
the	VBN	O
nucleic	IN	O
acid	DT	O
level,	NNP	O
they	.	O
were	IN	O
reflected	DT	O
as	JJ	O
incomplete	NN	O
repetitions	,	O
of	PRP	O
AGC.	VBD	O
Following	VBN	O
this	IN	O
serine-rich	JJ	O
region,	NNS	O
there	IN	O
appeared	.	O
a	VBG	O
basic	DT	O
domain	JJ	O
(corresponding	,	O
to	EX	O
amino	VBD	O
acid	DT	O
residues	JJ	O
Nos.	NN	O
71-89)	VBG	O
comprising	TO	O
10	VB	O
basic	JJ	O
amino	NNS	O
acid	.	O
residues	)	O
among	VBG	O
19	CD	O
residues.	JJ	O
BNAP	NN	O
is	NN	O
supposed	NNS	O
to	IN	O
be	CD	O
localized	.	O
in	NNP	O
the	VBZ	O
nucleus.	VBN	O
Two	TO	O
possible	VB	O
signals	VBN	O
localized	IN	O
in	DT	O
the	.	O
nucleus	CD	O
were	JJ	O
observed	NNS	O
(NLSs).	VBN	O
The	IN	O
first	DT	O
signal	NN	O
was	VBD	O
found	VBN	O
in	.	O
the	DT	O
basic	JJ	O
domain	NN	O
of	VBD	O
BNAP	VBN	O
and	IN	O
its	DT	O
sequence	JJ	O
YRKKR	NN	O
(SEQ	IN	O
ID	NNP	O
NO:96)	CC	O
(corresponding	PRP$	O
to	NN	O
amino	NNP	O
acid	NNP	O
residues	NNP	O
Nos.	)	O
75-79)	VBG	O
was	TO	O
similar	VB	O
to	JJ	O
NLS	NNS	O
(GRKKR)	.	O
(SEQ	)	O
ID	VBD	O
NO:80)	JJ	O
of	TO	O
Tat	NNP	O
of	)	O
HIV-1.	NNP	O
The	NNP	O
second	)	O
signal	IN	O
was	NNP	O
located	IN	O
in	.	O
the	DT	O
C	JJ	O
terminus	NN	O
and	VBD	O
its	VBN	O
sequence	IN	O
KKYRK	DT	O
(corresponding	NNP	O
to	NN	O
amino	CC	O
acid	PRP$	O
residues	NN	O
Nos.	NNP	O
502-506)	VBG	O
was	TO	O
similar	VB	O
to	JJ	O
NLS	NNS	O
(KKKRK	.	O
(SEQ	)	O
ID	VBD	O
NO:81))	JJ	O
of	TO	O
the	NNP	O
large	NNP	O
T	NNP	O
antigen	NNP	O
of	)	O
SV40.	IN	O
The	DT	O
presence	JJ	O
of	NNP	O
these	NN	O
two	IN	O
presumable	.	O
NLSs	DT	O
suggested	NN	O
the	IN	O
localization	DT	O
of	CD	O
BNAP	JJ	O
in	NNP	O
the	VBD	O
nucleus.	DT	O
However	NN	O
the	IN	O
possibility	NNP	O
that	IN	O
other	DT	O
basic	.	O
clusters	RB	O
might	DT	O
act	NN	O
as	IN	O
NLSs	JJ	O
could	JJ	O
not	NNS	O
be	MD	O
excluded.	VB	O
BNAP	IN	O
has	NNP	O
several	MD	O
phosphorylation	RB	O
sites	VB	O
and	.	O
the	NNP	O
activity	VBZ	O
of	JJ	O
BNAP	NN	O
may	NNS	O
be	CC	O
controlled	DT	O
through	NN	O
phosphorylation	IN	O
thereof.	NNP	O
(3)	MD	O
Northern	VB	O
Blot	VBN	O
Analysis	IN	O
Northern	NN	O
blot	.	O
analysis	)	O
was	NNP	O
performed	NNP	O
as	NNP	O
described	NNP	O
in	NN	O
Example	NN	O
1	VBD	O
(2).	VBN	O
Thus,	IN	O
the	VBN	O
clone	IN	O
GEN-078D05TA13	NNP	O
(corresponding	CD	O
to	.	O
nucleotides	,	O
Nos.	DT	O
323	NN	O
to	NNP	O
1558	VBG	O
in	TO	O
the	NNS	O
BNAP	.	O
gene	CD	O
sequence)	TO	O
was	CD	O
amplified	IN	O
by	DT	O
PCR,	NNP	O
the	NN	O
PCR	)	O
product	VBD	O
was	VBN	O
purified	IN	O
and	,	O
labeled	DT	O
with	NNP	O
[32P]-dCTP	NN	O
(random-primed	VBD	O
DNA	VBN	O
labeling	CC	O
kit,	VBN	O
Boehringer	IN	O
Mannheim),	NNP	O
and	JJ	O
the	NNP	O
expression	VBG	O
of	,	O
BNAP	NNP	O
mRNA	,	O
in	CC	O
normal	DT	O
human	NN	O
tissues	IN	O
was	NNP	O
examined	NN	O
using	IN	O
an	JJ	O
MTN	JJ	O
blot	NNS	O
with	VBD	O
the	VBN	O
labeled	VBG	O
product	DT	O
as	NNP	O
a	NN	O
probe.	IN	O
As	DT	O
a	JJ	O
result	NN	O
of	IN	O
Northern	DT	O
blot	.	O
analysis,	IN	O
a	DT	O
3.0	NN	O
kb	IN	O
transcript	NNP	O
of	NN	O
BNAP	,	O
was	DT	O
detected	CD	O
(8-hour	NN	O
exposure)	NN	O
in	IN	O
the	NNP	O
brain	VBD	O
among	VBN	O
eight	JJ	O
human	)	O
adult	IN	O
tissues	DT	O
tested,	NN	O
namely	IN	O
heart,	CD	O
brain,	NNS	O
placenta,	NN	O
lung,	NNS	O
liver,	,	O
skeletal	RB	O
muscle,	,	O
kidney	,	O
and	,	O
pancreas	,	O
and,	,	O
after	JJ	O
longer	,	O
exposure	NN	O
(24	CC	O
hours),	NNS	O
a	,	O
dim	IN	O
band	JJR	O
of	NN	O
the	CD	O
same	,	O
size	DT	O
was	JJ	O
detected	NN	O
in	IN	O
the	DT	O
heart.	JJ	O
BNAP	NN	O
was	VBD	O
found	VBN	O
equally	IN	O
expressed	DT	O
in	.	O
several	NNP	O
sites	VBD	O
of	VBN	O
brain	RB	O
tested	VBN	O
whereas,	IN	O
in	JJ	O
other	NNS	O
tissues,	IN	O
no	NN	O
signal	VBN	O
was	,	O
detected	IN	O
at	JJ	O
all	,	O
even	DT	O
after	NN	O
72	VBD	O
hours	VBN	O
of	IN	O
exposure.	DT	O
hNRP	RB	O
mRNA	IN	O
was	CD	O
found	NNS	O
expressed	IN	O
everywhere	.	O
in	NN	O
the	NN	O
human	VBD	O
tissues	VBN	O
tested	VBN	O
whereas	RB	O
the	IN	O
expression	DT	O
of	JJ	O
BNAP	NNS	O
mRNA	VBN	O
was	IN	O
tissue-specific.	DT	O
(4)	NN	O
Radiation	IN	O
Hybrid	NNP	O
Mapping	NN	O
Chromosomal	VBD	O
mapping	.	O
of	)	O
the	NNP	O
BNAP	NNP	O
clone	NNP	O
was	NNP	O
performed	NN	O
by	IN	O
means	DT	O
of	NNP	O
radiation	NN	O
hybrid	VBD	O
mapping	VBN	O
Cox,	IN	B
D.	NNS	I
R.,	IN	I
et	NN	I
al.,	JJ	I
Science,	NN	I
250,	,	I
245-250	NNP	I
(1990)].[	,	O
Thus,	FW	O
a	,	O
total	,	O
human	,	O
genome	CD	O
radiation	.	O
hybrid	,	O
clone	DT	O
(G3RH)	JJ	O
panel	JJ	O
was	NN	O
purchased	NN	O
from	JJ	O
Research	NN	O
Genetics,	)	O
Inc.,	NN	O
AL,	VBD	O
USA	VBN	O
and	IN	O
PCR	NNP	O
was	,	O
carried	,	O
out	,	O
for	NNP	O
chromosomal	CC	O
mapping	NNP	O
analysis	VBD	O
according	VBN	O
to	RP	O
the	IN	O
product	JJ	O
manual	NN	O
using	NN	O
two	VBG	O
primers,	TO	O
A1	DT	O
and	NN	O
A2,	JJ	O
respectively	VBG	O
having	CD	O
the	,	O
nucleotide	NNP	O
sequences	CC	O
shown	,	O
in	RB	O
Table	VBG	O
5.	DT	O
The	JJ	O
results	NNS	O
obtained	VBN	O
were	IN	O
analyzed	JJ	O
utilizing	.	O
softwares	DT	O
usable	NNS	O
on	VBN	O
the	VBD	O
Internet	VBN	O
Boehnke,	JJ	B
M.,	NNS	I
et	JJ	I
al.,	IN	I
Am.	DT	I
J.	NNP	I
Hum.	,	I
Genet.,	,	I
46,	FW	I
581-586	,	I
(1991)].[	.	O
As	NNP	O
a	.	O
result,	,	O
the	,	O
BNAP	CD	O
gene	.	O
was	IN	O
found	DT	O
strongly	,	O
linked	DT	O
to	NNP	O
the	NN	O
marker	VBD	O
DXS990	VBN	O
(LOD=1000,	RB	O
cR8000=−0.00).	VBN	O
Since	TO	O
DXS990	DT	O
is	NN	O
a	NNP	O
marker	,	O
localized	.	O
on	IN	O
the	NNP	O
chromosome	VBZ	O
Xq21.3-q22,	DT	O
it	NN	O
was	VBN	O
established	IN	O
that	DT	O
BNAP	NN	O
is	,	O
localized	PRP	O
to	VBD	O
the	VBN	O
chromosomal	IN	O
locus	NNP	O
Xq21.3-q22	VBZ	O
where	VBN	O
genes	TO	O
involved	DT	O
in	JJ	O
several	NN	O
signs	NNP	O
or	WRB	O
symptoms	NNS	O
of	VBN	O
X-chromosome-associated	IN	O
mental	JJ	O
retardation	NNS	O
are	CC	O
localized.	NNS	O
The	IN	O
nucleosome	JJ	O
is	JJ	O
not	NN	O
only	VBP	O
a	.	O
fundamental	DT	O
chromosomal	NN	O
structural	VBZ	O
unit	RB	O
characteristic	RB	O
of	DT	O
eukaryotes	JJ	O
but	JJ	O
also	JJ	O
a	NN	O
gene	NN	O
expression	IN	O
regulating	NNS	O
unit.	CC	O
Several	RB	O
results	DT	O
indicate	NN	O
that	NN	O
genes	VBG	O
with	.	O
high	JJ	O
transcription	NNS	O
activity	VBP	O
are	IN	O
sensitive	NNS	O
to	IN	O
nuclease	JJ	O
treatment,	NN	O
suggesting	NN	O
that	VBP	O
the	JJ	O
chromosome	TO	O
structure	VB	O
changes	,	O
with	VBG	O
the	IN	O
transcription	DT	O
activity	NN	O
Elgin,	NN	B
S.	NNS	I
C.	IN	I
R.,	DT	I
J.	NN	I
Biol.	NN	I
Chem.,	,	I
263,	NNP	I
19259-19262	NNP	I
(1988)].[	,	O
NAP-I	NNP	O
has	.	O
been	,	O
cloned	,	O
in	CD	O
yeast,	.	O
mouse	NNP	O
and	VBZ	O
human	VBN	O
and	VBN	O
is	IN	O
one	,	O
of	NN	O
the	CC	O
factors	JJ	O
capable	CC	O
of	VBZ	O
promoting	CD	O
nucleosome	IN	O
construction	DT	O
in	NNS	O
vivo.	JJ	O
In	IN	O
a	VBG	O
study	JJ	O
performed	NN	O
on	IN	O
their	.	O
sequences,	IN	O
NAPs	DT	O
containing	NN	O
the	VBN	O
epitope	IN	O
of	PRP$	O
the	,	O
specific	NNP	O
antibody	VBG	O
4A8	DT	O
were	NN	O
detected	IN	O
in	DT	O
human,	JJ	O
mouse,	NN	O
frog,	CD	O
Drosophila	VBD	O
and	VBN	O
yeast	IN	O
(Saccharomyces	,	O
cerevisiae)	,	O
Ishimi,	,	B
Y.,	NNP	I
et	CC	I
al.,	NNP	I
Eur.	NNP	I
J.	)	I
Biochem.,	,	I
162,	,	I
19-24	FW	I
(1987)].[	,	O
In	.	O
these	.	O
experiments,	,	O
NAPs,	,	O
upon	CD	O
SDS-PAGE	.	O
analysis,	IN	O
electrophoretically	DT	O
migrated	,	O
to	,	O
positions	IN	O
corresponding	NNP	O
to	,	O
a	RB	O
molecular	VBN	O
weight	TO	O
between	NNS	O
50	VBG	O
and	TO	O
60	DT	O
kDa,	JJ	O
whereas	NN	O
the	IN	O
recombinant	CD	O
BNAP	CC	O
slowly	CD	O
migrated	,	O
to	IN	O
a	DT	O
position	JJ	O
of	NNP	O
about	RB	O
80	VBD	O
kDa.	TO	O
The	DT	O
epitope	NN	O
of	IN	O
4A8	IN	O
was	CD	O
shown	.	O
to	DT	O
be	NN	O
localized	IN	O
in	CD	O
the	VBD	O
second,	VBN	O
well-conserved,	TO	O
hydrophobic	VB	O
motif.	VBN	O
And,	IN	O
it	DT	O
was	,	O
simultaneously	,	O
shown	JJ	O
that	.	O
the	,	O
triplet	PRP	O
FNF	VBD	O
is	RB	O
important	VBN	O
as	IN	O
a	DT	O
part	NN	O
of	NNP	O
the	VBZ	O
epitope	JJ	O
Fujii-Nakata,	IN	B
T.,	DT	I
et	NN	I
al.,	IN	I
J.	DT	I
Biol.	NN	I
Chem.,	,	I
267,	,	I
20980-20986	FW	I
(1992)].[	,	O
BNAP	NNP	O
also	.	O
contained	,	O
this	,	O
consensus	CD	O
motif	.	O
in	NNP	O
domain	RB	O
II.	VBD	O
The	DT	O
fact	NN	O
that	NN	O
domain	IN	O
II	NN	O
is	.	O
markedly	DT	O
hydrophobic	NN	O
and	IN	O
the	NN	O
fact	NNP	O
that	VBZ	O
domain	RB	O
II	JJ	O
can	CC	O
be	DT	O
recognized	NN	O
by	IN	O
the	NN	O
immune	NNP	O
system	MD	O
suggest	VB	O
that	VBN	O
it	IN	O
is	DT	O
probably	NN	O
presented	NN	O
on	VBP	O
the	IN	O
BNAP	PRP	O
surface	VBZ	O
and	RB	O
is	VBN	O
possibly	IN	O
involved	DT	O
in	NNP	O
protein-protein	NN	O
interactions.	CC	O
Domain	VBZ	O
I,	RB	O
too,	VBN	O
may	IN	O
be	JJ	O
involved	.	O
in	NN	O
protein-protein	,	O
interactions.	,	O
Considering	MD	O
that	VB	O
these	VBN	O
are	IN	O
conserved	JJ	O
generally	.	O
among	VBG	O
NAPs,	IN	O
though	DT	O
to	VBP	O
a	VBN	O
relatively	RB	O
low	IN	O
extent,	,	O
it	RB	O
is	TO	O
conceivable	DT	O
that	RB	O
they	JJ	O
must	,	O
be	PRP	O
essential	VBZ	O
for	JJ	O
nucleosome	IN	O
construction,	PRP	O
although	MD	O
the	VB	O
functional	JJ	O
meaning	IN	O
of	JJ	O
the	,	O
conserved	IN	O
domains	DT	O
is	JJ	O
still	NN	O
unknown.	IN	O
The	DT	O
hNRP	JJ	O
gene	NNS	O
is	VBZ	O
expressed	RB	O
in	.	O
thyroid	DT	O
gland,	NN	O
stomach,	NN	O
kidney,	VBZ	O
intestine,	VBN	O
leukemia,	IN	O
lung	NN	O
cancer,	,	O
mammary	,	O
cancer	,	O
and	,	O
so	,	O
on	NN	O
Simon,	,	B
H.	JJ	I
U.,	NN	I
et	CC	I
al.,	RB	I
Biochem.	IN	I
J.,	,	I
297,	NNP	I
389-397	,	I
(1994)].[	FW	O
Like	,	O
that,	.	O
NAPs	,	O
are	,	O
expressed	CD	O
everywhere	.	O
and	IN	O
are	,	O
thought	NNP	O
to	VBP	O
be	VBN	O
playing	RB	O
an	CC	O
important	VBP	O
role	VBN	O
in	TO	O
fundamental	VB	O
nucleosome	VBG	O
formation.	DT	O
BNAP	JJ	O
may	NN	O
be	IN	O
involved	JJ	O
in	JJ	O
brain-specific	.	O
nucleosome	NNP	O
formation	MD	O
and	VB	O
an	VBN	O
insufficiency	IN	O
thereof	JJ	O
may	JJ	O
cause	NN	O
neurological	CC	O
diseases	DT	O
or	NN	O
mental	NN	O
retardation	MD	O
as	VB	O
a	JJ	O
result	NNS	O
of	CC	O
deviated	JJ	O
functions	NN	O
of	IN	O
neurons.	DT	O
BNAP	NN	O
was	IN	O
found	JJ	O
strongly	NNS	O
linked	IN	O
to	.	O
a	NNP	O
marker	VBD	O
on	VBN	O
the	RB	O
X-chromosome	VBN	O
q21.3-q22	TO	O
where	DT	O
sequences	NN	O
involved	IN	O
in	DT	O
several	JJ	O
symptoms	NN	O
of	WRB	O
X-chromosome-associated	NNS	O
mental	VBN	O
retardation	IN	O
are	JJ	O
localized.	NNS	O
This	IN	O
center-surrounding	JJ	O
region	JJ	O
of	NN	O
X-chromosome	VBP	O
was	.	O
rich	DT	O
in	JJ	O
genes	NN	O
responsible	IN	O
for	NNP	O
α-thalassemia,	VBD	O
mental	JJ	O
retardation	IN	O
(ATR-X)	NNS	O
or	JJ	O
some	IN	O
other	,	O
forms	JJ	O
of	NN	O
mental	)	O
retardation	CC	O
Gibbons,	DT	B
R.	JJ	I
J.,	NNS	I
et	IN	I
al.,	JJ	I
Cell,	NN	I
80,	,	I
837-845	NNP	I
(1995)].[	,	O
Like	FW	O
the	,	O
analysis	,	O
of	,	O
the	CD	O
ATR-X	.	O
gene	IN	O
which	DT	O
seems	NN	O
to	IN	O
regulate	DT	O
the	NNP	O
nucleosome	NN	O
structure,	WDT	O
the	VBZ	O
present	TO	O
inventors	VB	O
suppose	DT	O
that	JJ	O
BNAP	,	O
may	DT	O
be	JJ	O
involved	NNS	O
in	VBP	O
a	IN	O
certain	NNP	O
type	MD	O
of	VB	O
X-chromosome-linked	VBN	O
mental	IN	O
retardation.	DT	O
According	JJ	O
to	NN	O
this	IN	O
example,	JJ	O
the	JJ	O
novel	.	O
BNAP	VBG	O
gene	TO	O
is	DT	O
provided	,	O
and,	DT	O
when	NN	O
said	NNP	O
gene	NN	O
is	VBZ	O
used,	VBN	O
it	,	O
is	WRB	O
possible	VBD	O
to	NN	O
detect	VBZ	O
the	,	O
expression	PRP	O
of	VBZ	O
said	JJ	O
gene	TO	O
in	VB	O
various	DT	O
tissues	NN	O
and	IN	O
to	VBD	O
produce	NN	O
the	IN	O
BNAP	JJ	O
protein	NNS	O
by	CC	O
the	TO	O
technology	VB	O
of	DT	O
genetic	NNP	O
engineering.	NN	O
Through	IN	O
these,	DT	O
it	NN	O
is	IN	O
possible	JJ	O
to	.	O
study	IN	O
the	,	O
brain	PRP	O
nucleosome	VBZ	O
formation	JJ	O
deeply	TO	O
involved,	VB	O
as	DT	O
mentioned	NN	O
above,	JJ	O
in	NN	O
variegated	RB	O
activities	,	O
essential	IN	O
to	VBN	O
cells	,	O
as	IN	O
well	JJ	O
as	NNS	O
the	JJ	O
functions	TO	O
of	NNS	O
cranial	RB	O
nerve	RB	O
cells	IN	O
and	DT	O
to	NNS	O
diagnose	IN	O
various	JJ	O
neurological	NN	O
diseases	NNS	O
or	CC	O
mental	TO	O
retardation	VB	O
in	JJ	O
which	JJ	O
these	NNS	O
are	CC	O
involved	JJ	O
and	NN	O
screen	IN	O
out	WDT	O
and	DT	O
evaluate	VBP	O
drugs	VBN	O
for	CC	O
the	VBN	O
treatment	RP	O
or	CC	O
prevention	VB	O
of	NNS	O
such	IN	O
diseases.	DT	O
Example	NN	O
7	CC	O
Human	NN	O
Skeletal	IN	O
Muscle-Specific	JJ	O
Ubiquitin-Conjugating	.	O
Enzyme	JJ	O
Gene	CD	O
(UBE2G	NNP	O
Gene)	NNP	O
The	NNP	O
ubiquitin	NNP	O
system	NNP	O
is	NNP	O
a	NNP	O
group	)	O
of	DT	O
enzymes	JJ	O
essential	NN	O
for	VBZ	O
cellular	DT	O
processes	NN	O
and	IN	O
is	NNS	O
conserved	JJ	O
from	IN	O
yeast	JJ	O
to	NNS	O
human.	CC	O
Said	VBZ	O
system	VBN	O
is	IN	O
composed	NN	O
of	TO	O
ubiquitin-activating	.	O
enzymes	NNP	O
(UBAs),	NN	O
ubiquitin-conjugating	VBZ	O
enzymes	VBN	O
(UBCs),	IN	O
ubiquitin	JJ	O
protein	NNS	O
ligases	,	O
(UBRs)	JJ	O
and	NNS	O
26S	,	O
proteasome	JJ	O
particles.	NN	O
Ubiquitin	NNS	O
is	)	O
transferred	CC	O
from	CD	O
the	NN	O
above-mentioned	.	O
UBAs	NNP	O
to	VBZ	O
several	VBN	O
UBCs,	IN	O
whereby	DT	O
it	JJ	O
is	NNP	O
activated.	TO	O
UBCs	JJ	O
transfer	,	O
ubiquitins	NN	O
to	PRP	O
target	VBZ	O
proteins	.	O
with	NNP	O
or	NN	O
without	VBZ	O
the	TO	O
participation	VB	O
of	NNS	O
UBRs.	IN	O
These	CC	O
ubiquitin-conjugated	IN	O
target	DT	O
proteins	NN	O
are	IN	O
said	.	O
to	DT	O
induce	JJ	O
a	NN	O
number	NNS	O
of	VBP	O
cellular	VBD	O
responses,	TO	O
such	VB	O
as	DT	O
protein	NN	O
degradation,	IN	O
protein	JJ	O
modification,	,	O
protein	JJ	O
translocation,	IN	O
DNA	JJ	O
repair,	,	O
cell	NN	O
cycle	,	O
control,	JJ	O
transcription	,	O
control,	NNP	O
stress	,	O
responses,	NN	O
etc.	NN	O
and	,	O
immunological	NN	O
responses	,	O
Jentsch,	NN	B
S.,	,	I
et	.	I
al.,	CC	I
Biochim.	JJ	I
Biophys.	NNS	I
Acta,	,	I
1089,	,	I
127-139	FW	I
(1991);	,	I
Hershko,	.	B
A.	.	I
and	,	I
Ciechanover,	,	I
A.,	CD	I
Annu.	:	I
Rev.	,	I
Biochem.,	NNP	I
61,	CC	I
761-807	,	I
(1992);	,	I
Jentsch,	.	B
S.,	.	I
Annu.	,	I
Rev.	,	I
Genet.,	CD	I
26,	:	I
179-207	,	I
(1992);	,	I
Ciechanover,	.	B
A.,	.	I
Cell,	,	I
79,	,	I
13-21	CD	I
(1994)].[	:	O
UBCs	,	O
are	,	O
key	,	O
components	,	O
of	CD	O
this	.	O
system	NNS	O
and	VBP	O
seem	JJ	O
to	NNS	O
have	IN	O
distinct	DT	O
substrate	NN	O
specificities	CC	O
and	VBP	O
modulate	TO	O
different	VB	O
functions.	JJ	O
For	NN	O
example,	NNS	O
Saccharomyces	CC	O
cerevisiae	VB	O
UBC7	JJ	O
is	.	O
induced	IN	O
by	,	O
cadmium	NNP	O
and	NN	O
involved	NNP	O
in	VBZ	O
resistance	VBN	O
to	IN	O
cadmium	NN	O
poisoning	CC	O
Jungmann,	VBN	B
J.,	IN	I
et	NN	I
al.,	TO	I
Nature,	VB	I
361,	VBG	I
369-371	,	I
(1993)].[	,	O
Degradation	FW	O
of	,	O
MAT-α2	,	O
is	,	O
also	CD	O
executed	.	O
by	NN	O
UBC7	IN	O
and	NNP	O
UBC6	VBZ	O
Chen,	RB	B
P.,	VBN	I
et	IN	I
al.,	NNP	I
Cell,	CC	I
74,	NNP	I
357-369	,	I
(1993)].[	,	O
The	FW	O
novel	,	O
gene	,	O
obtained	,	O
in	CD	O
this	.	O
example	DT	O
is	JJ	O
UBC7-like	NN	O
gene	VBN	O
strongly	IN	O
expressed	DT	O
in	NN	O
human	VBZ	O
skeletal	JJ	O
muscle.	NN	O
In	RB	O
the	VBN	O
following,	IN	O
cloning	JJ	O
and	JJ	O
DNA	.	O
sequencing	IN	O
thereof	DT	O
are	,	O
described.	VBG	O
(1)	CC	O
Cloning	NNP	O
and	VBG	O
DNA	NNS	O
Sequencing	VBP	O
of	.	O
Human	)	O
Skeletal	NN	O
Muscle-Specific	CC	O
Ubiquitin-Conjugating	NNP	O
Enzyme	NNP	O
Gene	IN	O
(Ube2G	NNP	O
Gene)	NNP	O
Following	NNP	O
the	NNP	O
same	NNP	O
procedure	NNP	O
as	NNP	O
in	)	O
Example	VBG	O
1	DT	O
(1),	JJ	O
cDNA	NN	O
clones	IN	O
were	IN	O
arbitrarily	NNP	O
selected	CD	O
from	,	O
a	JJ	O
human	NNS	O
fetal	VBD	O
brain	RB	O
cDNA	VBN	O
library	IN	O
and	DT	O
subjected	JJ	O
to	NN	O
sequence	NN	O
analysis,	NN	O
and	NN	O
database	CC	O
searches	VBN	O
were	TO	O
performed.	VB	O
As	,	O
a	CC	O
result,	NN	O
a	NNS	O
cDNA	VBD	O
clone,	.	O
GEN-423A12,	IN	O
was	DT	O
found	,	O
to	DT	O
have	NN	O
a	,	O
significantly	,	O
high	VBD	O
level	VBN	O
of	TO	O
homology	VB	O
to	DT	O
the	RB	O
genes	JJ	O
coding	NN	O
for	IN	O
ubiquitin-conjugating	NN	O
enzymes	TO	O
(UBCs)	DT	O
in	NNS	O
various	VBG	O
species.	IN	O
Since	JJ	O
said	NNS	O
GEN-423A12	)	O
clone	IN	O
was	JJ	O
lacking	.	O
in	IN	O
the	VBD	O
5′	NNP	O
side,	NN	O
5′	VBD	O
RACE	VBG	O
was	IN	O
performed	DT	O
in	CD	O
the	,	O
same	CD	O
manner	NNP	O
as	VBD	O
in	VBN	O
Example	IN	O
2	DT	O
(2)	JJ	O
to	NN	O
obtain	IN	O
an	IN	O
entire	NNP	O
coding	CD	O
region.	)	O
For	TO	O
said	VB	O
5′	DT	O
RACE,	JJ	O
two	NN	O
primers,	.	O
P1	IN	O
and	VBD	O
P2,	CD	O
respectively	,	O
having	CD	O
the	,	O
nucleotide	NNP	O
sequences	CC	O
shown	,	O
in	RB	O
Table	VBG	O
6	DT	O
were	JJ	O
used.	NNS	O
The	VBN	O
5′	IN	O
RACE	JJ	O
product	CD	O
was	VBD	O
inserted	.	O
into	DT	O
pT7Blue(R)	CD	O
T-Vector	NNP	O
and	NN	O
clones	VBD	O
with	VBN	O
an	IN	O
insert	)	O
proper	NN	O
in	CC	O
size	NNS	O
were	IN	O
selected.	DT	O
Four	JJ	O
of	NN	O
the	IN	O
5′	NN	O
RACE	VBD	O
clones	.	O
obtained	CD	O
from	IN	O
two	DT	O
independent	CD	O
PCR	NNP	O
reactions	NNS	O
contained	VBN	O
the	IN	O
same	CD	O
sequence	JJ	O
but	NNP	O
were	NNS	O
different	VBD	O
in	DT	O
length.	JJ	O
By	NN	O
sequencing	CC	O
the	VBD	O
above	JJ	O
clones,	IN	O
the	.	O
coding	IN	O
sequence	VBG	O
and	DT	O
adjacent	JJ	O
5′-	,	O
and	DT	O
3′-flanking	VBG	O
sequences	NN	O
of	CC	O
the	JJ	O
novel	JJ	O
gene	CC	O
were	JJ	O
determined.	NNS	O
As	IN	O
a	DT	O
result,	JJ	O
it	NN	O
was	VBD	O
revealed	.	O
that	IN	O
the	DT	O
novel	,	O
gene	PRP	O
has	VBD	O
a	VBN	O
total	IN	O
length	DT	O
of	JJ	O
617	NN	O
nucleotides.	VBZ	O
This	DT	O
gene	JJ	O
was	NN	O
named	IN	O
human	CD	O
skeletal	.	O
muscle-specific	DT	O
ubiquitin-conjugating	NN	O
enzyme	VBD	O
gene	VBN	O
(UBE2G	JJ	O
gene).	JJ	O
To	JJ	O
exclude	JJ	O
the	NN	O
conceivable	NN	O
possibility	NNP	O
that	.	O
this	TO	O
sequence	VB	O
was	DT	O
a	JJ	O
chimera	NN	O
clone,	IN	O
RT-PCR	DT	O
was	NN	O
performed	VBD	O
in	DT	O
the	NN	O
same	,	O
manner	NNP	O
as	VBD	O
in	VBN	O
Example	IN	O
6	DT	O
(1)	JJ	O
using	NN	O
the	IN	O
sense	IN	O
primer	NNP	O
to	CD	O
amplify	)	O
said	VBG	O
sequence	DT	O
from	NN	O
the	NN	O
human	TO	O
fetal	VB	O
brain	VBD	O
cDNA	NN	O
library.	IN	O
As	DT	O
a	JJ	O
result,	JJ	O
a	NN	O
single	NN	O
PCR	.	O
product	IN	O
was	DT	O
obtained,	,	O
whereby	DT	O
it	JJ	O
was	NNP	O
confirmed	NN	O
that	VBD	O
said	,	O
sequence	WRB	O
is	PRP	O
not	VBD	O
a	VBN	O
chimera	IN	O
one.	VBD	O
The	NN	O
UBE2G	VBZ	O
gene	RB	O
contains	DT	O
an	NN	O
open	.	O
reading	DT	O
frame	NNP	O
of	NN	O
510	VBZ	O
nucleotides,	DT	O
which	JJ	O
is	NN	O
shown	NN	O
under	IN	O
SEQ	CD	O
ID	,	O
NO:23,	WDT	O
the	VBZ	O
amino	VBN	O
acid	IN	O
sequence	NNP	O
encoded	NNP	O
thereby	,	O
comprises	DT	O
170	NN	O
amino	JJ	O
acid	NN	O
residues,	VBD	O
as	RB	O
shown	VBZ	O
under	CD	O
SEQ	NN	O
ID	NN	O
NO:22,	,	O
and	IN	O
the	VBN	O
nucleotide	IN	O
sequence	NNP	O
of	NNP	O
the	,	O
entire	CC	O
UBE2G	DT	O
cDNA	JJ	O
is	NN	O
as	IN	O
shown	DT	O
under	JJ	O
SEQ	NNP	O
ID	NN	O
NO:24.	VBZ	O
As	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:24,	.	O
the	IN	O
estimable	VBN	O
initiation	IN	O
codon	NNP	O
was	NNP	O
located	,	O
at	DT	O
nucleotides	JJ	O
Nos.	NN	O
19-21,	NN	O
corresponding	VBD	O
to	VBN	O
the	IN	O
first	NNS	O
ATG	.	O
triplet	,	O
of	VBG	O
the	TO	O
cDNA	DT	O
clone.	JJ	O
Since	NNP	O
no	NN	O
preceding	IN	O
in-frame	DT	O
termination	NN	O
codon	.	O
was	IN	O
found,	DT	O
it	VBG	O
was	JJ	O
deduced	NN	O
that	NN	O
this	VBD	O
clone	,	O
contains	PRP	O
the	VBD	O
entire	VBN	O
open	IN	O
reading	DT	O
frame	NN	O
on	VBZ	O
the	DT	O
following	JJ	O
grounds.	JJ	O
Thus,	NN	O
(a)	NN	O
the	IN	O
amino	DT	O
acid	JJ	O
sequence	.	O
is	,	O
highly	)	O
homologous	DT	O
to	NN	O
S.	NN	O
cerevisiae	NN	O
UBC7	VBZ	O
and	RB	O
said	JJ	O
initiation	TO	O
codon	NNP	O
agrees	NN	O
with	NNP	O
that	CC	O
of	VBD	O
yeast	NN	O
UBC7,	NN	O
supporting	VBZ	O
said	IN	O
ATG	DT	O
as	IN	O
such.	NN	O
(b)	,	O
The	VBG	O
sequence	VBD	O
AGGATGA	NNP	O
is	IN	O
similar	.	O
to	)	O
the	DT	O
consensus	NN	O
sequence	NNP	O
(A/G)CCATGG	VBZ	O
around	JJ	O
the	TO	O
initiation	DT	O
codon	NN	O
Kozak,	NN	B
M.,	NNP	I
J.	IN	I
Biol.	DT	I
Chem.,	NN	I
266,	NN	I
19867-19870	,	I
(1991)].[	,	O
(2)	NNP	O
Comparison	.	O
in	,	O
Amino	,	O
Acid	CD	O
Sequence	.	O
Between	)	O
UBE2G	NNP	O
and	IN	O
UBCs	NNP	O
Comparison	NNP	O
in	NNP	O
amino	NNP	O
acid	NNP	O
sequence	CC	O
between	NNP	O
UBE2G	NNP	O
and	IN	O
UBCs	NN	O
suggested	NN	O
that	NN	O
the	IN	O
active	NNP	O
site	CC	O
cystein	NNP	O
capable	VBD	O
of	IN	O
binding	DT	O
to	JJ	O
ubiquitin	NN	O
should	NN	O
be	JJ	O
the	IN	O
90th	VBG	O
residue	TO	O
cystein.	VB	O
The	MD	O
peptides	VB	O
encoded	DT	O
by	CD	O
these	JJ	O
genes	.	O
seem	DT	O
to	NNS	O
belong	VBN	O
to	IN	O
the	DT	O
same	NNS	O
family.	VBP	O
(3)	TO	O
Northern	VB	O
Blot	TO	O
Analysis	DT	O
Northern	JJ	O
blot	.	O
analysis	)	O
was	NNP	O
carried	NNP	O
out	NNP	O
as	NNP	O
described	NN	O
in	NN	O
Example	VBD	O
1	VBN	O
(2).	RP	O
Thus,	IN	O
the	VBN	O
entire	IN	O
sequence	NNP	O
of	CD	O
UBE2G	.	O
was	,	O
amplified	DT	O
by	JJ	O
PCR,	NN	O
the	IN	O
PCR	NNP	O
product	VBD	O
was	VBN	O
purified	IN	O
and	,	O
labeled	DT	O
with	NNP	O
[32P]-dCTP	NN	O
(random-primed	VBD	O
DNA	VBN	O
labeling	CC	O
kit,	VBN	O
Boehringer	IN	O
Mannheim)	NNP	O
and	JJ	O
the	NNP	O
expression	VBG	O
of	,	O
UBE2G	NNP	O
mRNA	)	O
in	CC	O
normal	DT	O
human	NN	O
tissues	IN	O
using	NNP	O
the	NN	O
labeled	IN	O
product	JJ	O
as	JJ	O
a	NNS	O
probe.	VBG	O
The	DT	O
membrane	JJ	O
used	NN	O
was	IN	O
an	DT	O
MTN	.	O
blot.	DT	O
As	NN	O
a	VBN	O
result	VBD	O
of	DT	O
the	NNP	O
Northern	.	O
blot	IN	O
analysis,	DT	O
4.4	NN	O
kb,	IN	O
2.4	DT	O
kb	NNP	O
and	NN	O
1.6	,	O
kb	CD	O
transcripts	,	O
could	CD	O
be	NN	O
detected	CC	O
in	CD	O
all	NN	O
16	NNS	O
human	MD	O
adult	VB	O
tissues,	VBN	O
namely	IN	O
heart,	DT	O
brain,	CD	O
placenta,	JJ	O
lung,	NN	O
liver,	,	O
skeletal	RB	O
muscle,	,	O
kidney,	,	O
pancreas,	,	O
spleen,	,	O
thyroid	,	O
gland,	JJ	O
urinary	,	O
bladder,	,	O
testis,	,	O
ovary,	,	O
small	JJ	O
intestine,	,	O
large	JJ	O
intestine	,	O
and	,	O
peripheral	,	O
blood	JJ	O
leukocye,	,	O
after	JJ	O
18	NN	O
hours	CC	O
of	JJ	O
exposure.	NN	O
Strong	,	O
expression	IN	O
of	CD	O
these	NNS	O
transcripts	IN	O
was	.	O
observed	JJ	O
in	NN	O
skeletal	IN	O
muscle.	DT	O
(4)	NNS	O
Radiation	VBD	O
Hybrid	VBN	O
Mapping	IN	O
Chromosomal	JJ	O
mapping	.	O
of	)	O
the	NNP	O
UBE2G	NNP	O
clone	NNP	O
was	NNP	O
performed	NN	O
by	IN	O
radiation	DT	O
hybrid	NNP	O
mapping	NN	O
in	VBD	O
the	VBN	O
same	IN	O
manner	NN	O
as	JJ	O
in	NN	O
Example	IN	O
6	DT	O
(4).	JJ	O
The	NN	O
primers	IN	O
C1	IN	O
and	NNP	O
C4	CD	O
used	.	O
in	DT	O
PCR	NNS	O
for	NNP	O
chromosomal	CC	O
mapping	NNP	O
analysis	VBD	O
respectively	IN	O
correspond	NNP	O
to	IN	O
nucleotides	JJ	O
Nos.	NN	O
415-435	NN	O
and	RB	O
nucleotides	NN	O
Nos.	TO	O
509-528	NNS	O
in	.	O
the	JJ	O
sequence	CC	O
shown	JJ	O
under	.	O
SEQ	JJ	O
ID	IN	O
NO:24	DT	O
and	NN	O
their	VBN	O
nucleotide	IN	O
sequences	NNP	O
are	NNP	O
as	NNP	O
shown	CC	O
below	PRP$	O
in	JJ	O
Table	NNS	O
7.	VBP	O
As	IN	O
a	VBN	O
result,	IN	O
the	IN	O
UBE2G	JJ	O
gene	.	O
was	IN	O
found	DT	O
linked	,	O
to	DT	O
the	NNP	O
markers	NN	O
D1S446	VBD	O
(LOD=12.52,	VBN	O
cR8000=8.60)	VBN	O
and	TO	O
D1S235	DT	O
(LOD=9.14,	NNS	O
cR8000=22.46).	NNP	O
These	,	O
markers	)	O
are	CC	O
localized	NNP	O
to	,	O
the	.	O
chromosome	DT	O
bands	NNS	O
1q42.13-q42.3.	VBP	O
UBE2G	VBN	O
was	TO	O
expressed	DT	O
strongly	NN	O
in	VBZ	O
skeletal	.	O
muscle	NNP	O
and	VBD	O
very	VBN	O
weakly	RB	O
in	IN	O
all	JJ	O
other	NN	O
tissues	CC	O
examined.	RB	O
All	RB	O
other	IN	O
UBCs	DT	O
are	JJ	O
involved	NNS	O
in	.	O
essential	DT	O
cellular	JJ	O
functions,	NNP	O
such	VBP	O
as	VBN	O
cell	IN	O
cycle	JJ	O
control,	JJ	O
and	,	O
those	JJ	O
UBCs	IN	O
are	NN	O
expressed	NN	O
ubiquitously.	,	O
However,	CC	O
the	DT	O
expression	NNP	O
pattern	VBP	O
of	VBN	O
UBE2G	.	O
might	,	O
suggest	DT	O
a	NN	O
muscle-specific	NN	O
role	IN	O
thereof.	NNP	O
While	MD	O
the	VB	O
three	DT	O
transcripts	JJ	O
differing	NN	O
in	.	O
size	IN	O
were	DT	O
detected,	CD	O
attempts	NNS	O
failed	VBG	O
to	IN	O
identify	NN	O
which	VBD	O
corresponds	,	O
to	NNS	O
the	VBD	O
cDNA	TO	O
clone.	VB	O
The	WDT	O
primary	VBZ	O
structure	TO	O
of	DT	O
the	NN	O
UBE2G	.	O
product	DT	O
showed	JJ	O
an	NN	O
extreme	IN	O
homology	DT	O
to	NNP	O
yeast	NN	O
UBC7.	VBD	O
On	DT	O
the	JJ	O
other	NN	O
hand,	TO	O
nematode	VB	O
UBC7	.	O
showed	IN	O
strong	DT	O
homology	JJ	O
to	,	O
yeast	NN	O
UBC7.	NNP	O
It	VBD	O
is	JJ	O
involved	NN	O
in	TO	O
degradation	VB	O
of	.	O
the	PRP	O
repressor	VBZ	O
and	VBN	O
further	IN	O
confers	NN	O
resistance	IN	O
to	DT	O
cadmium	NN	O
in	CC	O
yeasts.	JJ	O
The	NNS	O
similarities	NN	O
among	TO	O
these	VB	O
proteins	IN	O
suggest	.	O
that	DT	O
they	NNS	O
belong	IN	O
to	DT	O
the	NNS	O
same	VBP	O
family.	IN	O
It	PRP	O
is	VBP	O
speculated	TO	O
that	DT	O
UBE2G	JJ	O
is	.	O
involved	PRP	O
in	VBZ	O
degradation	VBN	O
of	IN	O
muscle-specific	NNP	O
proteins	VBZ	O
and	VBN	O
that	IN	O
a	NN	O
defect	IN	O
in	JJ	O
said	NNS	O
gene	CC	O
could	IN	O
lead	DT	O
to	NN	O
such	IN	O
diseases	VBD	O
as	NN	O
muscular	MD	O
dystrophy.	VB	O
Recently,	TO	O
another	JJ	O
proteolytic	NNS	O
enzyme,	IN	O
calpain	JJ	O
3,	.	O
was	,	O
found	DT	O
to	JJ	O
be	,	O
responsible	VBP	O
for	,	O
limb-girdle	VBD	O
muscular	VBN	O
dystrophy	TO	O
type	VB	O
2A	JJ	O
Richard,	IN	B
I.,	JJ	I
et	JJ	I
al.,	NN	I
Cell,	NN	I
81,	CD	I
27-40	,	I
(1995)].[	,	O
At	NN	O
the	,	O
present,	,	O
the	,	O
chromosomal	CD	O
location	.	O
of	IN	O
UBE2G	DT	O
suggests	,	O
no	DT	O
significant	JJ	O
relationship	NN	O
with	IN	O
any	NNP	O
hereditary	VBZ	O
muscular	DT	O
disease	JJ	O
but	NN	O
it	IN	O
is	DT	O
likely	JJ	O
that	JJ	O
a	NN	O
relation	CC	O
to	PRP	O
the	VBZ	O
gene	JJ	O
will	IN	O
be	DT	O
unearthed	NN	O
by	TO	O
linkage	DT	O
analysis	NN	O
in	MD	O
future.	VB	O
In	VBN	O
accordance	IN	O
with	NN	O
this	NN	O
example,	IN	O
the	.	O
novel	IN	O
UBE2G	NN	O
gene	IN	O
is	DT	O
provided	,	O
and	DT	O
the	JJ	O
use	NNP	O
of	NN	O
said	VBZ	O
gene	VBN	O
enables	CC	O
detection	DT	O
of	NN	O
its	IN	O
expression	VBD	O
in	NN	O
various	NNS	O
tissues	NN	O
and	IN	O
production	PRP$	O
of	NN	O
the	IN	O
UBE2G	JJ	O
protein	NNS	O
by	CC	O
the	NN	O
technology	IN	O
of	DT	O
genetic	NNP	O
engineering.	NN	O
Through	IN	O
these,	DT	O
it	NN	O
becomes	IN	O
possible	JJ	O
to	.	O
study	IN	O
the	,	O
degradation	PRP	O
of	VBZ	O
muscle-specific	JJ	O
proteins	TO	O
deeply	VB	O
involved	DT	O
in	NN	O
basic	IN	O
activities	JJ	O
variegated	NNS	O
and	RB	O
essential	VBN	O
to	IN	O
cells,	JJ	O
as	NNS	O
mentioned	VBN	O
above,	CC	O
and	JJ	O
the	TO	O
functions	,	O
of	IN	O
skeletal	VBN	O
muscle,	,	O
to	CC	O
diagnose	DT	O
various	NNS	O
muscular	IN	O
diseases	JJ	O
in	,	O
which	TO	O
these	VB	O
are	JJ	O
involved	JJ	O
and	NNS	O
further	IN	O
to	WDT	O
screen	DT	O
out	VBP	O
and	VBN	O
evaluate	CC	O
drugs	RBR	O
for	TO	O
the	VB	O
treatment	RP	O
and	CC	O
prevention	VB	O
of	NNS	O
such	IN	O
diseases.	DT	O
Example	NN	O
8	CC	O
TMP-2	NN	O
Gene	IN	O
(1)	JJ	O
TMP-2	.	O
Gene	JJ	O
Cloning	CD	O
and	JJ	O
DNA	NNP	O
Sequencing	)	O
Following	NNP	O
the	NNP	O
procedure	NNP	O
of	CC	O
Example	NNP	O
1	NNP	O
(1),	VBG	O
cDNA	DT	O
clones	NN	O
were	IN	O
arbitrarily	NNP	O
selected	CD	O
from	,	O
a	JJ	O
human	NNS	O
fetal	VBD	O
brain	RB	O
cDNA	VBN	O
library	IN	O
and	DT	O
subjected	JJ	O
to	NN	O
sequence	NN	O
analysis,	NN	O
and	NN	O
database	CC	O
searches	VBN	O
were	TO	O
performed.	VB	O
As	,	O
a	CC	O
result,	NN	O
a	NNS	O
clone	VBD	O
(GEN-092E10)	.	O
having	IN	O
a	DT	O
cDNA	,	O
sequence	DT	O
highly	NN	O
homologous	)	O
to	VBG	O
a	DT	O
transmembrane	NN	O
protein	NN	O
gene	RB	O
(accession	JJ	O
No.:	TO	O
U19878)	DT	O
was	NN	O
found	NN	O
out.	NN	O
Membrane	JJ	O
protein	:	O
genes	)	O
have	VBD	O
so	VBN	O
far	.	O
been	NNP	O
cloned	NN	O
in	NNS	O
frog	VBP	O
(Xenopus	RB	O
laevis)	RB	O
and	VBN	O
human.	VBN	O
These	IN	O
are	NN	O
considered	NNP	O
to	)	O
be	CC	O
a	.	O
gene	DT	O
for	VBP	O
a	VBN	O
transmembrane	TO	O
type	VB	O
protein	DT	O
having	NN	O
a	IN	O
follistatin	DT	O
module	NN	O
and	NN	O
an	NN	O
epidermal	VBG	O
growth	DT	O
factor	NN	O
(EGF)	NN	O
domain	CC	O
(accession	DT	O
No.:	JJ	O
U19878).	NN	O
The	NN	O
sequence	)	O
information	NN	O
of	NN	O
the	:	O
above	.	O
protein	DT	O
gene	NN	O
indicated	NN	O
that	IN	O
the	DT	O
GEN-092E10	JJ	O
clone	NN	O
was	NN	O
lacking	VBD	O
in	IN	O
the	DT	O
5′	NNP	O
region,	NN	O
so	VBD	O
that	VBG	O
the	IN	O
λgt10	DT	O
cDNA	CD	O
library	,	O
(human	IN	O
fetal	IN	O
brain	DT	O
5′-STRETCH	NNP	O
PLUS	NN	O
cDNA;	NN	O
Clontech)	JJ	O
was	NN	O
screened	NN	O
using	JJ	O
the	NNP	O
GEN-092E10	:	O
clone	)	O
as	VBD	O
a	VBN	O
probe,	VBG	O
whereby	DT	O
a	NNP	O
cDNA	NN	O
clone	IN	O
containing	DT	O
a	,	O
further	WRB	O
5′	DT	O
upstream	NN	O
region	NN	O
was	VBG	O
isolated.	DT	O
Both	JJ	O
strands	CD	O
of	JJ	O
this	NN	O
cDNA	VBD	O
clone	.	O
were	DT	O
sequenced,	NNS	O
whereby	IN	O
the	DT	O
sequence	NN	O
covering	NN	O
the	VBD	O
entire	,	O
coding	WRB	O
region	DT	O
became	NN	O
clear.	VBG	O
This	DT	O
gene	JJ	O
was	NN	O
named	NN	O
TMP-2	VBD	O
gene.	.	O
The	DT	O
TMP-2	NN	O
gene	VBD	O
was	VBN	O
found	NNP	O
to	.	O
contain	DT	O
an	NNP	O
open	NN	O
reading	VBD	O
frame	VBN	O
of	TO	O
1,122	VB	O
nucleotides,	DT	O
as	JJ	O
shown	NN	O
under	NN	O
SEQ	IN	O
ID	CD	O
NO:26,	,	O
encoding	IN	O
an	VBN	O
amino	IN	O
acid	NNP	O
sequence	NNP	O
of	,	O
374	VBG	O
residues,	DT	O
as	NN	O
shown	JJ	O
under	NN	O
SEQ	IN	O
ID	CD	O
NO:25.	,	O
The	IN	O
nucleotide	VBN	O
sequence	IN	O
of	NNP	O
the	NNP	O
entire	.	O
TMP-2	DT	O
cDNA	JJ	O
clone	NN	O
comprises	IN	O
1,721	DT	O
nucleotides,	JJ	O
as	NNP	O
shown	NN	O
under	NN	O
SEQ	VBZ	O
ID	CD	O
NO:27.	,	O
As	IN	O
shown	VBN	O
under	IN	O
SEQ	NNP	O
ID	NNP	O
NO:	.	O
27,	IN	O
the	VBN	O
5′	IN	O
noncoding	NNP	O
region	NNP	O
was	:	O
generally	,	O
rich	DT	O
in	CD	O
GC.	JJ	O
Several	NN	O
candidates	VBD	O
for	RB	O
the	JJ	O
initiation	IN	O
codon	.	O
were	JJ	O
found	NNS	O
but,	IN	O
according	DT	O
to	NN	O
the	NN	O
scanning	VBD	O
model,	VBN	O
the	,	O
5th	VBG	O
ATG	TO	O
of	DT	O
the	VBG	O
cDNA	,	O
clone	DT	O
(bases	CD	O
Nos.	NNP	O
368-370)	IN	O
was	DT	O
estimated	NN	O
as	NN	O
the	NNS	O
initiation	.	O
codon.	)	O
The	VBD	O
termination	VBN	O
codon	IN	O
was	DT	O
located	NN	O
at	.	O
nucleotides	DT	O
Nos.	NN	O
1490-1492.	NN	O
The	VBD	O
polyadenylation	VBN	O
signal	IN	O
(AATAAA)	NNS	O
was	.	O
located	.	O
at	DT	O
nucleotides	NN	O
Nos.	NN	O
1703-1708.	)	O
The	VBD	O
calculated	VBN	O
molecular	IN	O
weight	NNS	O
of	.	O
the	.	O
TMP-2	DT	O
gene	JJ	O
product	JJ	O
was	NN	O
41,400	IN	O
daltons.	DT	O
As	NNP	O
mentioned	NN	O
above,	NN	O
the	VBD	O
transmembrane	CD	O
genes	.	O
have	IN	O
a	VBN	O
follistatin	,	O
module	DT	O
and	NN	O
an	NNS	O
EGF	VBP	O
domain.	DT	O
These	NN	O
motifs	NN	O
were	CC	O
also	DT	O
found	NNP	O
conserved	.	O
in	DT	O
the	NNS	O
novel	VBD	O
human	RB	O
gene	VBN	O
of	VBN	O
the	IN	O
present	DT	O
invention.	JJ	O
The	JJ	O
TMP-2	NN	O
gene	IN	O
of	DT	O
the	JJ	O
present	.	O
invention	DT	O
presumably	NNP	O
plays	NN	O
an	IN	O
important	DT	O
role	JJ	O
in	NN	O
cell	RB	O
proliferation	VBZ	O
or	DT	O
intercellular	JJ	O
communication,	NN	O
since,	IN	O
on	NN	O
the	NN	O
amino	CC	O
acid	JJ	O
level,	,	O
said	,	O
gene	IN	O
shows	DT	O
homology,	NN	O
across	JJ	O
the	,	O
EGF	VBD	O
domain,	NN	O
to	NNS	O
TGF-α	,	O
(transforming	IN	O
growth	DT	O
factor-α;	NNP	O
Derynck,	,	B
R.,	TO	I
et	NNP	I
al.,	VBG	I
Cell,	NN	I
38,	:	I
287-297	,	I
(1984)],beta-cellulin	,	O
Igarashi,	FW	B
K.	,	I
and	,	I
Folkman,	,	I
J.,	CD	I
Science,	,	I
259,	JJ	I
1604-1607	,	I
(1993)],[	NNP	O
heparin-binding	CC	O
EGF-like	,	O
growth	,	O
factor	,	O
Higashiyama,	,	B
S.,	CD	I
et	,	I
al.,	JJ	I
Science,	JJ	I
251,	NN	I
936-939	NN	I
(1991)]	,	I
[and	,	O
schwannoma-derived	FW	O
growth	,	O
factor	,	O
Kimura,	,	B
H.,	CD	I
et	NN	I
al.,	CC	I
Nature,	JJ	I
348,	NN	I
257-260	NN	I
(1990)].[	,	O
(2)	,	O
Northern	FW	O
Blot	,	O
Analysis	,	O
Northern	,	O
blot	CD	O
analysis	.	O
was	)	O
carried	NNP	O
out	NNP	O
as	NNP	O
described	NNP	O
in	NN	O
Example	NN	O
1	VBD	O
(2).	VBN	O
Thus,	RP	O
the	IN	O
clone	VBN	O
GEN-092E10	IN	O
was	NNP	O
amplified	CD	O
by	.	O
PCR,	,	O
the	DT	O
PCR	NN	O
product	NNP	O
was	VBD	O
purified	VBN	O
and	IN	O
labeled	,	O
with	DT	O
[32P]-dCTP	NNP	O
(random-primed	NN	O
DNA	VBD	O
labeling	VBN	O
kit,	CC	O
Boehringer	VBN	O
Mannheim),	IN	O
and	NNP	O
the	JJ	O
expression	NNP	O
of	VBG	O
TMP-2	,	O
mRNA	NNP	O
in	,	O
normal	CC	O
human	DT	O
tissues	NN	O
was	IN	O
examined	NNP	O
using	NN	O
an	IN	O
MTN	JJ	O
blot	JJ	O
with	NNS	O
the	VBD	O
labeled	VBN	O
product	VBG	O
as	DT	O
a	NNP	O
probe.	NN	O
As	IN	O
a	DT	O
result,	JJ	O
high	NN	O
levels	IN	O
of	DT	O
expression	.	O
were	IN	O
detected	DT	O
in	,	O
brain	JJ	O
and	NNS	O
prostate	IN	O
gland.	NN	O
Said	VBD	O
TMP-2	VBN	O
gene	IN	O
mRNA	NN	O
was	CC	O
about	NN	O
2	.	O
kb	NNP	O
in	NNP	O
size.	NN	O
According	NN	O
to	VBD	O
the	IN	O
present	CD	O
invention,	NNS	O
the	IN	O
novel	.	O
human	VBG	O
TMP-2	TO	O
gene	DT	O
is	JJ	O
provided	,	O
and	DT	O
the	JJ	O
use	JJ	O
of	NNP	O
said	NN	O
gene	VBZ	O
makes	VBN	O
it	CC	O
possible	DT	O
to	NN	O
detect	IN	O
the	VBD	O
expression	NN	O
of	VBZ	O
said	PRP	O
gene	JJ	O
in	TO	O
various	VB	O
tissues	DT	O
or	NN	O
produce	IN	O
the	VBD	O
human	NN	O
TMP-2	IN	O
protein	JJ	O
by	NNS	O
the	CC	O
technology	VB	O
of	DT	O
genetic	JJ	O
engineering	NNP	O
and,	NN	O
through	IN	O
these,	DT	O
it	NN	O
becomes	IN	O
possible	JJ	O
to	NN	O
study	,	O
brain	IN	O
tumor	,	O
and	PRP	O
prostatic	VBZ	O
cancer,	JJ	O
which	TO	O
are	VB	O
closely	NN	O
associated	NN	O
with	CC	O
cell	JJ	O
proliferation	,	O
or	WDT	O
intercellular	VBP	O
communication,	RB	O
as	VBN	O
mentioned	IN	O
above,	NN	O
to	NN	O
diagnose	CC	O
these	JJ	O
diseases	,	O
and	IN	O
to	VBN	O
screen	,	O
out	TO	O
and	VB	O
evaluate	DT	O
drugs	NNS	O
for	CC	O
the	TO	O
treatment	VB	O
and	RP	O
prevention	CC	O
of	VB	O
such	NNS	O
diseases.	IN	O
Example	DT	O
9	NN	O
Human	CC	O
NPIK	NN	O
Gene	IN	O
(1)	JJ	O
Human	.	O
NPIK	JJ	O
Gene	CD	O
Cloning	NNP	O
and	NNP	O
DNA	NNP	O
Sequencing	)	O
Following	NNP	O
the	NNP	O
procedures	NNP	O
of	NNP	O
Example	CC	O
1	NNP	O
and	NNP	O
Example	VBG	O
2,	DT	O
cDNA	NNS	O
clones	IN	O
were	NNP	O
arbitrarily	CD	O
selected	CC	O
from	NNP	O
a	,	O
human	NN	O
fetal	NNS	O
brain	VBD	O
cDNA	RB	O
library	VBN	O
and	IN	O
subjected	DT	O
to	JJ	O
sequence	NN	O
analysis,	NN	O
and	NN	O
database	NN	O
searches	CC	O
were	VBN	O
performed.	TO	O
As	VB	O
a	,	O
result,	CC	O
two	NN	O
cDNA	NNS	O
clones	VBD	O
highly	.	O
homologous	IN	O
to	DT	O
the	,	O
gene	CD	O
coding	NN	O
for	NNS	O
an	RB	O
amino	JJ	O
acid	TO	O
sequence	DT	O
conserved	NN	O
in	VBG	O
phosphatidylinositol	IN	O
3	DT	O
and	NN	O
4	NN	O
kinases	NN	O
Kunz,	VBN	B
J.,	IN	I
et	NN	I
al.,	CD	I
Cell,	CC	I
73,	CD	I
585-596	NNS	I
(1993)]	,	I
[were	,	O
obtained.	FW	O
These	,	O
were	,	O
named	,	O
GEN-428B12c1	CD	O
and	NN	O
GEN-428B12c2	VBD	O
and	.	O
the	DT	O
entire	VBD	O
sequences	VBN	O
of	NNP	O
these	CC	O
were	NNP	O
determined	CC	O
as	DT	O
in	JJ	O
the	NNS	O
foregoing	IN	O
examples.	DT	O
As	VBD	O
a	VBN	O
result,	IN	O
the	IN	O
GEN-428B12c1	DT	O
cDNA	NN	O
clone	.	O
and	IN	O
the	DT	O
GEN-428B12c2	,	O
clone	DT	O
were	NNP	O
found	NN	O
to	NN	O
have	CC	O
coding	DT	O
sequences	NNP	O
differing	NN	O
by	VBD	O
12	VBN	O
amino	TO	O
acid	VB	O
residues	VBG	O
at	NNS	O
the	VBG	O
5′	IN	O
terminus,	CD	O
the	NN	O
GEN-428B12c1	NN	O
cDNA	NNS	O
clone	IN	O
being	DT	O
longer	CD	O
by	,	O
12	DT	O
amino	NNP	O
acid	NN	O
residues.	NN	O
The	VBG	O
GEN-428B12c1	JJR	O
cDNA	IN	O
sequence	CD	O
of	NN	O
the	NN	O
human	.	O
NPIK	DT	O
gene	NNP	O
contained	NN	O
an	NN	O
open	IN	O
reading	DT	O
frame	JJ	O
of	NNP	O
2,487	NN	O
nucleotides,	VBD	O
as	DT	O
shown	JJ	O
under	NN	O
SEQ	NN	O
ID	IN	O
NO:32,	CD	O
encoding	,	O
an	IN	O
amino	VBN	O
acid	IN	O
sequence	NNP	O
comprising	NNP	O
829	,	O
amino	VBG	O
acid	DT	O
residues,	NN	O
as	NN	O
shown	NN	O
under	VBG	O
SEQ	CD	O
ID	JJ	O
NO:31.	NN	O
The	,	O
nucleotide	IN	O
sequence	VBN	O
of	IN	O
the	NNP	O
full-length	NNP	O
cDNA	.	O
clone	DT	O
comprised	JJ	O
3,324	NN	O
nucleotides	IN	O
as	DT	O
shown	JJ	O
under	NN	O
SEQ	NN	O
ID	VBD	O
NO:33.	CD	O
The	NNS	O
estimated	IN	O
initiation	VBN	O
codon	IN	O
was	NNP	O
located,	NNP	O
as	.	O
shown	DT	O
under	VBN	O
SEQ	NN	O
ID	NN	O
NO:33,	VBD	O
at	,	O
nucleotides	IN	O
Nos.	VBN	O
115-117	IN	O
corresponding	NNP	O
to	NNP	O
the	,	O
second	IN	O
ATG	JJ	O
triplet	.	O
of	JJ	O
the	NN	O
cDNA	TO	O
clone.	DT	O
The	JJ	O
termination	NNP	O
codon	NN	O
was	IN	O
located	DT	O
at	NN	O
nucleotides	.	O
Nos.	DT	O
2602-2604	NN	O
and	NN	O
the	VBD	O
polyadenylation	VBN	O
signal	IN	O
(AATAAA)	NNS	O
at	.	O
Nos.	JJ	O
3305-3310.	CC	O
On	DT	O
the	NN	O
other	NN	O
hand,	)	O
the	IN	O
GEN-428B12c2	.	O
cDNA	.	O
sequence	IN	O
of	DT	O
the	JJ	O
human	,	O
NPIK	DT	O
gene	NNP	O
contained	NN	O
an	NN	O
open	IN	O
reading	DT	O
frame	JJ	O
of	NNP	O
2,451	NN	O
nucleotides,	VBD	O
as	DT	O
shown	JJ	O
under	NN	O
SEQ	NN	O
ID	IN	O
NO:29.	CD	O
The	,	O
amino	IN	O
acid	VBN	O
sequence	IN	O
encoded	NNP	O
thereby	NNP	O
comprised	.	O
817	DT	O
amino	NN	O
acid	JJ	O
residues,	NN	O
as	VBD	O
shown	RB	O
under	VBN	O
SEQ	CD	O
ID	JJ	O
NO:28.	NN	O
The	,	O
nucleotide	IN	O
sequence	VBN	O
of	IN	O
the	NNP	O
full-length	NNP	O
cDNA	.	O
clone	DT	O
comprised	JJ	O
3,602	NN	O
nucleotides,	IN	O
as	DT	O
shown	JJ	O
under	NN	O
SEQ	NN	O
ID	VBD	O
NO:30.	CD	O
The	,	O
estimated	IN	O
initiation	VBN	O
codon	IN	O
was	NNP	O
located,	NNP	O
as	.	O
shown	DT	O
under	VBN	O
SEQ	NN	O
ID	NN	O
NO:30,	VBD	O
at	,	O
nucleotides	IN	O
Nos.	VBN	O
429-431	IN	O
corresponding	NNP	O
to	NNP	O
the	,	O
7th	IN	O
ATG	JJ	O
triplet	.	O
of	JJ	O
the	NN	O
cDNA	TO	O
clone.	DT	O
The	CD	O
termination	NNP	O
codon	NN	O
was	IN	O
located	DT	O
at	NN	O
nucleotides	.	O
Nos.	DT	O
2880-2882	NN	O
and	NN	O
the	VBD	O
polyadenylation	VBN	O
signal	IN	O
(AATAAA)	NNS	O
at	.	O
Nos.	JJ	O
3583-3588.	CC	O
(2)	DT	O
Northern	NN	O
Blot	NN	O
Analysis	)	O
Northern	IN	O
blot	.	O
analysis	.	O
was	)	O
carried	NNP	O
out	NNP	O
as	NNP	O
described	NNP	O
in	NN	O
Example	NN	O
1	VBD	O
(2).	VBN	O
Thus,	RP	O
the	IN	O
entire	VBN	O
sequence	IN	O
of	NNP	O
human	CD	O
NPIK	.	O
was	,	O
amplified	DT	O
by	JJ	O
PCR,	NN	O
the	IN	O
PCR	JJ	O
product	NNP	O
was	VBD	O
purified	VBN	O
and	IN	O
labeled	,	O
with	DT	O
[32P]-dCTP	NNP	O
(random-primed	NN	O
DNA	VBD	O
labeling	VBN	O
kit,	CC	O
Boehringer	VBN	O
Mannheim),	IN	O
and	NNP	O
normal	JJ	O
human	NNP	O
tissues	VBG	O
were	,	O
examined	NNP	O
for	,	O
expression	CC	O
of	JJ	O
the	JJ	O
human	NNS	O
NPIK	VBD	O
mRNA	VBN	O
using	IN	O
the	NN	O
MTN	IN	O
blot	DT	O
membrane	JJ	O
with	NNP	O
the	NN	O
labeled	VBG	O
product	DT	O
as	NNP	O
a	NN	O
probe.	NN	O
As	IN	O
a	DT	O
result,	JJ	O
the	NN	O
expression	IN	O
of	DT	O
the	.	O
human	IN	O
NPIK	DT	O
gene	,	O
was	DT	O
observed	NN	O
in	IN	O
16	DT	O
various	JJ	O
human	NNP	O
adult	NN	O
tissues	VBD	O
examined	VBN	O
and	IN	O
an	CD	O
about	JJ	O
3.8	JJ	O
kb	NN	O
transcript	NNS	O
and	VBD	O
an	CC	O
about	DT	O
5	IN	O
kb	CD	O
one	NNS	O
could	NN	O
be	CC	O
detected.	DT	O
Using	IN	O
primer	CD	O
A	NNS	O
having	CD	O
the	MD	O
nucleotide	VB	O
sequence	.	O
shown	VBG	O
below	NN	O
in	NNP	O
Table	VBG	O
8	DT	O
and	JJ	O
containing	NN	O
the	VBN	O
initiation	IN	O
codon	IN	O
of	JJ	O
the	CD	O
GEN-428B12c2	CC	O
cDNA	VBG	O
and	DT	O
primer	NN	O
B	NN	O
shown	IN	O
in	DT	O
table	NNP	O
8	NN	O
and	CC	O
containing	NN	O
the	NNP	O
termination	VBN	O
codon,	IN	O
PCR	JJ	O
was	CD	O
performed	CC	O
with	VBG	O
Human	DT	O
Fetal	NN	O
Brain	,	O
Marathon-Ready	NNP	O
cDNA	VBD	O
(Clontech)	VBN	O
as	IN	O
a	NNP	O
template,	NNP	O
and	NNP	O
the	JJ	O
nucleotide	NN	O
sequence	)	O
of	IN	O
the	DT	O
PCR	,	O
product	CC	O
was	DT	O
determined.	JJ	O
As	NN	O
a	IN	O
result,	DT	O
it	NNP	O
was	NN	O
found	VBD	O
that	.	O
the	IN	O
human	DT	O
NPIK	,	O
mRNA	PRP	O
expressed	VBD	O
included	VBN	O
one	IN	O
lacking	DT	O
in	JJ	O
nucleotides	NNP	O
Nos.	NN	O
1060-1104	VBD	O
of	VBD	O
the	CD	O
GEN-428B12c1	NN	O
cDNA	IN	O
sequence	JJ	O
(SEQ	.	O
ID	CD	O
NO:33)	IN	O
(amino	DT	O
acids	NNP	O
Nos.	NN	O
316-330	NN	O
of	NNP	O
the	NNP	O
amino	)	O
acid	JJ	O
sequence	NNS	O
under	.	O
SEQ	CD	O
ID	IN	O
NO:31)	DT	O
and	NN	O
one	JJ	O
lacking	NN	O
in	IN	O
nucleotides	NNP	O
Nos.	NNP	O
1897-1911	)	O
of	CC	O
the	CD	O
GEN-428B12c1	NN	O
cDNA	IN	O
sequence	JJ	O
(SEQ	.	O
ID	CD	O
NO:33)	IN	O
(amino	DT	O
acids	NNP	O
Nos.	NN	O
595-599	NN	O
of	NNP	O
the	NNP	O
amino	)	O
acid	JJ	O
sequence	NNS	O
under	.	O
SEQ	CD	O
ID	IN	O
NO:31).	DT	O
It	NN	O
was	JJ	O
further	NN	O
revealed	IN	O
that	NNP	O
polymorphism	NNP	O
existed	.	O
in	PRP	O
this	VBD	O
gene	RBR	O
(428B12c1.fasta),	VBD	O
as	IN	O
shown	NN	O
below	VBN	O
in	IN	O
Table	DT	O
9,	NN	O
in	,	O
the	IN	O
region	VBN	O
of	IN	O
bases	IN	O
Nos.	NNP	O
1941-1966	,	O
of	IN	O
the	DT	O
GEN-428B12c1	NN	O
cDNA	IN	O
sequence	NNS	O
shown	.	O
under	CD	O
SEQ	IN	O
ID	DT	O
NO:33,	NNP	O
whereby	NN	O
a	NN	O
mutant	VBN	O
protein	IN	O
was	NNP	O
encoded	NNP	O
which	,	O
resulted	WRB	O
from	DT	O
the	JJ	O
mutation	NN	O
of	VBD	O
IQDSCEITT	VBN	O
(amino	WDT	O
acid	VBD	O
residues	IN	O
Nos.	DT	O
610-618	NN	O
in	IN	O
the	NNP	O
amino	JJ	O
acid	NN	O
sequence	NNS	O
(SEQ	.	O
ID	JJ	O
NO:31)	IN	O
encoded	DT	O
by	NN	O
GEN-428B12c1)	NN	O
into	NN	O
YKILVISA.	NNP	O
(3)	NNP	O
Chromosomal	)	O
Mapping	VBN	O
of	IN	O
Human	)	O
NPIK	IN	O
Gene	.	O
by	)	O
FISH	NNP	O
Chromosomal	NNP	O
mapping	IN	O
of	NNP	O
the	NNP	O
human	NNP	O
NPIK	IN	O
gene	NNP	O
was	NNP	O
carried	NN	O
out	IN	O
by	DT	O
FISH	JJ	O
as	NNP	O
described	NN	O
in	VBD	O
Example	VBN	O
1	RP	O
(3).	IN	O
As	NNP	O
a	IN	O
result,	VBN	O
it	IN	O
was	NNP	O
found	CD	O
that	.	O
the	IN	O
locus	DT	O
of	,	O
the	PRP	O
human	VBD	O
NPIK	VBN	O
gene	IN	O
is	DT	O
in	NN	O
the	IN	O
chromosomal	DT	O
position	JJ	O
1q21.1-q21.3.	NNP	O
The	NN	O
human	VBZ	O
NPIK	IN	O
gene,	DT	O
a	JJ	O
novel	NN	O
human	.	O
gene,	DT	O
of	JJ	O
the	NNP	O
present	,	O
invention	DT	O
included	JJ	O
two	JJ	O
cDNAs	,	O
differing	IN	O
in	DT	O
the	JJ	O
5′	NN	O
region	VBD	O
and	CD	O
capable	NN	O
of	VBG	O
encoding	IN	O
829	DT	O
and	CD	O
817	NN	O
amino	CC	O
acid	JJ	O
residues,	IN	O
as	VBG	O
mentioned	CD	O
above.	CC	O
In	CD	O
view	NN	O
of	NN	O
this	,	O
and	IN	O
further	VBN	O
in	.	O
view	IN	O
of	NN	O
the	IN	O
findings	DT	O
that	CC	O
the	RBR	O
mRNA	IN	O
corresponding	NN	O
to	IN	O
this	DT	O
gene	NNS	O
includes	IN	O
two	DT	O
deletable	NN	O
sites	VBG	O
and	TO	O
there	DT	O
occurs	NN	O
polymorphism	VBZ	O
in	CD	O
a	JJ	O
specific	NNS	O
region	CC	O
corresponding	EX	O
to	VBZ	O
amino	NN	O
acid	IN	O
residues	DT	O
Nos.	JJ	O
610-618	NN	O
of	VBG	O
the	TO	O
GEN-428B12c1	VB	O
amino	JJ	O
acid	NNS	O
sequence	.	O
(SEQ	CD	O
ID	IN	O
NO:31),	DT	O
whereby	NNP	O
a	NN	O
mutant	NN	O
protein	NN	O
is	NNP	O
encoded,	NNP	O
it	,	O
is	WRB	O
conceivable	DT	O
that	JJ	O
human	NN	O
NPIK	VBZ	O
includes	,	O
species	PRP	O
resulting	VBZ	O
from	JJ	O
a	IN	O
certain	JJ	O
number	NNP	O
of	VBZ	O
combinations,	NNS	O
namely	VBG	O
human	IN	O
NPIK,	DT	O
deletion-containing	JJ	O
human	NN	O
NPIK,	IN	O
human	,	O
NPIK	RB	O
mutant	JJ	O
and/or	,	O
deletion-containing	JJ	O
human	JJ	O
NPIK	,	O
mutant.	JJ	O
Recently,	NNP	O
several	NN	O
proteins	VBD	O
belonging	JJ	O
to	JJ	O
the	NNP	O
family	.	O
including	,	O
the	JJ	O
above-mentioned	NNS	O
PI3	VBG	O
and	TO	O
4	DT	O
kinases	NN	O
have	VBG	O
protein	DT	O
kinase	JJ	O
activity	NNP	O
Dhand,	CC	B
R.,	CD	I
et	NNS	I
al.,	VBP	I
EMBO	VBN	I
J.,	NN	I
13,	NN	I
522-533	,	I
(1994);	,	I
Stack,	FW	B
J.	,	I
H.	NNP	I
and	,	I
Emr,	,	I
S.	CD	I
D.,	:	I
J.	,	I
Biol.	NNP	I
Chem.,	NNP	I
269,	CC	I
31552-31562	,	I
(1994);	NNP	I
Hartley,	,	B
K.	NNP	I
O.,	.	I
et	,	I
al.,	,	I
Cell,	CD	I
82,	:	I
848-856	,	I
(1995)].[	NNP	O
It	,	O
was	FW	O
also	,	O
revealed	,	O
that	,	O
a	CD	O
protein	.	O
belonging	PRP	O
to	VBD	O
this	RB	O
family	VBN	O
is	IN	O
involved	DT	O
in	NN	O
DNA	VBG	O
repair	TO	O
Hartley,	DT	B
K.	NN	I
O.,	VBZ	I
et	VBN	I
al.,	IN	I
Cell,	NNP	I
82,	NN	I
849-856	,	I
(1995)]	NNP	I
[and	,	O
is	FW	O
a	,	O
causative	,	O
gene	,	O
of	CD	O
ataxia	NN	O
Savitsky,	CC	B
K.,	VBZ	I
et	DT	I
al.,	JJ	I
Science,	NN	I
268,	IN	I
1749-1753	JJ	I
(1995)].[	,	O
It	,	O
can	FW	O
be	,	O
anticipated	,	O
that	,	O
the	CD	O
human	.	O
NPIK	PRP	O
gene-encoded	MD	O
protein	VB	O
highly	VBN	O
homologous	IN	O
to	DT	O
the	JJ	O
family	NNP	O
of	JJ	O
these	NN	O
PI	RB	O
kinases	JJ	O
is	TO	O
a	DT	O
novel	NN	O
enzyme	IN	O
phosphorylating	DT	O
lipids	NNP	O
or	NNS	O
proteins.	VBZ	O
According	DT	O
to	JJ	O
this	NN	O
example,	VBG	O
the	NNS	O
novel	CC	O
human	.	O
NPIK	VBG	O
gene	TO	O
is	DT	O
provided.	,	O
The	DT	O
use	JJ	O
of	JJ	O
said	NNP	O
gene	NN	O
makes	VBZ	O
it	.	O
possible	DT	O
to	NN	O
detect	IN	O
the	VBD	O
expression	NN	O
of	VBZ	O
said	PRP	O
gene	JJ	O
in	TO	O
various	VB	O
tissues	DT	O
and	NN	O
manufacture	IN	O
the	VBD	O
human	NN	O
NPIK	IN	O
protein	JJ	O
by	NNS	O
the	CC	O
technology	VB	O
of	DT	O
genetic	JJ	O
engineering	NNP	O
and,	NN	O
through	IN	O
these,	DT	O
it	NN	O
becomes	IN	O
possible	JJ	O
to	NN	O
study	,	O
lipid-	IN	O
or	,	O
protein-phosphrylating	PRP	O
enzymes	VBZ	O
such	JJ	O
as	TO	O
mentioned	VB	O
above,	JJ	O
study	CC	O
DNA	JJ	O
repairing,	NNS	O
study	JJ	O
or	IN	O
diagnose	VBN	O
diseases	,	O
in	VB	O
which	NNP	O
these	,	O
are	NN	O
involved,	CC	O
for	JJ	O
example	NNS	O
cancer,	IN	O
and	WDT	O
screen	DT	O
out	VBP	O
and	,	O
evaluate	IN	O
drugs	NN	O
for	,	O
the	CC	O
treatment	NN	O
or	RB	O
prevention	CC	O
thereof.	VB	O
(4)	NNS	O
Construction	IN	O
of	DT	O
an	NN	O
Expression	CC	O
Vector	NN	O
for	.	O
Fusion	)	O
Protein	NN	O
To	IN	O
subclone	DT	O
the	NNP	O
coding	NNP	O
region	IN	O
for	NNP	O
a	NNP	O
human	TO	O
NPIK	VB	O
gene	DT	O
(GEN-428B12c2),	NN	O
first	NN	O
of	IN	O
all,	DT	O
two	JJ	O
primers,	NNP	O
C1	NN	O
and	,	O
C2,	RB	O
having	IN	O
the	,	O
sequences	CD	O
shown	,	O
below	NNP	O
in	CC	O
Table	,	O
10	VBG	O
were	DT	O
formed	NNS	O
based	VBN	O
on	IN	O
the	IN	O
information	JJ	O
on	CD	O
the	VBD	O
DNA	VBN	O
sequences	VBN	O
obtained	IN	O
above	DT	O
in	NN	O
(1).	IN	O
Both	DT	O
of	NN	O
the	NNS	O
primers	VBN	O
C1	IN	O
and	IN	O
C2	.	O
have	DT	O
a	IN	O
BglII	DT	O
site,	NNS	O
and	NNP	O
primer	CC	O
C2	NNP	O
is	VBP	O
an	DT	O
antisense	NNP	O
primer.	,	O
Using	CC	O
these	NN	O
two	NNP	O
primers,	VBZ	O
cDNA	DT	O
derived	JJ	O
from	.	O
human	VBG	O
fetal	DT	O
brain	CD	O
mRNA	,	O
was	NN	O
amplified	VBD	O
by	IN	O
PCR	JJ	O
to	JJ	O
provide	NN	O
a	NN	O
product	VBD	O
having	VBN	O
a	IN	O
length	NNP	O
of	TO	O
about	VB	O
2500	DT	O
bases.	NN	O
The	VBG	O
amplified	DT	O
cDNA	NN	O
was	IN	O
precipitated	IN	O
from	CD	O
ethanol	.	O
and	DT	O
inserted	JJ	O
into	NN	O
pT7BlueT-Vector	VBD	O
(product	VBN	O
of	IN	O
Novagen)	NN	O
and	CC	O
subcloning	VBN	O
was	IN	O
completed.	NN	O
The	NN	O
entire	IN	O
sequence	)	O
was	CC	O
determined	NN	O
in	VBD	O
the	.	O
same	DT	O
manner	JJ	O
as	NN	O
above	VBD	O
in	VBN	O
Examples.	IN	O
As	DT	O
a	JJ	O
result,	NN	O
it	IN	O
was	IN	O
revealed	IN	O
that	.	O
this	IN	O
gene	DT	O
had	,	O
polymorphism	PRP	O
shown	VBD	O
above	VBN	O
in	IN	O
Table	DT	O
9.	NN	O
The	VBD	O
above	VBN	O
cDNA	VBN	O
was	IN	O
cleaved	IN	O
by	JJ	O
BglII	.	O
and	DT	O
subjected	JJ	O
to	NN	O
agarose	VBD	O
gel	VBN	O
electrophoresis.	IN	O
The	NNP	O
cDNA	CC	O
was	VBN	O
then	TO	O
excised	VB	O
from	JJ	O
agarose	.	O
gel	DT	O
and	NN	O
collected	VBD	O
using	RB	O
GENECLEAN	VBN	O
II	IN	O
KIT	JJ	O
(product	NN	O
of	CC	O
Bio	VBD	O
101).	VBG	O
The	NNP	O
cDNA	NNP	O
was	NNP	O
inserted	NN	O
into	IN	O
pBlueBacHis2B-Vector	NNP	O
(product	.	O
of	DT	O
Invitrogen)	NN	O
at	VBD	O
the	VBN	O
BglII	IN	O
cleavage	NN	O
site	NN	O
and	IN	O
subcloning	)	O
was	IN	O
completed.	DT	O
The	NNP	O
fusion	NN	O
vector	NN	O
thus	CC	O
obtained	NN	O
had	VBD	O
a	.	O
BglII	DT	O
cleavage	NN	O
site	NN	O
and	RB	O
was	VBN	O
an	VBD	O
expression	DT	O
vector	NNP	O
for	NN	O
a	NN	O
fusion	CC	O
protein	VBD	O
of	DT	O
the	NN	O
contemplated	NN	O
gene	IN	O
product	DT	O
(about	NN	O
91	NN	O
kd)	IN	O
and	DT	O
38	JJ	O
amino	NN	O
acids	NN	O
derived	IN	O
from	CD	O
pBlueBacHis2B-Vector	)	O
and	CC	O
containing	CD	O
a	NN	O
polyhistidine	NNS	O
region	VBN	O
and	IN	O
an	NN	O
epitope	CC	O
recognizing	VBG	O
Anti-Xpress™	DT	O
antibody	JJ	O
(product	NN	O
of	CC	O
Invitrogen).	DT	O
(5)	NN	O
Transfection	VBG	O
into	NNP	O
Insect	NN	O
Cell	NN	O
Sf-9	IN	O
The	.	O
human	)	O
NPIK	NN	O
gene	IN	O
was	NNP	O
expressed	NNP	O
according	NNP	O
to	DT	O
the	JJ	O
Baculovirus	NNP	O
expression	NN	O
system.	VBD	O
Baculovirus	VBN	O
is	VBG	O
a	TO	O
cyclic	DT	O
double-stranded	NNP	O
insect-pathogenic	NN	O
virus	.	O
and	NNP	O
can	VBZ	O
produce	DT	O
large	JJ	O
amounts	JJ	O
of	JJ	O
inclusion	NN	O
bodies	CC	O
named	MD	O
polyhedrins	VB	O
in	JJ	O
the	NNS	O
cells	IN	O
of	NN	O
insects.	NNS	O
Using	VBN	O
Bac-N-Blue™	NNS	O
Transfection	IN	O
Kit	DT	O
utilizing	NNS	O
this	IN	O
characteristic	.	O
of	VBG	O
Baculovirus	NNP	O
and	NNP	O
developed	NNP	O
by	VBG	O
Invitrogen,	DT	O
the	NN	O
Baculovirus	IN	O
expression	NNP	O
was	CC	O
carried	VBN	O
out.	IN	O
Stated	,	O
more	DT	O
specifically,	NNP	O
4	NN	O
μg	VBD	O
of	VBN	O
pBlueBacHis2B	.	O
containing	VBN	O
the	RBR	O
region	,	O
of	CD	O
the	NN	O
human	IN	O
NPIK	NN	O
gene	VBG	O
and	DT	O
1	NN	O
μg	IN	O
of	DT	O
Bac-N-Blue™	JJ	O
DNA	NNP	O
(product	NN	O
of	CC	O
Invitrogen)	CD	O
were	NN	O
co-transfected	IN	O
into	NNP	O
Sf-9	NNP	O
cells	NN	O
in	IN	O
the	)	O
presence	VBD	O
of	JJ	O
Insectin™	IN	O
liposomes	NNP	O
(product	NNS	O
of	IN	O
Invitrogen).	DT	O
Prior	NN	O
to	IN	O
co-transfection,	NNP	O
LacZ	NNS	O
gene	NN	O
was	IN	O
incorporated	.	O
into	RB	O
Bac-N-Blue™	TO	O
DNA,	,	O
so	NNP	O
that	NN	O
LacZ	VBD	O
would	VBN	O
be	IN	O
expressed	NNP	O
only	,	O
when	IN	O
homologous	DT	O
recombination	NNP	O
took	MD	O
place	VB	O
between	VBN	O
the	RB	O
Bac-N-Blue™	WRB	O
DNA	JJ	O
and	NN	O
pBlueBacHis2B.	VBD	O
Thus	NN	O
when	IN	O
the	DT	O
co-transfected	NNP	O
Sf-9	NNP	O
cells	CC	O
were	.	O
incubated	RB	O
on	WRB	O
agar	DT	O
medium,	JJ	O
the	JJ	O
plaques	NNS	O
of	VBD	O
the	VBN	O
virus	IN	O
expressing	NN	O
the	,	O
contemplated	DT	O
gene	NNS	O
were	IN	O
easily	DT	O
detected	NN	O
as	VBG	O
blue	DT	O
plaques.	VBN	O
The	NN	O
blue	VBD	O
plaques	RB	O
were	VBN	O
excised	IN	O
from	JJ	O
each	.	O
agar	DT	O
and	NN	O
suspended	NNS	O
in	VBD	O
400	VBN	O
μl	IN	O
of	DT	O
medium	NN	O
to	CC	O
disperse	VBN	O
the	IN	O
virus	CD	O
thereon.	NN	O
The	IN	O
suspension	NN	O
was	TO	O
subjected	VB	O
to	DT	O
centrifugation	NN	O
to	.	O
give	DT	O
a	NN	O
supernatant	VBD	O
containing	VBN	O
the	TO	O
virus.	NN	O
Sf-9	TO	O
cells	VB	O
were	DT	O
infected	NN	O
with	VBG	O
the	DT	O
virus	.	O
again	JJ	O
to	NNS	O
increase	VBD	O
the	VBN	O
titre	IN	O
and	DT	O
to	NN	O
obtain	RB	O
a	TO	O
large	VB	O
amount	DT	O
of	NN	O
infective	CC	O
virus	TO	O
solution.	VB	O
(6)	DT	O
Preparation	JJ	O
of	NN	O
Human	IN	O
NPIK	JJ	O
The	NN	O
expression	.	O
of	)	O
the	NN	O
contemplated	IN	O
human	NNP	O
NPIK	NNP	O
gene	DT	O
was	NN	O
confirmed	IN	O
three	DT	O
days	JJ	O
after	JJ	O
infection	NNP	O
with	NN	O
the	VBD	O
virus	VBN	O
as	CD	O
follows.	NNS	O
Sf-9	IN	O
cells	NN	O
were	IN	O
collected	DT	O
and	NN	O
washed	IN	O
with	.	O
PBS.	JJ	O
The	NNS	O
cells	VBD	O
were	VBN	O
boiled	CC	O
with	VBN	O
a	IN	O
SDS-PAGE	.	O
loading	DT	O
buffer	NNS	O
for	VBD	O
5	VBN	O
minutes	IN	O
and	DT	O
SDS-PAGE	JJ	O
was	NN	O
performed.	NN	O
According	IN	O
to	CD	O
the	NNS	O
western	CC	O
blot	NNP	O
technique	VBD	O
using	.	O
Anti-Xpress	VBG	O
as	TO	O
an	DT	O
antibody,	JJ	O
the	NN	O
contemplated	NN	O
protein	VBG	O
was	NNP	O
detected	IN	O
at	DT	O
the	,	O
position	DT	O
of	JJ	O
its	NN	O
presumed	VBD	O
molecular	VBN	O
weight.	IN	O
By	DT	O
contrast,	NN	O
in	IN	O
the	PRP$	O
case	JJ	O
of	JJ	O
control	.	O
cells	IN	O
uninfected	,	O
with	IN	O
the	DT	O
virus,	NN	O
no	IN	O
band	NN	O
corresponding	NNS	O
to	VBN	O
human	IN	O
NPIK	DT	O
was	,	O
observed	DT	O
in	NN	O
the	VBG	O
same	TO	O
test.	JJ	O
Stated	NNP	O
more	VBD	O
specifically,	VBN	O
three	IN	O
days	DT	O
after	JJ	O
the	.	O
infection	VBN	O
of	RBR	O
15	,	O
flasks	CD	O
(175-cm2,	NNS	O
FALCON)	IN	O
of	DT	O
semi-confluent	NN	O
Sf-9	IN	O
cells,	CD	O
the	NNS	O
cells	,	O
were	)	O
harvested	IN	O
and	JJ	O
washed	NNP	O
with	,	O
PBS,	DT	O
followed	NNS	O
by	VBD	O
resuspension	VBN	O
in	CC	O
a	VBN	O
buffer	IN	O
(20	,	O
mM	VBN	O
Tris/HCl	IN	O
(pH	NN	O
7.5),	IN	O
1	DT	O
mM	NN	O
EDTA	CD	O
and	NN	O
1	NNP	O
mM	VB	O
DTT).	,	O
The	CD	O
suspended	NN	O
cells	NNP	O
were	CC	O
lysed	CD	O
by	NNS	O
4	.	O
time-sonications	DT	O
for	JJ	O
30	NNS	O
seconds	VBD	O
at	VBN	O
4°	IN	O
C.	CD	O
with	NNS	O
30	IN	O
seconds	CD	O
intervals.	NNS	O
The	IN	O
sonicated	CD	O
cells	NNP	O
were	IN	O
subjected	CD	O
to	NNS	O
centrifugation	.	O
and	DT	O
the	JJ	O
supernatant	NNS	O
was	VBD	O
collected.	VBN	O
The	TO	O
protein	NN	O
in	CC	O
the	DT	O
supernatant	NN	O
was	VBD	O
immunoprecipitated	.	O
using	DT	O
an	NN	O
Anti-Xpress	IN	O
antibody	DT	O
and	NN	O
obtained	VBD	O
as	VBN	O
a	VBG	O
slurry	DT	O
of	JJ	O
protein	NN	O
A-Sepharose	CC	O
beads.	VBN	O
The	IN	O
slurry	DT	O
was	NN	O
boiled	IN	O
with	JJ	O
a	JJ	O
SDS-PAGE	.	O
loading	DT	O
buffer	NN	O
for	VBD	O
5	VBN	O
minutes.	IN	O
SDS-PAGE	DT	O
was	JJ	O
performed	NN	O
for	NN	O
identification	IN	O
and	CD	O
quantification	.	O
of	NN	O
NPIK.	VBD	O
The	VBN	O
slurry	IN	O
itself	NN	O
was	CC	O
subjected	NN	O
to	IN	O
the	.	O
following	DT	O
assaying.	NN	O
(7)	PRP	O
Confirmation	VBD	O
of	VBN	O
PI4	TO	O
Kinase	DT	O
Activity	VBG	O
NPIK	.	O
was	)	O
expected	NN	O
to	IN	O
have	NNP	O
the	NNP	O
activity	NNP	O
of	NNP	O
incorporation	VBD	O
phosphoric	VBN	O
acid	TO	O
at	VB	O
the	DT	O
4-position	NN	O
of	IN	O
the	NN	O
inositol	JJ	O
ring	NN	O
of	IN	O
phosphatidylinositol	DT	O
(PI),	NN	O
namely,	IN	O
PI4	DT	O
Kinase	JJ	O
activity.	NN	O
PI4	IN	O
Kinase	NN	O
activity	,	O
of	,	O
NPIK	NNP	O
was	NNP	O
assayed	.	O
according	NNP	O
to	NNP	O
the	NN	O
method	IN	O
of	NNP	O
Takenawa,	VBD	O
et	VBN	O
al.	VBG	O
Yamakawa,	TO	B
A.	DT	I
and	NN	I
Takenawa,	IN	I
T.,	,	I
J.	RB	I
Biol.	.	I
Chem.,	,	I
263,	NNP	I
17555-17560	CC	I
(1988))	,	I
(as	,	O
shown	NNP	O
below.	.	O
First	,	O
prepared	,	O
was	CD	O
a	)	O
mixture	IN	O
of	VBN	O
10	.	O
μl	RB	O
of	VBN	O
a	VBD	O
NPIK	DT	O
slurry	NN	O
(20	IN	O
mM	CD	O
Tris/HCl	NN	O
(pH	IN	O
7.5),	DT	O
1	NNP	O
mM	NN	O
EDTA,	CD	O
1	NN	O
mM	NNP	O
DTT	VB	O
and	,	O
50%	CD	O
protein	NN	O
A	,	O
beads),	CD	O
10	NN	O
μl	NNP	O
of	CC	O
a	NN	O
PI	NN	O
solution	NNP	O
(prepared	,	O
by	CD	O
drying	NN	O
5	IN	O
mg	DT	O
of	NNP	O
a	NN	O
PI-containing	VBN	O
commercial	IN	O
chloroform	VBG	O
solution	CD	O
in	NN	O
a	IN	O
stream	DT	O
of	JJ	O
nitrogen	JJ	O
onto	NN	O
a	NN	O
glass	IN	O
tube	DT	O
wall,	NN	O
adding	IN	O
1	NN	O
ml	IN	O
of	DT	O
20	NN	O
mM	NN	O
Tris/HCl	,	O
(pH	VBG	O
7.5)	CD	O
buffer	NN	O
and	IN	O
forming	CD	O
micelles	NNS	O
by	NNP	O
sonication),	VB	O
10	)	O
μl	NN	O
of	CC	O
an	NN	O
applied	NNS	O
buffer	IN	O
(210	,	O
mM	CD	O
Tris/HCl	NN	O
(pH	IN	O
7.5),	DT	O
5	JJ	O
mM	NN	O
EGTA	CD	O
and	NN	O
100	NNP	O
mM	VB	O
MgCl2)	,	O
and	CD	O
10	NN	O
μl	NNP	O
of	CC	O
distilled	CD	O
water.	NNS	O
Thereto	)	O
was	CC	O
added	CD	O
10	NN	O
μl	IN	O
of	JJ	O
an	.	O
ATP	NNP	O
solution	VBD	O
(5	VBN	O
μl	CD	O
of	NN	O
500	IN	O
μM	DT	O
ATP,	NNP	O
4.9	NN	O
μl	CD	O
of	NN	O
distilled	IN	O
water	CD	O
and	JJ	O
0.1	,	O
μl	CD	O
of	NN	O
γ-32P	IN	O
ATP	JJ	O
(6000	NN	O
Ci/mmol,	CC	O
product	CD	O
of	NN	O
NEN	IN	O
Co.,	JJ	O
Ltd.)).	NNP	O
The	CD	O
reaction	,	O
was	NN	O
started	IN	O
at	NNP	O
30°	,	O
C.	.	O
and	DT	O
continued	NN	O
for	VBD	O
2,	VBN	O
5,	IN	O
10	CD	O
and	NNP	O
20	CC	O
minutes.	VBD	O
The	IN	O
time	,	O
10	,	O
minutes	CD	O
was	CC	O
set	CD	O
as	.	O
incubation	DT	O
time	NN	O
because	CD	O
a	NNS	O
straight-line	VBD	O
increase	VBN	O
was	IN	O
observed	NN	O
around	NN	O
10	IN	O
minutes	DT	O
in	JJ	O
incorporation	NN	O
of	VBD	O
phosphoric	VBN	O
acid	IN	O
into	CD	O
PI	NNS	O
in	IN	O
the	NN	O
assaying	IN	O
process	JJ	O
described	NN	O
below.	IN	O
After	NNP	O
completion	IN	O
of	DT	O
the	NN	O
reaction,	NN	O
PI	VBD	O
was	.	O
fractionated	IN	O
by	NN	O
the	IN	O
solvent	DT	O
extraction	,	O
method	NNP	O
and	VBD	O
finally	VBN	O
re-suspended	IN	O
in	DT	O
chloroform.	JJ	O
The	NN	O
suspension	NN	O
was	CC	O
developed	RB	O
by	JJ	O
thin	IN	O
layer	.	O
chromatography	DT	O
(TLC)	NN	O
and	VBD	O
the	VBN	O
radioactivity	IN	O
of	JJ	O
the	NN	O
reaction	NN	O
product	)	O
at	CC	O
the	DT	O
PI4P-position	NN	O
was	IN	O
assayed	DT	O
using	NN	O
an	NN	O
analyzer	IN	O
(trade	DT	O
name:	NNP	O
Bio-Image;	VBD	O
product	VBN	O
of	VBG	O
Fuji	DT	O
Photo	NN	O
Film	NN	O
Co.,	:	O
Ltd.).	:	O
FIG.	NN	O
1	IN	O
shows	NNP	O
the	NNP	O
results.	NNP	O
FIG.	,	O
1	.	O
is	.	O
an	CD	O
analytical	VBZ	O
diagram	DT	O
of	.	O
the	.	O
results	CD	O
of	VBZ	O
assaying	DT	O
the	JJ	O
radioactivity	NN	O
based	IN	O
on	DT	O
TLC	NNS	O
as	IN	O
mentioned	VBG	O
above.	DT	O
The	NN	O
right	VBN	O
lane	IN	O
(2)	NNP	O
is	IN	O
the	VBN	O
fraction	.	O
of	DT	O
Sf-9	JJ	O
cell	NN	O
cytoplasm	)	O
infected	VBZ	O
with	DT	O
the	NN	O
NPIK-containing	IN	O
virus,	NNP	O
whereas	NN	O
the	NN	O
left	VBN	O
lane	IN	O
(1)	DT	O
is	NNP	O
the	,	O
fraction	IN	O
of	DT	O
uninfected	NN	O
Sf-9	NN	O
cell	)	O
cytoplasm.	VBZ	O
Also,	DT	O
predetermined	NN	O
amounts	IN	O
of	JJ	O
Triton	NNP	O
X-100	NN	O
and	.	O
adenosine	,	O
were	VBD	O
added	NNS	O
to	IN	O
the	NNP	O
above	NNP	O
reaction	CC	O
system	NN	O
to	VBD	O
check	VBN	O
how	TO	O
such	DT	O
addition	JJ	O
would	NN	O
affect	NN	O
the	TO	O
PI4	VB	O
Kinase	WRB	O
activity.	JJ	O
The	NN	O
PI4	MD	O
Kinase	VB	O
activity	DT	O
was	NNP	O
assayed	NNP	O
in	.	O
the	DT	O
same	NNP	O
manner	NNP	O
as	NN	O
above.	VBD	O
FIG.	VBN	O
2	IN	O
shows	DT	O
the	JJ	O
results.	NN	O
The	IN	O
results	.	O
confirmed	.	O
that	CD	O
NPIK	VBZ	O
had	DT	O
a	.	O
typical	DT	O
PI4	NNS	O
Kinaze	VBD	O
activity	IN	O
accelerated	NNP	O
by	VBD	O
Triton	DT	O
X-100	JJ	O
and	NNP	O
inhibited	NNP	O
by	NN	O
adenosine.	VBN	O
Example	IN	O
10	NNP	O
Nel-Related	NNP	O
Protein	CC	O
Type	VBN	O
1	IN	O
(NRP1)	.	O
Gene	JJ	O
and	CD	O
Nel-Related	JJ	O
Protein	NNP	O
Type	NNP	O
2	CD	O
(NRP2)	)	O
Gene	NNP	O
(1)	CC	O
Cloning	NNP	O
and	NNP	O
DNA	NNP	O
Sequencing	CD	O
of	)	O
NRP1	NNP	O
Gene	)	O
and	NN	O
NRP2	CC	O
Gene	NNP	O
EGF-like	NNP	O
repeats	IN	O
have	NNP	O
been	NNP	O
found	CC	O
in	NNP	O
many	NNP	O
membrane	NNP	O
proteins	NNS	O
and	VBP	O
in	VBN	O
proteins	VBN	O
related	IN	O
to	JJ	O
growth	NN	O
regulation	NNS	O
and	CC	O
differentiation.	IN	O
This	NNS	O
motif	VBN	O
seems	TO	O
to	NN	O
be	NN	O
involved	CC	O
in	.	O
protein-protein	DT	O
interactions.	NN	O
Recently,	VBZ	O
a	TO	O
gene	VB	O
encoding	VBN	O
nel,	IN	O
a	JJ	O
novel	.	O
peptide	,	O
containing	DT	O
five	NN	O
EGF-like	VBG	O
repeats,	,	O
was	DT	O
cloned	JJ	O
from	NN	O
a	VBG	O
chick	CD	O
embryonic	JJ	O
cDNA	,	O
library	VBD	O
Matsuhashi,	VBN	B
S.,	IN	I
et	DT	I
al.,	NN	I
Dev.	JJ	I
Dynamics,	NN	I
203,	JJ	I
212-222	,	I
(1995)].[	,	O
This	FW	O
product	,	O
is	.	O
considered	,	O
to	,	O
be	CD	O
a	.	O
transmembrane	DT	O
molecule	NN	O
with	VBZ	O
its	VBN	O
EGF-like	TO	O
repeats	VB	O
in	DT	O
the	NN	O
extracellular	NN	O
domain.	IN	O
A	PRP$	O
4.5	JJ	O
kb	NNS	O
transcript	IN	O
(nel	DT	O
mRNA)	JJ	O
is	.	O
expressed	DT	O
in	CD	O
various	NN	O
tissues	NN	O
at	JJ	O
the	)	O
embryonic	VBZ	O
stage	VBN	O
and	IN	O
exclusively	JJ	O
in	NNS	O
brain	IN	O
and	DT	O
retina	JJ	O
after	NN	O
hatching.	CC	O
Following	RB	O
the	IN	O
procedure	NN	O
of	CC	O
Example	NN	O
1	IN	O
(1),	.	O
cDNA	VBG	O
clones	DT	O
were	NN	O
randomly	IN	O
selected	NNP	O
from	CD	O
a	,	O
human	JJ	O
fetal	NNS	O
brain	VBD	O
cDNA	RB	O
library	VBN	O
and	IN	O
subjected	DT	O
to	JJ	O
sequence	NN	O
analysis,	NN	O
followed	NN	O
by	NN	O
database	CC	O
searching.	VBN	O
As	TO	O
a	VB	O
result,	,	O
two	VBN	O
cDNA	IN	O
clones	NN	O
with	.	O
significantly	IN	O
high	DT	O
homology	,	O
to	CD	O
the	NN	O
above-mentioned	NNS	O
nel	IN	O
were	RB	O
found	JJ	O
and	NN	O
named	TO	O
GEN-073E07	DT	O
and	JJ	O
GEN-093E05,	NNS	O
respectively.	VBD	O
Since	VBN	O
both	CC	O
clones	VBN	O
were	NNP	O
lacking	CC	O
in	,	O
the	.	O
5′	IN	O
portion,	DT	O
5′	NNS	O
RACE	VBD	O
was	VBG	O
performed	IN	O
in	DT	O
the	CD	O
same	,	O
manner	CD	O
as	NNP	O
in	VBD	O
Example	VBN	O
2	IN	O
(2)	DT	O
to	JJ	O
obtain	NN	O
the	IN	O
entire	IN	O
coding	NNP	O
regions.	CD	O
As	)	O
for	TO	O
the	VB	O
primers	DT	O
for	JJ	O
5′	NN	O
RACE,	.	O
primers	IN	O
having	IN	O
an	DT	O
arbitrary	NNS	O
sequence	IN	O
obtained	CD	O
from	,	O
the	NNS	O
cDNA	VBG	O
sequences	DT	O
of	JJ	O
the	NN	O
above	VBN	O
clones	IN	O
were	DT	O
synthesized	NN	O
while	NNS	O
the	IN	O
anchor	DT	O
primer	JJ	O
attached	NNS	O
to	VBD	O
a	VBN	O
commercial	IN	O
kit	DT	O
was	NN	O
used	NN	O
as	VBN	O
such.	TO	O
5′	DT	O
RACE	JJ	O
clones	NN	O
obtained	VBD	O
from	VBN	O
the	IN	O
PCR	.	O
were	CD	O
sequenced	NNP	O
and	NNS	O
the	VBN	O
sequences	IN	O
seemingly	DT	O
covering	NNP	O
the	VBD	O
entire	VBN	O
coding	CC	O
regions	DT	O
of	NNS	O
both	RB	O
genes	VBG	O
were	DT	O
obtained.	JJ	O
These	NN	O
genes	NNS	O
were	IN	O
respectively	DT	O
named	NNS	O
nel-related	VBD	O
protein	.	O
type	DT	O
1	NNS	O
(NRP1)	VBD	O
gene	RB	O
and	VBN	O
nel-related	JJ	O
protein	NN	O
type	NN	O
2	CD	O
(NRP2)	)	O
gene.	NN	O
The	CC	O
NRP1	JJ	O
gene	NN	O
contains	NN	O
an	CD	O
open	)	O
reading	.	O
frame	DT	O
of	NNP	O
2,430	NN	O
nucleotides,	VBZ	O
as	DT	O
shown	JJ	O
under	NN	O
SEQ	NN	O
ID	IN	O
NO:35,	CD	O
the	,	O
amino	IN	O
acid	VBN	O
sequence	IN	O
deduced	NNP	O
therefrom	NNP	O
comprises	,	O
810	DT	O
amino	NN	O
acid	JJ	O
residues,	NN	O
as	VBD	O
shown	JJ	O
under	NNS	O
SEQ	CD	O
ID	NN	O
NO:34,	NN	O
and	,	O
the	IN	O
nucleotide	VBN	O
sequence	IN	O
of	NNP	O
the	NNP	O
entire	,	O
cDNA	CC	O
clone	DT	O
of	JJ	O
said	NN	O
NRP1	IN	O
gene	DT	O
comprises	JJ	O
2,977	NN	O
nucleotides,	NN	O
as	IN	O
shown	VBD	O
under	NNP	O
SEQ	NN	O
ID	VBZ	O
NO:36.	CD	O
On	,	O
the	IN	O
other	VBN	O
hand,	IN	O
the	NNP	O
NRP2	NNP	O
gene	.	O
contains	IN	O
an	DT	O
open	JJ	O
reading	,	O
frame	DT	O
of	NNP	O
2,448	NN	O
nucleotides,	VBZ	O
as	DT	O
shown	JJ	O
under	NN	O
SEQ	NN	O
ID	IN	O
NO:38,	CD	O
the	,	O
amino	IN	O
acid	VBN	O
sequence	IN	O
deduced	NNP	O
therefrom	NNP	O
comprises	,	O
816	DT	O
amino	NN	O
acid	JJ	O
residues,	NN	O
as	VBD	O
shown	JJ	O
under	NNS	O
SEQ	CD	O
ID	NN	O
NO:37,	NN	O
and	,	O
the	IN	O
nucleotide	VBN	O
sequence	IN	O
of	NNP	O
the	NNP	O
entire	,	O
cDNA	CC	O
clone	DT	O
of	JJ	O
said	NN	O
NRP2	IN	O
gene	DT	O
comprises	JJ	O
3,198	NN	O
nucleotides,	NN	O
as	IN	O
shown	VBD	O
under	NNP	O
SEQ	NN	O
ID	VBZ	O
NO:39.	CD	O
Furthermore,	,	O
the	IN	O
coding	VBN	O
regions	IN	O
were	NNP	O
amplified	NNP	O
by	.	O
RT-PCR	,	O
to	DT	O
exclude	NN	O
the	NNS	O
possibility	VBD	O
that	VBN	O
either	IN	O
of	NNP	O
the	TO	O
sequences	VB	O
obtained	DT	O
was	NN	O
a	IN	O
chimeric	DT	O
cDNA.	IN	O
The	DT	O
deduced	NNS	O
NRP1	VBN	O
and	VBD	O
NRP2	DT	O
gene	JJ	O
products	.	O
both	DT	O
showed	JJ	O
highly	NNP	O
hydrophobic	CC	O
N	NNP	O
termini	NN	O
capable	NNS	O
of	DT	O
functioning	VBD	O
as	RB	O
signal	JJ	O
peptides	NNP	O
for	NN	O
membrane	NN	O
insertion.	IN	O
As	VBG	O
compared	IN	O
with	JJ	O
chick	NNS	O
embryonic	IN	O
nel,	NN	O
they	.	O
both	IN	O
appeared	VBN	O
to	IN	O
have	NN	O
no	JJ	O
hydrophobic	,	O
transmembrane	PRP	O
domain.	DT	O
Comparison	VBD	O
among	TO	O
NRP1,	VB	O
NRP2	DT	O
and	JJ	O
nel	NN	O
with	.	O
respect	NNP	O
to	IN	O
the	,	O
deduced	NNP	O
peptide	CC	O
sequences	NNS	O
revealed	IN	O
that	NN	O
NRP2	TO	O
has	DT	O
80%	VBN	O
homology	NN	O
on	NNS	O
the	VBD	O
amino	IN	O
acid	NNP	O
level	VBZ	O
and	NN	O
is	NN	O
more	IN	O
closely	DT	O
related	NN	O
to	JJ	O
nel	NN	O
than	CC	O
NRP1	VBZ	O
having	RBR	O
50%	RB	O
homology.	VBN	O
The	TO	O
cysteine	NNS	O
residues	IN	O
in	NNP	O
cysteine-rich	VBG	O
domains	NN	O
and	.	O
EGF-like	DT	O
repeats	NN	O
were	NNS	O
found	IN	O
completely	JJ	O
conserved.	NNS	O
The	CC	O
most	JJ	O
remarkable	NNS	O
difference	VBD	O
between	VBN	O
the	RB	O
NRPs	.	O
and	DT	O
the	RBS	O
chick	JJ	O
protein	NN	O
was	IN	O
that	DT	O
the	NNP	O
human	CC	O
homologs	DT	O
lack	NN	O
the	NN	O
putative	VBD	O
transmembrane	IN	O
domain	DT	O
of	JJ	O
nel.	NNS	O
However,	VBP	O
even	DT	O
in	JJ	O
this	NN	O
lacking	NN	O
region,	IN	O
the	.	O
nucleotide	,	O
sequences	RB	O
of	IN	O
NRPs	DT	O
were	JJ	O
very	,	O
similar	DT	O
to	JJ	O
that	NNS	O
of	IN	O
nel.	NNP	O
Furthermore,	VBD	O
the	RB	O
two	JJ	O
NRPs	TO	O
each	DT	O
possessed	IN	O
six	.	O
EGF-like	,	O
repeats,	DT	O
whereas	CD	O
nel	NNP	O
has	DT	O
only	VBD	O
five.	CD	O
Other	JJ	O
unique	,	O
motifs	JJ	O
of	NN	O
nel	VBZ	O
as	RB	O
reported	.	O
by	JJ	O
Matsuhashi	JJ	O
et	NNS	O
al.	IN	O
Matsuhashi,	NN	B
S.,	IN	I
et	VBN	I
al.,	IN	I
Dev.	NNP	I
Dynamics,	CC	I
203,	.	I
212-222	,	I
(1995)]	,	I
[were	FW	O
also	,	O
found	.	O
in	,	O
the	,	O
NRPs	CD	O
at	NN	O
equivalent	VBD	O
positions.	RB	O
Since	VBN	O
as	IN	O
mentioned	DT	O
above,	NNP	O
it	IN	O
was	JJ	O
shown	.	O
that	IN	O
the	RB	O
two	VBN	O
deduced	,	O
NRP	PRP	O
peptides	VBD	O
are	VBN	O
not	IN	O
transmembrane	DT	O
proteins,	CD	O
the	VBD	O
NRPs	NNP	O
might	NNS	O
be	VBP	O
secretory	RB	O
proteins	JJ	O
or	,	O
proteins	DT	O
anchored	NNP	O
to	MD	O
membranes	VB	O
as	JJ	O
a	NNS	O
result	CC	O
of	NNS	O
posttranslational	VBN	O
modification.	TO	O
The	NNS	O
present	IN	O
inventors	DT	O
speculate	NN	O
that	IN	O
NRPs	JJ	O
might	.	O
function	DT	O
as	JJ	O
ligands	NNS	O
by	VBP	O
stimulating	IN	O
other	NNP	O
molecules	MD	O
such	VB	O
as	IN	O
EGF	NNS	O
receptors.	IN	O
The	VBG	O
present	JJ	O
inventors	NNS	O
further	JJ	O
found	IN	O
that	NNP	O
an	.	O
extra	DT	O
EGF-like	JJ	O
repeat	NNS	O
could	RBR	O
be	VBD	O
encoded	IN	O
in	DT	O
nel	JJ	O
upon	JJ	O
frame	NN	O
shifting	MD	O
of	VB	O
the	VBN	O
membrane	IN	O
domain	NNS	O
region	IN	O
of	JJ	O
nel.	NN	O
When	IN	O
paralleled	DT	O
and	NN	O
compared	NN	O
with	NN	O
NRP2	IN	O
and	.	O
nel,	WRB	O
the	VBN	O
frame-shifted	CC	O
amino	VBN	O
acid	IN	O
sequence	NNP	O
showed	CC	O
similarities	,	O
over	DT	O
the	JJ	O
whole	NN	O
range	NN	O
of	NN	O
NRP2	VBD	O
and	NNS	O
of	IN	O
nel,	DT	O
suggesting	JJ	O
that	NN	O
NRP2	IN	O
might	NNP	O
be	CC	O
a	IN	O
human	,	O
counterpart	VBG	O
of	IN	O
nel.	NNP	O
In	MD	O
contrast,	VB	O
NRP1	DT	O
is	JJ	O
considered	NN	O
to	IN	O
be	.	O
not	IN	O
a	,	O
human	NNP	O
counterpart	VBZ	O
of	VBN	O
nel	TO	O
but	VB	O
a	RB	O
homologous	DT	O
gene.	JJ	O
(2)	NN	O
Northern	IN	O
Blot	NNS	O
Analysis	CC	O
Northern	DT	O
blot	JJ	O
analysis	.	O
was	)	O
carried	NNP	O
out	NNP	O
as	NNP	O
described	NNP	O
in	NN	O
Example	NN	O
1	VBD	O
(2).	VBN	O
Thus,	RP	O
the	IN	O
entire	VBN	O
sequences	IN	O
of	NNP	O
both	CD	O
clones	.	O
cDNAs	,	O
were	DT	O
amplified	JJ	O
by	NNS	O
PCR,	IN	O
the	DT	O
PCR	NNS	O
products	VBP	O
were	VBD	O
purified	VBN	O
and	IN	O
labeled	,	O
with	DT	O
[32P]-dCTP	NNP	O
(random-primed	NNS	O
DNA	VBD	O
labeling	VBN	O
kit,	CC	O
Boehringer	VBN	O
Mannheim)	IN	O
and	NNP	O
human	JJ	O
normal	NNP	O
tissues	VBG	O
were	,	O
examined	NNP	O
for	)	O
NRP	CC	O
mRNA	JJ	O
expression	JJ	O
using	NNS	O
an	VBD	O
MTN	VBN	O
blot	IN	O
with	NNP	O
the	NN	O
labeled	NN	O
products	VBG	O
as	DT	O
two	NNP	O
probes.	NN	O
Sixteen	IN	O
adult	DT	O
tissues	JJ	O
and	NNS	O
four	IN	O
human	CD	O
fetal	.	O
tissues	JJ	O
were	NN	O
examined	NNS	O
for	CC	O
the	CD	O
expression	JJ	O
pattern	JJ	O
of	NNS	O
two	VBD	O
NRPs.	VBN	O
As	IN	O
a	DT	O
result	NN	O
of	NN	O
the	IN	O
Northern	CD	O
blot	.	O
analysis,	IN	O
it	DT	O
was	NN	O
found	IN	O
that	DT	O
a	NNP	O
3.5	NN	O
kb	,	O
transcript	PRP	O
of	VBD	O
NRP1	VBN	O
was	IN	O
weakly	DT	O
expressed	CD	O
in	NN	O
fetal	NN	O
and	IN	O
adult	NNP	O
brain	VBD	O
and	RB	O
kidney.	VBN	O
A	IN	O
3.6	NN	O
kb	CC	O
transcript	NN	O
of	NN	O
NRP2	CC	O
was	.	O
strongly	DT	O
expressed	CD	O
in	NN	O
adult	NN	O
and	IN	O
fetal	NNP	O
brain	VBD	O
alone,	RB	O
with	VBN	O
weak	IN	O
expression	NN	O
thereof	CC	O
in	JJ	O
fetal	NN	O
kidney	,	O
as	IN	O
well.	JJ	O
This	NN	O
suggests	NN	O
that	IN	O
NRPs	JJ	O
might	NN	O
play	IN	O
a	.	O
brain-specific	DT	O
role,	VBZ	O
for	IN	O
example	NNP	O
as	MD	O
signal	VB	O
molecules	DT	O
for	JJ	O
growth	,	O
regulation.	IN	O
In	NN	O
addition,	IN	O
these	JJ	O
genes	NNS	O
might	IN	O
have	NN	O
a	.	O
particular	IN	O
function	,	O
in	DT	O
kidney.	NNS	O
(3)	MD	O
Chromosomal	VB	O
Mapping	DT	O
of	JJ	O
NRP1	NN	O
Gene	IN	O
and	.	O
NRP2	)	O
Gene	NNP	O
by	NNP	O
Fish	IN	O
Chromosomal	NNP	O
mapping	NNP	O
of	CC	O
the	NNP	O
NRP1	NNP	O
gene	IN	O
and	NNP	O
NRP2	NNP	O
gene	NN	O
was	IN	O
performed	DT	O
by	NNP	O
FISH	NN	O
as	CC	O
described	NNP	O
in	NN	O
Example	VBD	O
1	VBN	O
(3).	IN	O
As	NNP	O
a	IN	O
result,	VBN	O
it	IN	O
was	NNP	O
revealed	CD	O
that	.	O
the	IN	O
chromosomal	DT	O
locus	,	O
of	PRP	O
the	VBD	O
NRP1	VBN	O
gene	IN	O
is	DT	O
localized	JJ	O
to	NN	O
11p15.1-p15.2	IN	O
and	DT	O
the	NNP	O
chromosomal	NN	O
locus	VBZ	O
of	VBN	O
the	TO	O
NRP2	CD	O
gene	CC	O
to	DT	O
12q13.11-q13.12.	JJ	O
According	NN	O
to	IN	O
the	DT	O
present	NNP	O
invention,	NN	O
the	TO	O
novel	.	O
human	VBG	O
NRP1	TO	O
gene	DT	O
and	JJ	O
NRP2	,	O
gene	DT	O
are	JJ	O
provided	JJ	O
and	NNP	O
the	NN	O
use	CC	O
of	NNP	O
said	NN	O
genes	VBP	O
makes	VBN	O
it	CC	O
possible	DT	O
to	NN	O
detect	IN	O
the	VBD	O
expression	NNS	O
of	VBZ	O
said	PRP	O
genes	JJ	O
in	TO	O
various	VB	O
tissues	DT	O
and	NN	O
produce	IN	O
the	VBD	O
human	NNS	O
NRP1	IN	O
and	JJ	O
NRP2	NNS	O
proteins	CC	O
by	VB	O
the	DT	O
technology	JJ	O
of	NNP	O
genetic	CC	O
engineering.	NNP	O
They	NNS	O
can	IN	O
further	DT	O
be	NN	O
used	IN	O
in	JJ	O
the	.	O
study	PRP	O
of	MD	O
the	RB	O
brain	VB	O
neurotransmission	VBN	O
system,	IN	O
diagnosis	DT	O
of	NN	O
various	IN	O
diseases	DT	O
related	NN	O
to	NN	O
neurotransmission	,	O
in	NN	O
the	IN	O
brain,	JJ	O
and	NNS	O
the	VBN	O
screening	TO	O
and	NN	O
evaluation	IN	O
of	DT	O
drugs	,	O
for	CC	O
the	DT	O
treatment	NN	O
and	CC	O
prevention	NN	O
of	IN	O
such	NNS	O
diseases.	IN	O
Furthermore,	DT	O
the	NN	O
possibility	CC	O
is	NN	O
suggested	IN	O
that	JJ	O
these	.	O
EGF	,	O
domain-containing	DT	O
NRPs	NN	O
act	VBZ	O
as	VBN	O
growth	IN	O
factors	DT	O
in	NNP	O
brain,	NN	O
hence	NNP	O
they	NN	O
may	IN	O
be	NN	O
useful	NNS	O
in	IN	O
the	,	O
diagnosis	NN	O
and	PRP	O
treatment	MD	O
of	VB	O
various	JJ	O
kinds	IN	O
of	DT	O
intracerebral	NN	O
tumor	CC	O
and	NN	O
effective	IN	O
in	JJ	O
nerve	NNS	O
regeneration	IN	O
in	JJ	O
cases	NN	O
of	CC	O
degenerative	JJ	O
nervous	IN	O
diseases.	DT	O
Example	NN	O
11	IN	O
GSPT1-Related	NNS	O
Protein	IN	O
(GSPT1-TK)	JJ	O
Gene	JJ	O
(1)	.	O
GSPT1-TK	JJ	O
Gene	CD	O
Cloning	JJ	O
and	NNP	O
DNA	)	O
Sequencing	NNP	O
The	)	O
human	NNP	O
GSPT1	NNP	O
gene	NNP	O
is	CC	O
one	NNP	O
of	VBG	O
the	DT	O
human	JJ	O
homologous	NNP	O
genes	NN	O
of	VBZ	O
the	CD	O
yeast	IN	O
GST1	DT	O
gene	JJ	O
that	JJ	O
encodes	NNS	O
the	IN	O
GTP-binding	DT	O
protein	NN	O
essential	NNP	O
for	NN	O
the	WDT	O
G1	VBZ	O
to	DT	O
S	NNP	O
phase	NN	O
transition	NN	O
in	IN	O
the	DT	O
cell	NNP	O
cycle.	TO	O
The	NNP	O
yeast	NN	O
GST1	NN	O
gene,	IN	O
first	DT	O
identified	NN	O
as	.	O
a	DT	O
protein	NN	O
capable	NNP	O
of	,	O
complementing	RB	O
a	VBN	O
temperature-sensitive	IN	O
gst1	DT	O
(G1-to-S	NN	O
transition)	JJ	O
mutant	IN	O
of	VBG	O
Saccharomyces	DT	O
cerevisiae,	JJ	O
was	NN	O
isolated	NNP	O
from	)	O
a	NN	O
yeast	IN	O
genomic	NNP	O
library	,	O
Kikuchi,	VBD	B
Y.,	VBN	I
Shimatake,	IN	I
H.	DT	I
and	JJ	I
Kikuchi,	JJ	I
A.,	NN	I
EMBO	,	I
J.,	,	I
7,	,	I
1175-1182	NNP	I
(1988)]	CC	I
[and	,	O
encoded	,	O
a	NNP	O
protein	,	O
with	,	O
a	CD	O
target	NN	O
site	CC	O
of	VBD	O
cAMP-dependent	DT	O
protein	NN	O
kinases	IN	O
and	DT	O
a	NN	O
GTPase	NN	O
domain.	IN	O
The	JJ	O
human	NN	O
GSPT1	NNS	O
gene	CC	O
was	DT	O
isolated	NNP	O
from	.	O
a	DT	O
KB	JJ	O
cell	NNP	O
cDNA	NN	O
library	VBD	O
by	VBN	O
hybridization	IN	O
using	DT	O
the	NNP	O
yeast	NN	O
GST1	NN	O
gene	NN	O
as	IN	O
a	NN	O
probe	VBG	O
Hoshino,	DT	B
S.,	NN	I
Miyazawa,	NNP	I
H.,	NN	I
Enomoto,	IN	I
T.,	DT	I
Hanaoka,	NN	I
F.,	,	I
Kikuchi,	,	I
Y.,	,	I
Kikuchi,	,	I
A.	,	I
and	,	I
Ui,	,	I
M.,	,	I
EMBO	,	I
J.,	,	I
8,	,	I
3807-3814	NNP	I
(1989)].[	CC	O
The	,	O
deduced	,	O
protein	NNP	O
of	,	O
said	,	O
GSPT1	CD	O
gene,	.	O
like	DT	O
yeast	JJ	O
GST1,	NN	O
has	IN	O
a	VBD	O
GTP-binding	NNP	O
domain	,	O
and	IN	O
a	NN	O
GTPase	,	O
activity	VBZ	O
center,	DT	O
and	JJ	O
plays	NN	O
an	CC	O
important	DT	O
role	NNP	O
in	NN	O
cell	,	O
proliferation.	CC	O
Furthermore,	VBZ	O
a	DT	O
breakpoint	JJ	O
for	NN	O
chromosome	IN	O
re-arrangement	NN	O
has	.	O
been	,	O
observed	DT	O
in	NN	O
the	IN	O
GSPT1	NN	O
gene	NN	O
located	VBZ	O
in	VBN	O
the	VBN	O
chromosomal	IN	O
locus	DT	O
16p13.3	NNP	O
in	NN	O
patients	VBN	O
with	IN	O
acute	DT	O
nonlymphocytic	JJ	O
leukemia	NN	O
(ANLL)	CD	O
Ozawa,	IN	B
K.,	NNS	I
Murakami,	IN	I
Y.,	JJ	I
Eki,	JJ	I
T.,	NN	I
Yokoyama,	)	I
K.	,	I
Soeda,	,	I
E.,	,	I
Hoshino,	,	I
S.	,	I
Ui,	,	I
M.	,	I
and	NNP	I
Hanaoka,	,	I
F.,	,	I
Somatic	,	I
Cell	NNP	I
and	,	I
Molecular	NNP	I
Genet.,	CC	I
18,	,	I
189-194	,	I
(1992)].[	NNP	O
cDNA	NNP	O
clones	CC	O
were	NNP	O
randomly	,	O
selected	,	O
from	CD	O
a	.	O
human	NN	O
fetal	NNS	O
brain	VBD	O
cDNA	RB	O
library	VBN	O
and	IN	O
subjected	DT	O
to	JJ	O
sequence	NN	O
analysis	NN	O
as	NN	O
described	NN	O
in	CC	O
Example	VBN	O
1	TO	O
(1)	VB	O
and	NN	O
database	IN	O
searching	VBN	O
was	IN	O
performed	NNP	O
and,	CD	O
as	)	O
a	CC	O
result,	NN	O
a	NN	O
clone	VBD	O
having	VBN	O
a	,	O
0.3	IN	O
kb	DT	O
cDNA	,	O
sequence	DT	O
highly	NN	O
homologous	VBG	O
to	DT	O
the	CD	O
above-mentioned	NN	O
GSPT1	NN	O
gene	NN	O
was	RB	O
found	JJ	O
and	TO	O
named	DT	O
GEN-077A09.	JJ	O
The	NNP	O
GEN-077A09	NN	O
clone	VBD	O
seemed	VBN	O
to	CC	O
be	VBN	O
lacking	.	O
in	DT	O
the	NNP	O
5′	NN	O
region,	VBD	O
so	TO	O
that	VB	O
5′	VBG	O
RACE	IN	O
was	DT	O
carried	CD	O
out	,	O
in	IN	O
the	DT	O
same	CD	O
manner	NNP	O
as	VBD	O
in	VBN	O
Example	RP	O
2	IN	O
(2)	DT	O
to	JJ	O
obtain	NN	O
the	IN	O
entire	IN	O
coding	NNP	O
region.	CD	O
The	)	O
primers	TO	O
used	VB	O
for	DT	O
the	JJ	O
5′	NN	O
RACE	.	O
were	DT	O
P1	NNS	O
and	VBN	O
P2	IN	O
primers	DT	O
respectively	CD	O
having	NNP	O
the	VBD	O
nucleotide	NNP	O
sequences	CC	O
shown	NNP	O
in	NNS	O
Table	RB	O
11	VBG	O
as	DT	O
designed	JJ	O
based	NNS	O
on	VBN	O
the	IN	O
known	JJ	O
cDNA	CD	O
sequence	IN	O
of	VBN	O
the	VBN	O
above-mentioned	IN	O
cDNA,	DT	O
and	VBN	O
the	NN	O
anchor	NN	O
primer	IN	O
used	DT	O
was	JJ	O
the	,	O
one	CC	O
attached	DT	O
to	NN	O
the	NN	O
commercial	VBN	O
kit.	VBD	O
Thirtyfive	DT	O
cycles	CD	O
of	VBN	O
PCR	TO	O
were	DT	O
performed	JJ	O
under	.	O
the	JJ	O
following	NNS	O
conditions:	IN	O
94°	NNP	O
C.	VBD	O
for	VBN	O
45	IN	O
seconds,	DT	O
58°	JJ	O
C.	:	O
for	CD	O
45	NNP	O
seconds	IN	O
and	CD	O
72°	,	O
C.	CD	O
for	NNP	O
2	IN	O
minutes.	CD	O
Finally,	NNS	O
elongation	CC	O
reaction	CD	O
was	NNP	O
carried	IN	O
out	CD	O
at	.	O
72°	,	O
C.	NN	O
for	NN	O
7	VBD	O
minutes.	VBN	O
Several	RP	O
of	IN	O
the	CD	O
5′	NNP	O
RACE	IN	O
clones	CD	O
obtained	.	O
from	JJ	O
the	IN	O
above	DT	O
PCR	CD	O
were	NNP	O
sequenced	NNS	O
and	VBN	O
the	IN	O
base	DT	O
sequence	JJ	O
of	NNP	O
that	VBD	O
cDNA	VBN	O
clone	CC	O
showing	DT	O
overlapping	JJ	O
between	NN	O
the	IN	O
5′	DT	O
RACE	NN	O
clones	NN	O
and	VBG	O
the	VBG	O
GEN-077A09	IN	O
clone	DT	O
was	CD	O
determined	NNP	O
to	NNS	O
thereby	CC	O
reveal	DT	O
the	NNP	O
sequence	NN	O
regarded	VBD	O
as	VBN	O
covering	TO	O
the	VB	O
entire	VB	O
coding	DT	O
region.	NN	O
This	VBD	O
was	IN	O
named	VBG	O
GSPT1-related	DT	O
protein	JJ	O
“GSPT1-TK	NN	O
gene”.	.	O
The	DT	O
GSPT1-TK	VBD	O
gene	VBN	O
was	JJ	O
found	NN	O
to	JJ	O
contain	.	O
an	DT	O
open	NNP	O
reading	NN	O
frame	VBD	O
of	VBN	O
1,497	TO	O
nucleotides,	VB	O
as	DT	O
shown	JJ	O
under	NN	O
SEQ	NN	O
ID	IN	O
NO:41.	CD	O
The	,	O
amino	IN	O
acid	VBN	O
sequence	IN	O
deduced	NNP	O
therefrom	NNP	O
contained	.	O
499	DT	O
amino	NN	O
acid	JJ	O
residues,	NN	O
as	VBD	O
shown	NNS	O
under	VBD	O
SEQ	CD	O
ID	NN	O
NO:40.	NN	O
The	,	O
nucleotide	IN	O
sequence	VBN	O
of	IN	O
the	NNP	O
whole	NNP	O
cDNA	.	O
clone	DT	O
of	JJ	O
the	NN	O
GSPT1-TK	IN	O
gene	DT	O
was	JJ	O
found	NN	O
to	NN	O
comprise	IN	O
2,057	DT	O
nucleotides,	NNP	O
as	NN	O
shown	VBD	O
under	VBN	O
SEQ	TO	O
ID	VB	O
NO:42,	CD	O
and	,	O
the	IN	O
molecular	VBN	O
weight	IN	O
was	NNP	O
calculated	NNP	O
at	,	O
55,740	CC	O
daltons.	DT	O
The	JJ	O
first	NN	O
methionine	VBD	O
code	VBN	O
(ATG)	IN	O
in	CD	O
the	.	O
open	DT	O
reading	JJ	O
frame	NN	O
had	NN	O
no	)	O
in-frame	IN	O
termination	DT	O
codon	JJ	O
but	NN	O
this	NN	O
ATG	VBD	O
was	DT	O
surrounded	JJ	O
by	NN	O
a	NN	O
sequence	CC	O
similar	DT	O
to	NNP	O
the	VBD	O
Kozak	VBN	O
consensus	IN	O
sequence	DT	O
for	NN	O
translational	JJ	O
initiation.	TO	O
Therefore,	DT	O
it	NNP	O
was	NN	O
concluded	NN	O
that	IN	O
this	JJ	O
ATG	.	O
triplet	,	O
occurring	PRP	O
in	VBD	O
positions	VBN	O
144-146	IN	O
of	DT	O
the	NNP	O
relevant	NN	O
sequence	VBG	O
is	IN	O
the	NNS	O
initiation	CD	O
codon.	IN	O
Furthermore,	DT	O
a	JJ	O
polyadenylation	NN	O
signal,	VBZ	O
AATAAA,	DT	O
was	NN	O
observed	.	O
13	,	O
nucleotides	DT	O
upstream	NN	O
from	,	O
the	,	O
polyadenylation	VBD	O
site.	VBN	O
Human	CD	O
GSPT1-TK	NNS	O
contains	RB	O
a	IN	O
glutamic	DT	O
acid	NN	O
rich	.	O
region	JJ	O
near	NNP	O
the	VBZ	O
N	DT	O
terminus,	JJ	O
and	NN	O
18	JJ	O
of	NN	O
20	IN	O
glutamic	DT	O
acid	NNP	O
residues	,	O
occurring	CC	O
in	CD	O
this	IN	O
region	CD	O
of	JJ	O
human	NN	O
GSPT1-TK	NNS	O
are	VBG	O
conserved	IN	O
and	DT	O
align	NN	O
perfectly	IN	O
with	JJ	O
those	NNP	O
of	VBP	O
the	VBN	O
human	CC	O
GSPT1	VBZ	O
protein.	RB	O
Several	IN	O
regions	DT	O
(G1,	IN	O
G2,	DT	O
G3,	JJ	O
G4	NNP	O
and	.	O
G5)	JJ	O
of	NNS	O
GTP-binding	,	O
proteins	,	O
that	,	O
are	NNP	O
responsible	CC	O
for	)	O
guanine	IN	O
nucleotide	NNP	O
binding	NNS	O
and	WDT	O
hydrolysis	VBP	O
were	JJ	O
found	IN	O
conserved	JJ	O
in	JJ	O
the	NN	O
GSPT1-TK	CC	O
protein	NN	O
just	VBD	O
as	VBN	O
in	VBN	O
the	IN	O
human	DT	O
GSPT1	NNP	O
protein.	NN	O
Thus,	RB	O
the	IN	O
DNA	IN	O
sequence	DT	O
of	JJ	O
human	NNP	O
GSPT1-TK	.	O
was	,	O
found	DT	O
89.4%	NNP	O
identical,	NN	O
and	IN	O
the	JJ	O
amino	NNP	O
acid	VBD	O
sequence	VBN	O
deduced	NN	O
therefrom	,	O
92.4%	CC	O
identical,	DT	O
with	NN	O
the	JJ	O
corresponding	NN	O
sequence	VBD	O
of	IN	O
human	NN	O
GSPT1	,	O
which	IN	O
supposedly	DT	O
plays	JJ	O
an	NN	O
important	IN	O
role	JJ	O
in	NNP	O
the	WDT	O
G1	RB	O
to	VBZ	O
S	DT	O
phase	JJ	O
transition	NN	O
in	IN	O
the	DT	O
cell	NNP	O
cycle.	TO	O
Said	NNP	O
amino	NN	O
acid	NN	O
sequence	IN	O
showed	DT	O
50.8%	NN	O
identity	.	O
with	NNP	O
that	NN	O
of	NN	O
yeast	NN	O
GST1.	VBD	O
(2)	NN	O
Northern	NN	O
Blot	IN	O
Analysis	DT	O
Northern	IN	O
blot	NN	O
analysis	.	O
was	)	O
carried	NNP	O
out	NNP	O
as	NNP	O
described	NNP	O
in	NN	O
Example	NN	O
1	VBD	O
(2).	VBN	O
Thus,	RP	O
the	IN	O
GEN-077A09	VBN	O
cDNA	IN	O
clone	NNP	O
was	CD	O
amplified	.	O
by	,	O
PCR,	DT	O
the	NNP	O
PCR	NN	O
product	NN	O
was	VBD	O
purified	VBN	O
and	IN	O
labeled	,	O
with	DT	O
[32P]-dCTP	NNP	O
(random-primed	NN	O
DNA	VBD	O
labeling	VBN	O
kit,	CC	O
Boehringer	VBN	O
Mannheim),	IN	O
and	NNP	O
normal	JJ	O
human	NNP	O
tissues	VBG	O
were	,	O
examined	NNP	O
for	,	O
the	CC	O
expression	JJ	O
of	JJ	O
GSPT1-TK	NNS	O
mRNA	VBD	O
therein	VBN	O
using	IN	O
an	DT	O
MTN	NN	O
blot	IN	O
with	NNP	O
the	NN	O
labeled	NN	O
product	VBG	O
as	DT	O
a	NNP	O
probe.	NN	O
As	IN	O
a	DT	O
result	JJ	O
of	NN	O
the	IN	O
Northern	DT	O
blot	.	O
analysis,	IN	O
a	DT	O
2.7	NN	O
kb	IN	O
major	DT	O
transcript	NNP	O
was	NN	O
detected	,	O
in	DT	O
various	CD	O
tissues.	NN	O
The	JJ	O
level	NN	O
of	VBD	O
human	VBN	O
GSPT1-TK	IN	O
expression	JJ	O
seemed	.	O
highest	DT	O
in	NN	O
brain	IN	O
and	JJ	O
in	NNP	O
testis.	NN	O
(3)	VBD	O
Chromosome	JJS	O
Mapping	IN	O
of	NN	O
GSPT1-TK	CC	O
Gene	IN	O
by	.	O
Fish	)	O
Chromosome	NNP	O
mapping	NNP	O
of	IN	O
the	NNP	O
GSPT1-TK	NNP	O
gene	IN	O
was	NNP	O
performed	NNP	O
by	NN	O
FISH	IN	O
as	DT	O
described	NNP	O
in	NN	O
Example	VBD	O
1	VBN	O
(3).	IN	O
As	NNP	O
a	IN	O
result,	VBN	O
it	IN	O
was	NNP	O
found	CD	O
that	.	O
the	IN	O
GSPT1-TK	DT	O
gene	,	O
is	PRP	O
localized	VBD	O
at	VBN	O
the	IN	O
chromosomal	DT	O
locus	NNP	O
19p13.3.	NN	O
In	VBZ	O
this	VBN	O
chromosomal	IN	O
localization	DT	O
site,	JJ	O
reciprocal	NN	O
location	.	O
has	IN	O
been	DT	O
observed	JJ	O
very	NN	O
frequently	,	O
in	JJ	O
cases	NN	O
of	VBZ	O
acute	VBN	O
lymphocytic	VBN	O
leukemia	RB	O
(ALL)	RB	O
and	IN	O
acute	NNS	O
myeloid	IN	O
leukemia	JJ	O
(AML).	JJ	O
In	NN	O
addition,	)	O
it	CC	O
is	JJ	O
reported	NN	O
that	NN	O
acute	.	O
nonlymphocytic	IN	O
leukemia	,	O
(ANLL)	PRP	O
is	VBZ	O
associated	VBN	O
with	IN	O
rearrangements	JJ	O
involving	JJ	O
the	NN	O
human	)	O
GSPT1	VBZ	O
region	VBN	O
Ozawa,	IN	B
K.,	NNS	I
Murakami,	VBG	I
Y.,	DT	I
Eki,	JJ	I
T.,	NNP	I
Yokoyama,	NN	I
K.,	,	I
Soeda,	,	I
E.,	,	I
Hoshino,	,	I
S.,	,	I
Ui,	,	I
M.	,	I
and	,	I
Hanaoka,	,	I
F.,	,	I
Somatic	,	I
Cell	,	I
and	,	I
Molecular	NNP	I
Genet.,	CC	I
18,	,	I
189-194	,	I
(1992)].